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PATHOPHYSIOLOGY OF AGING 
 
A1 The Longevity Associated Variant of BPIFB4: A Possible 
Link Between Human Longevity, Cardiovascular Homeostasis  and 
Cellular Metabolism 
A.A. Puca1, C.C. Spinelli1, F. Villa2, A. Maciag2, A. Carrizzo1, A. Ferrario3, 
C. Vecchione1 
1University of Salerno, Baronissi, Italy; 2Multimedica IRCCS, Milano, Italy; 
3ITB-CNR, Segrate, Italy 
Background: Long-living individuals (LLIs) are genetically predisposed to 
delay aging and avoid cardiovascular disease. Indeed, our recent genome 
wide assay (GWA) study on exceptional longevity identified a four-SNPs 
haplotype (Longevity Associated Variant-LAV) in the BPIFB4 gene that 
reverted old mice decline of endothelial nitric oxide synthase activity and 
endothelial function and potentiated homing of CD34+LSK cells and 
revascularization in limb ischemia. To be noted, BPIFB4 overexpression 
activates heat shock proteins (HSPs), translation, ribosome biogenesis, 
and spliceosome. These highly energy-demanding processes are typical 
of cells under stress, stem or tumoural cells, where BPIFB4 is expressed, 
and that are exposed to hypoxic environment. 
Methods: MitoSOX and Sea Horse for radical stress and cell metabolism. 
In vivo treatment with adeno-associated virus containing GFP or LAV-
BPIFB4 in models of atherosclerosis and brain ischemia. 
Results: We have found that BPIFB4 is expressed in hypoxia and its 
overexpression activates OX phos and aerobic glycolysis, induces 
reduction of mitochondrial radical stress and differentiation processes. In 
vivo, LAV-BPIFB4 prevents atherosclerosis and reduces brain ischemia 
damage. 
Conclusions: LAV-BPIFB4 is a key protein in the regulation of 
cardiovascular homeostasis. 
 
A2 Pasta With Opuntia: A Functional Food with 
Hypoglycemic and Antioxidant Effects 
A. Aiello1, G. Accardi1, G. Candore1, C. Carru2, C.M. Gambino1, A. 
Nicosia3, C. Caruso1 
1University of Palermo, Palermo, Italy; 2University of Sassari, Sassari, 
Italy; 3IAMC-CNR, Torretta Granitola, Italy 
Background: Opuntia ficus-indica is a typical plant of the Mediterranean 
basin. Its leaves, the cladodes, contain mainly pectins, carotenotenoids 
and polysaccharides, and their extracts, rich in fibers, have health positive 
effects in animal models. However, little is known in humans.  The aim of 
this study was to evaluate the effect of pasta with Opuntia extracts on 
hematochemical, anti-inflammatory, antioxidant and anthropometric 
parameters to test its potential hypoglycemic, hypocholesterolemic and 
weight loss properties and its possible modulator action on gut microbiota. 
Methods: We have performed a nutritional intervention on 39 participants 
with metabolic syndrome, administering 500 gr/week of pasta with Opuntia 
for 30 days. At baseline, and after 30 days, blood tests were assessed. 
Additionally, qPCR assays were carried out to address any variations in 
the amount of Lactobacilli population from fecal samples. 
Results: After 30 days of pasta with Opuntia administration, a statistically 
significant decrease in serum levels of glucose, uric acid, total cholesterol, 
and nitrogen was observed. The results also showed a statistically 
significant variation of oxidative stress markers, such as SH protein, 
paraoxonase, and reduced glutathione, demonstrating its antioxidant 
effects. However, no changes were observed in anthropometric 
parameters while the neopterin, a marker of macrophage activation, 
increased its levels. Interestingly, a statistically significant reduction in 
Lactobacilli amount was measured. 
Conclusions: The study suggests hypoglycemic and antioxidant effects 
of pasta with Opuntia can be considered a functional food. 
 
A3 Associations of MMP-9 and MMP-2 Polymorphisms with 
the Risk, Severity, Short- and Long-Term Complications of 
Degenerative Mitral Valve Diseases:  A 4.8-Year Prospective Cohort 
Study 
C.R. Balistreri1, A. Alllegra1, F. Crapanzano1, C. Pisano1, O.F. Triolo1, V. 
Argano1, G. Candore1, D. Lio1, G. Ruvolo2 
1University of Palermo, Palermo, Italy; 2University of Rome 'Tor Vergata', 
Roma, Italy 
Background: Degenerative forms of mitral valve diseases (MVDs) are  
complex pathologies. Thus, it is difficult to make generalizations about 
MVD pathways or genetic risk factors. However, a key role of 
metalloproteinases (MMPs) in their pathophysiology is emerging. Thus, 
we performed a study to assess  eventual associations of some functional 
SNPs in MMP-2 and MMP-9 genes with MVD risk, symptom severity and 
short- and long-term (4.8 years) complications. 
Methods: For this purpose, 90 patients and two control groups were 
genotyped for MMP-2 and MMP-9 gene SNPs, and systemic levels of pro-
atrial natriuretic peptide (ANP), and two enzymes were quantified and 
correlated to the MMP-2 and MMP-9 SNPs. In addition, associations 
between these SNPs and symptom severity and short- and long-term 
complications were evaluated. 
Results: Interestingly, rs3918242 MMP-9 and rs2285053 MMP-2 SNPs 
were significantly represented in cases compared to two control groups, 
and were associated with a higher MVD risk. Cases stratified for New 
York Heart Association (NYHA) symptoms, and particularly NYHA III+IV, 
with rs3918242 CT+TT MMP-9 and rs2285053CT+TT genotypes also 
showed higher severity related to significant higher systemic levels of 
MMP enzymes and pro-ANP at enrollment and 4.8-year follow-up times. 
In addition, cases with these genotypes, and particularly NYHAIII+IV, had 
a very significant percentage of complications, particularly at the 4.8-year 
follow-up. Surprisingly, 20% of patient controls developed MVD at 4.8-
year follow-up and were carriers of these genotypes. 
Conclusions: The associations observed seem to suggest that the two 
SNPs  might represent useful biomarkers and targets for preventing and 
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monitoring MVDs, leading to a more appropriate  management and 
outcome. 
 
A4 Markers of Plaque Vulnerability Induced by Oxidized 
Lipids 
S. Gargiulo1, D. Rossin1, E. Staurenghi1, G. Testa1, P. Gamba1, G. Poli1, 
G. Leonarduzzi1 
1University of Turin, Orbassano, Italy 
Background: The driving force of atherogenesis is chronic inflammation, 
which promotes the development of a vulnerable plaque responsible for 
acute cardiovascular diseases. A vulnerable plaque is characterized by a 
lipid-rich core and a thin fibrous cap. Moreover, this plaque is infiltrated by 
macrophages that secrete MMPs, such as MMP-9, which degrade 
extracellular matrix, causing plaque rupture. It is known that oxidized LDLs 
cause atherosclerosis by accumulating in the arterial intima where they 
act as stimulators of inflammatory and immune response. In light of these 
facts, our studies focus on the contribution of oxysterols, derivatives of 
LDL-cholesterol oxidation, and 4-hydroxynonenal (HNE), an aldehyde 
generated by breakdown of polyunsaturated fatty acids, in inflammation 
and plaque instability. 
Methods: Proinflammatory molecules and MMP-9 levels were analyzed 
by qRT-PCR, western blotting, immunofluorescence and colorimetric 
tecniques. 
Results: In U937 cells, both 27-hydroxycholesterol (27OH) and HNE 
induced the expression of several cytokinesand MMP-9 through TLR4 
activation. Moreover, they sustained inflammation by upregulating COX-2 
and mPGES-1 levels, as well as iNOS and NO. Of note, inhibition of 
inflammatory molecule formation decreases MMP-9 release by 
macrophages, underlying the crucial role of inflammatory response in 
MMP-9 overexpression. We are now investigating whether an oxysterol 
mixture could modulate the expression of the proprotein convertase 
PCSK6, a new marker of plaque vulnerability. Our preliminary results 
indicate that oxysterols upregulate PCSK6 in U937 cells and smooth 
muscle cells. We are also investigating the possible link between PCSK6 
and MMP-9 activation. 
Conclusions: Our results suggest that oxidized lipids promote plaque 
vulnerability by enhancing inflammation and MMP-9 upregulation. 
 
A5 Cross-Talk Between Androgen Receptor and NGF 
Receptor (TrkA) In Neuronal Cells 
M. Di Donato1, P. Giovannelli1, G. Cernera1, E. Di Zazzo1, A. Di Santi1, G. 
Galasso1, F. Vitale1, A. Bilancio1, F. Auricchio1, G. Castoria1, A. Migliaccio1 
1Second University of Naples, Naples, Italy 
Background: Steroids and growth factors control neuronal development 
in physiological and pathological conditions. In addition to regulating 
neurite outgrowth, dendritic branching and axon regeneration, androgens 
exert a beneficial effect in the central nervous system. The decrease in 
male testosterone levels represents, indeed, an age-related risk factor for 
Alzheimer’s disease development and dementia. 
Methods: By using biochemical and DNA sequencing approaches we 
identified for the first time the expression of a classic androgen receptor 
(AR) in rat adrenal pheochromocytoma PC12 cells and primary mouse 
hippocampal neurons. siRNA experiments combined with the use of 
chemical inhibitors or small peptides interfering with AR action, have 
established a key role for AR in androgen and NGF signaling. 
Results: The cross talk between AR, FlnA, and TrkA regulates 
neuritogenesis in PC12 cells through activation of the PI3-K δ/Rac 
downstream pathway. Beta 1 integrin represents the link between TrkA 
and AR, thereby regulating the differentiative effects triggered by 
androgens or NGF in PC12 cells. 
Conclusions: Our study provides new clues that might lead to a better 
understanding of the complexity of AR and TrkA signaling in neuronal 
cells. Our investigation into AR-interacting partners may identify promising 
candidates to track and target in many neurodegenerative disorders and 
age-related dementia. 
 
A6 The Androgen Receptor In Human Skeletal Muscle 
Biopsies 
G. Cernera1, M. Di Donato1, P. Giovannelli1, G. Galasso1, A. Di Santi1, E. 
Di Zazzo1, F. Vitale1, G. Iolascon1, A. Migliaccio1, G. Castoria1 
1Second University of Naples, Naples, Italy 
Background: Aging is often accompanied by the loss of skeletal muscle 
mass, likely caused by deregulation of sex steroids hormones. Androgens 
increase muscle size through the androgen receptor (AR), which activates 
both genomic and non-genomic pathways to trigger various biological 
responses. Non-genomic androgen effects occur through interaction of AR 
with effectors or scaffolds, including the Src tyrosine-kinase and filamin A. 
Activation of the downstream effectors (paxillin, FAK, MAPK, Akt) then 
follows. 
Methods: The activation status of key molecules linking the AR non-
genomic axis with cytoskeleton organization was analyzed by Western 
blot of lysate proteins of human skeletal muscle biopsies from young or 
old women. 
Results: Phosphorylation of both Ser-2152 filamin A and Tyr-118 paxillin 
is stronger in biopsies from old women compared with those obtained 
from young women. Conversely, the expression of sex steroid receptors, 
AR and ERα, is weaker in samples from old women, as compared with 
those obtained from young women. 
Conclusions: This pilot study suggests that derangement of the AR axis 
occurs in skeletal muscle of old women. This event likely leads to 
excessive metabolic functions and loss of skeletal muscle. Further 
investigation in cultured cells and mouse models might help us in targeting 
the skeletal muscle AR axis with new compounds, such as new selective 
androgen receptor modulators or stapled-peptides, to improve the clinical 
outcome of age-related frailty and sarcopenia. 
 
A7 Oxysterols Along the Course of Alzheimer’s Disease 
E. Staurenghi1, G. Testa1, S. Gargiulo1, C. Zerbinati2, L. Iuliano2, G. 
Giaccone3, G. Poli1, G. Leonarduzzi1, P. Gamba1 
1University of Turin, Orbassano (TO), Italy; 2Sapienza University of Rome 
Latina, Italy; 3Foundation IRCCS Institute of Neurology Carlo Besta, 
Milano, Italy 
Background: Alzheimer’s disease (AD) is associated with 
neuroinflammation, oxidative stress and dysregulated lipid homeostasis 
within the brain. The molecular mechanisms underlying this disease are 
not clearand to date no biomarkers for AD early diagnosis are available. 
Oxysterols could represent new biomarkers for AD since their levels 
change in brains during AD progression. In particular, oxysterols derived 
from cholesterol oxidation by CYP46A1 and CYP27A1, respectively 24-
hydroxycholesterol and 27-hydroxycholesterol, and oxysterols derived 
from cholesterol auto-oxidation, such as 7-ketocholesterol, play a key role 
in AD progression. 
Methods: The brains were classified based on the Braak and Braak 
staging system of neurofibrillary pathology (early AD: stage 1 or 2; late 
AD: stage 4 to 6). In the control brains the presence of senile plaques and 
tau pathology was excluded. Oxysterols were measured by isotope 
dilution mass spectrometry. Inflammatory molecule expression was 
analyzed by qRT-PCR. 
Results: A variety of oxysterols, of both enzymatic and non enzymatic 
origin were identified and quantified in AD brains taking into account the 
different Braak and Braak stages of AD. The enhancement of a few 
inflammatory mediators and the proteolytic enzyme MMP-9 was also 
demonstrated in the brains in agreement with the progression of the 
disease. Conversely, a marked reduction of sirtuin 1, an enzyme that 
regulates several pathways involved in the anti-inflammatory response, 
was observed with the progression of AD. 
Conclusions: The pathogenic correlation between the amount of 
oxysterols in AD brains and neuroinflammation is highlighted. Oxysterols 
could represent novel markers for early diagnosis and progression of AD. 
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A8 Anemia in the Elderly: A Laboratory Evaluation in 
Hospitalized and Non-Hospitalized Patients       
M. Greco1, V. Celi1, E. Gulletta1, D.P. Foti1 
1University of Magna Graecia, Catanzaro, Italy 
Background: In the elderly, anemia is reported to be frequent and often 
not readily attributable to a single cause. This condition is often 
overlooked in medical records, although substantial evidences support the 
association of even mild conditions of anemia and increased mortality in 
older individuals. Aim of the present study was to investigate 
retrospectively the prevalence and the main laboratory features of anemia 
in a large cohort of hospitalized and non-hospitalized Calabrian patients 
aged 65 and over. 
Methods: In this observational study, we examined 4,576 consecutive 
patients, aged ≥65 years, referred to the laboratory of Clinical Pathology, 
University Hospital of Catanzaro, for red blood cell testing. Anemia was 
defined according to WHO [Hb <12g/dl in females (f), and <13g/dl in 
males (m), respectively]. Blood cell analyses were performed by ADVIA 
2120 (Siemens). 
Results: In the hospitalized (n=2,045), vs. non-hospitalized patients 
(n=2,531), prevalence of anemia was 35% vs. 21%. In both groups, the 
majority of patients (80-85%) had mild anemia (Hb:10-13g/dl), whereas 
severe anemia (<8 g/dl) was present in less than 3%. In both groups, the 
most common form was normocytic anemia (57-67%); microcytic anemia 
was prevalent in females [33-40% (f) vs. 20-30% (m)], but macrocytic 
anemia prevailed in males [7-13%(m) vs. 3-9%(f)]. Hypochromic anemia 
was more common in females [26-33%(f) vs. 20-29%(m)]. 
Conclusions: Our findings highlight, in our population, the wide 
prevalence of anemia in the elderly. While most patients are affected by 
mild anemia, gender differences among RBC indexes may account for the 
multiple causes linked to anemia. 
 
A9 MicroRNA Mediated Methylation in Cellular Senescence 
R. Lazzarini1, A. Giuliani1, E. Mensà1, M. Orciani1, M. Rippo1, A. 
Procopio1, L. Micolucci1, F. Olivieri1 
1Università Politecnica delle Marche, Ancona, Italy 
Background: Aging is a multifaceted process characterized by genetic 
and epigenetic genome modifications,  is associated with a gradual 
decline in the physiological functions of the human body, and is a key risk 
factor for many diseases. DNA methylation, histone modifications, and 
noncoding RNA species are the most studied epigenetic marks and have 
a central role in aging and age-related diseases. MicroRNA (miRNAs) 
reveal a complicated network of reciprocal interconnections in epigenetics: 
the epigenetic modifications can affect miRNA expression, but miRNAs 
can also control gene expression at the post-transcription level, including 
genes that are implicated in the epigenetic machinery. 
Methods: MiRNA profiles were determined from young and senescent 
primary cultured human umbilical vein endothelial cells (HUVECs) and 
dermal fibroblasts (HuDE). The protein and mRNA expression levels of 
DNMT1 were identified by, respectively, Western Blot and real time PCR. 
Results: MiR-148a was the most down-regulated mirRNA during 
replicative senescence of HUVEC and HuDE. DNA methyltransferase 1 
(DNMT1) and DNA methyltransferase 3B, are the validated targets of 
miR-148a. Our results showed a marked up-regulation of DNMT1 in both 
HUVEC and HuDE senescent cells compared with young cells. 
Conclusions: Our results demonstrate a complex relationship between 
epigenetic mechanisms and the aging process and suggest that 
experimental approaches should not only focus on DNA methylation but 
also on non-coding RNAs. DNA methylation and microRNA deregulation 
are involved in the phenomena known as “epigenetic drift,” which is 
characterized by gradual extensive demethylation of genome and 
hypermethylation of a number of promoter-associated CpG islands. 
 
A10 Correlation Between Bone Marrow Adipose Tissue, Aging 
and Osteoporosis: Is There a Role for miRNAs? 
A. Giuliani1, L. Micolucci1, R. Lazzarini1, E. Mensà2, F. Olivieri1, A. 
Procopio1 
1Università Politecnica delle Marche, Ancona, Italy; 2INRCA, Ancona, Italy 
Background: Marrow adipose tissue (MAT) accumulation is correlated 
with decreases in cortical bone and low bone mineral density. It is unclear 
whether MAT has a causal role or simply represents a passive response 
to bone loss. In any case, MAT accumulation and bone loss occur with 
age and aging represents a risk factor for osteoporosis. MiRNAs are a 
broad class of small noncoding RNAs that act mainly modulating gene 
expression; they can be released by cells and circulate in the bloodstream 
in a remarkably stable form, thus representing systemic and tissue 
specific diagnostic/prognostic biomarkers for a number of age-related 
diseases. Recently, their use as biomarkers of osteoporosis has been 
suggested. 
Methods: Adipocytes were obtained in vitro from bone marrow-derived 
stromal cells (BMSCs). MiRNA expression profiles of BMSCs and 
adipocytes were performed using human microRNA Array pool A (Applied 
Biosystems, Foster City, CA). Significantly deregulated miRNAs in 
adipocytes compared to BMSCs were validated by RT-qPCR. 
Results: A miRNA signature associated with bone marrow adipogenesis 
was identified. Validation analysis confirm the modulation of a set of 
miRNAs in bone marrow-derived adipocytes compared to BMSCs. A 
comparative analysis highlighted that some of them are aging- (miR-181a, 
miR-34a, miR-126, miR-155) and more interestingly osteoporosis- (miR-
146a and miR-21) associated miRNAs. 
Conclusions: These data suggest for the first time that bone marrow 
adipocytes could contribute to circulating microRNA signature associated 
with aging and age-related diseases such as osteoporosis. 
 
A11 Successful Aging and Longevity: The Role of Functional 
Foods 
G. Candore1, A. Aiello1, G. Accardi1, C. Gambino1, S. Vasto1, C. Caruso1 
1University of Palermo, Palermo, Italy 
Background: During the last two centuries the most elderly are becoming 
the population with the fastest growth in the Western World. Although the 
average life expectancy is increasing dramatically, the healthy lifespan is 
not growing at the same pace. This underscores the importance of studies 
on the prevention of age-related diseases in order to decrease medical, 
economic and social problems associated to aging, related to an 
increased number of individuals affected by incapacitating pathologies. In 
particular, data from experimental studies have consistently shown that 
nutrient-sensing pathways are involved in longevity, affecting the 
prevalence of age-related loss of function, including diseases. 
Methods: To discuss the potential relevance of diet and the nutrient-
sensing pathway in the attainment of successful aging and longevity, we 
performed nutritional intervention using Sicilian local foods, analyzing 
inflammatory and oxidative stress markers. 
Results: Data clearly demonstrate the positive effects of nutraceuticals, 
functional foods, and Mediterranean diet on several biological parameters. 
In fact, they could represent a prevention for many age-related diseases, 
and, if not a solution, at least a remedy to alleviate them. 
Conclusions: The possibility to use, in combination, both nutraceuticals 
and functional foods should allow creation of a new therapeutic strategy, 
based on an integrated approach, using a mixture of foods rich in 
bioactive molecules, starting from local dietary habits, to create a 
“nutrafunctional diet” applicable worldwide. 
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BIOMARKERS FOR MOLECULAR PREVENTION AND THERAPY 
 
BM1 Soluble Receptor for Advanced Glycation End Products: 
An Early Biomarker of Cardiometabolic Risk in Healthy Women 
E. Dozio1, E. Vianello1, G.V. Simone1, A.E. Malavazos2, R. Rogolini2, L. 
Tacchini1, M.M. Corsi Romanelli1 
1Università degli Studi di Milano, Milan, Italy; 2IRCCS Policlinico San 
Donato, San Donato Milanese, Italy 
Background: The receptor for advanced glycation end products (RAGE) 
is a cell-surface protein promoting inflammation, adipocyte hypertrophy, 
and insulin resistance. Besides the cell surface form, RAGE exists as a 
soluble molecule (sRAGE),  a decoy receptor which,  sequestering RAGE 
ligands, acts as a cytoprotective agent. To date,  it is unclear whether the 
lower sRAGE level observed in obesity is a marker of increased overall 
adiposity or reflects increases in particular fat depots. We evaluated the 
relationship among sRAGE and indicators of adiposity, including 
abdominal visceral (VAT) and epicardial visceral (EAT) adipose tissues, to 
explore the potential role of sRAGE as an earlier biomarker of 
cadiometabolic risk. 
Methods: Forty-seven healthy women (mean age 33.3 yrs) were enrolled. 
Anthropometric and biochemical data were recorded. Fat mass (FM) was 
estimated by bioimpedance analysis. Abdominal subcutaneous (SAT), 
VAT, and EAT volumes were measured by magnetic resonance. sRAGE 
was quantified by ELISA. 
Results: sRAGE was lower in obese compared both to normal- and over-
weight women and  in women with a waist circumference (WC) larger than 
the cutoff of 80 cm. A strong inverse association of sRAGE was observed 
with body mass index and FM. Concerning adipose tissue distribution, 
sRAGE inversely correlated with WC, EAT and VAT. In a multiple 
stepwise regression analysis, performed to emphasize the role of fat 
distribution, EAT volume was the only predictor of sRAGE. 
Conclusions: Lower sRAGE level reflects accumulation of visceral fat 
mainly at epicardial level and  is present  in advance of the appearance of 
metabolic complications. sRAGE quantification may be an early marker of 
cardiometabolic risk. 
 
BM2 cAmpRGD-Sunitinib Conjugates as Integrin Targeted 
Delivery Strategy for Inhibition of Angiogenesis and Tumor Growth 
F. Bianchini1, A. Sartori2, L. Battistini2, A. Pupi1, F. Zanardi2, L. Calorini1 
1University of Florence, Florence, Italy; 2University of Parma, Parma, Italy 
Background: New strategies for antiangiogenic treatment of cancer are 
under continuous investigation. The vascular endothelial growth factor 
receptor (VEGFR) signaling cascade and integrin αvβ3 exert a critical role 
in tumor angiogenesis  both representing valid targets for anti-angiogenic 
therapies. The αvβ3 intergin strongly contributes to neo-angiogenic 
vascular development directly and indirectly through its crosstalk with 
VEGFR.  Anti-VEGFR therapies and αvβ3 integrin antagonist treatments 
demonstrated efficient anti-angiogenic activity in preclinical models but an 
inefficient drug administration limits therapeutic efficiency of the 
treatments. Interestingly, radiolabeled ligands, which target the VEGF 
receptor or αvβ3 antagonist Cilengitide, have successfully been developed 
for early and sensitive lesion detection by using positron emission 
tomography. In the present study we introduced innovative dual 
conjugates in which  selective arginine-glycin-aspartic-(RGD) antagonists 
combine with Sunitinib, a receptor tyrosine kinase inhibitor (TKI) used as 
frontline treatment for anti-angiogenic and anti-tumor treatment. 
Methods: Inhibition of cell growth and adhesion to RGD substrate, 
apoptosis assay and tubulogenesis. 
Results: Different RGD-Sunitinib conjugates showed efficient inhibitory 
activity on cell adhesion in endothelial precursor cells and melanoma 
cells, expressing αvβ3 integrin. We found inhibition in TK activity in cells 
exposed to the different conjugates and a strong synergistic effect on the 
inhibition of tubulogenesis. 
Conclusions: A conjugate carrying two RGD moieties showed a 
significant synergistic effect on αvβ3 and VEGFR inhibition. This 
compound will be used as a new antiangiogenic treatment in tumor 
bearing mice and, upon radiolabeling, it might be used in preclinical 
molecular imaging of early cancer lesions. 
 
BM3 Serum Levels of Matrix Metalloproteinase-9 (MMP-9) and 
Tissue Inhibitor of MMP (TIMP-1) in Metabolic Syndrome Patients 
Treated with Mesoglycan 
S. Ricci1, A. Valvano2, G. Bosso2, U. Oliviero2 
1University of Rome "La Sapienza", Naples, Italy; 2University of Naples 
"Federico II", Naples, Italy 
Background: Mesoglycan is a glycosaminoglycan compound with 
antithrombotic and profibrinolityc activities, which has been shown to be 
clinically effective on vascular remodeling. Vascular remodeling is 
prevalently mediated by MMP-9 and TIMP-1. Herein we examined serum 
MMP-9 and TIMP-1 levels in sera from metabolic syndrome (MetS) 
patients treated with mesoglycan and compared these parameters with 
the elastic properties of the arterial wall. 
Methods: Thirty consecutive patients with MetS were enrolled. Patients 
were double-blind randomized in a 2:1 scheme: 20 patients received 
mesoglycan per os (50mg b.i.d.) and 10 patients received placebo for 90 
days. At baseline (time 0) and at the end of the 90-day period, all patients 
underwent an ultrasound evaluation to assess the elastic arterial wall 
properties using distensibility coefficient (DC) and brachial artery stiffness 
(b).  Blood samples were collected for measuring MMP-9, by ELISA and 
zymography, and TIMP-1, by ELISA. 
Results: After 90 days, treated patients showed a marked improvement in 
arterial elasticity, with an increase of DC and decrease of b-stiffness 
values, compared to both basal levels and placebo. Consistently, we 
observed a significant decrease of serum MMP-9 (p=0.035) and TIMP-1 
(p=0.049). Moreover, MMP-9 multimeric form (240kDa) activity was  
increased (p=0.046), with a positive correlation with DC values  (p=0.032, 
rho=0.52) and a negative correlation with b-stiffness values (p=0.005, 
rho=-0.58). 
Conclusions: This preliminary study suggests that in patients with MetS, 
mesoglycan exerts relevant effects on vascular remodeling by modulating 
MMP-9 expression and enzymatic activity. Thus, serum MMP-9 evaluation 
might give additional useful information in MetS patient management. 
 
BM4 Effect of Dual PI3K and FAK Inhibition in Squamous Lung 
Carcinoma with Reduced PTEN Level 
A. Cavazzoni1, E. Giovannetti2, A. Roberta1, R. Sciarrillo3, N. Van der 
Steen3, M. Tiseo4, A. Ardizzoni5, P. Petronini1 
1University of Parma, Parma, Italy; 2University of Pisa, Pisa, Italy; 3VU 
University Medical Center, Amsterdam, Netherlands; 4University Hospital 
of Parma, Parma, Italy; 5Policlinico S. Orsola-Malpighi, Bologna, Italy 
Background: Squamous cell carcinoma of the lung (SCLC) is a group of 
histologically non-small cell lung cancer (NSCLC) that account for 20% of 
all lung cancers; to date half of these patients present with metastatic 
disease, and the chemotherapy regimen is the only treatment proposed.  
Recent efforts to identify molecular "drivers" have shown some altered 
pathways including PI3K/Akt signaling.  The most relevant alterations are 
the overexpression and point mutations of PIK3CA and loss of expression 
of the PTEN tumor suppressor gene, pointing out their role as candidate 
targets for specific drugs. 
Methods: SKMES-1 SCLC cells were stably transfected with a pull of four 
plasmids carrying shRNA directed to PTEN mRNA and clones with stable 
reduction of PTEN levels were selected for further investigation. 
Results: Reduction of PTEN expression caused an increased growth 
rate, enhanced migration and invasiveness, and the acquisition of a 
mesenchymal phenotype, confirmed by increased miR-21 expression. 
Moreover an increased activation of both Akt and FAK kinases was 
reported.  In this context we investigated the effect of the combination of 
the PI3K inhibitor buparlisib and the FAK inhibitor defactinib: a synergistic 
inhibition of cell proliferation, associated with a reduction of cell migration 
and invasion was observed in cells with reduced PTEN level. These 
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results are related to a reduction of phosphorylation of  some kinases (Akt, 
FAK, JNK, GSK-3 α/β, AMPK-α2). 
Conclusions: These data support a role for PTEN reduction as a good 
predictive factor for the clinical application of PI3K and FAK inhibitors in 
SCLC. 
 
BM5 Clinical and Technological Output of the Telemedicine 
Kosmomed Program 
M. Bizzarri1, C. Aragno2, A. Palombo1, V. Griffo1, E. Palombi1, G. Titti3 
1Sapienza University of Rome, Roma, Italy; 2Kell Italia, Roma, Italy; 
3University Campus Biomedico, Roma, Italy 
Background: Kosmomed is an integrated project to provide innovative 
products and services for medical practice based on information and 
communication technology associated with satellite telecommunications. 
Methods: The program proposes a novel paradigm for satellite 
telemedicine solution by the development of a bandwidth reservation 
mechanism integrated with a data protection infrastructure. . The network 
allows coordinated access to the service platform with a guaranteed on-
demand bandwidth allocation and associated billing, finally able to provide 
quality of service for professional and sustainable telemedicine devices. 
Diagnostic equipment is easily accessible to individuals. 
Results: The program  improves and integrates new sensors/analyzing 
equipment for medical use by the creation of innovative acquisition 
interfaces, to reach improved performance in data acquisition and 
evaluation. 220 patients were enrolled and distributed along the different 
program services: a) tele-oncology; b) tele-dermatology; c) teleconsulting 
for childhood obesity; d) tele-consulting for  vascular disease; e) tele-
consulting on data acquired by electronic noise. User compliance and 
approval reached high scores. Cooperativity among clinicians has been 
highly improved, shortening time for diagnostic assessment and/or for 
specific treatment settings.  Diagnosis has been improved in almost 30% 
of cancer  patients. 
Conclusions: Specific technologic tools have been developed to enable: 
a) wireless control and monitoring of cardiac and pulmonary functions; b) 
integrated sensory tools in analyzing liquid/volatile  parameters; c) fractal 
and morphological digital image analysis devices.  The Kosmomed 
program is a reliable and affordable instrument for the delivery of health 
services. 
 
BM6 Evaluation of Multidrug-resistant (MDR) Klebsiella spp. 
Resistance Pattern in Khartoum, Sudan 
S.S. Gamil1, S.M. Alzain2, E. Khalil2 
1Institute of Endemic Diseases, Universityif Khartoum, Khartoum, Sudan; 
2Institute of Endemic Diseases, Faculty of Medicine, Khartoum, Sudan 
Background: Bacterial resistance to antimicrobial drugs has reached  
alarming levels. Multidrug-resistant (MDR) Klebsiella spp. has become a 
major public health concern in Sudan and many countries, causing failure 
in treatment with consequent huge health burden.    
Objective: To determine the prevalence and susceptibility of MDR 
Klebsiella spp. among different clinical isolates. 
Methods: A total of 349 Klebsiella spp. strains were isolated between 
June 2009 and October 2015. Different clinical specimens (mainly swab 
culture, urinary tract , and respiratory tract isolates) were identified and 
tested for their antimicrobial susceptibility. 
Results: Of the 349 Klebsiella spp. isolated, MDR Klebsiella spp. was 
present in 264 (76%). Resistance rates were recorded to: ampicillin-
sulbactam (95%), ceftotaxime (93%), tetracycline (82%),tazobactam- 
piperacillin (59%), chloramphenicol (51%), ciprofloxacin (45%), 
gentamycin (23%), and amikacin (9%). 
Conclusions: Klebsiella spp. showed high resistance against ampicillin-
sulbacatm and cefotaxime (95% and 93% respectively).  Amikacin was 
the most effective drug among the antibiotics tested (91% of the strains 
were susceptible). This study showed that  Klebsiella spp. presents high 
level of resistance. This issue needs to be addressed in national 
guidelines. Antimicrobial resistance surveillance and epidemiological 
analysis of patient data need to be conducted periodically and can be 
informative for appropriate management of antimicrobial resistance. 
 
BM7 Biological and Molecular Effects of Belimumab in 
Systemic Lupus Erythematosus Patients: A Pilot Study 
C. Pistis1, M. Fabris1, L. Quartuccio1, G. De Marchi1, F. Curcio1, S. De 
Vita1 
1University Hospital of Udine, Udine, Italy 
Background: Systemic lupus erythematosus (SLE) is a chronic 
autoimmune disease with variable clinical presentation and severity. The 
monoclonal antibody belimumab (BLM) targets B-lymphocyte stimulator 
(BLyS), a cytokine that is overexpressed in SLE and sustains B-cell 
proliferation and autoantibody secretion. BLM represents the first 
innovative SLE therapy in several years. 
Methods: The study involves 6 female SLE patients (mean age 50.8±5.5 
yrs) and 3 age-sex matched blood donors. Intravenous BLM was 
administered every 28 days. On day 0 and at 3, 6, 9 and 12 months 
follow-up, BLyS serum levels, and PBMC mRNA expression of BLyS, April 
(its cognate cytokine) and their three receptors (BAFFR, TACI and BCMA) 
were evaluated. 
Results: BLM generally induced an upregulation of BLyS serum levels 
(1390.4±359.3 pg/ml at day 0, 115922.9±7768.3 pg/ml at m6; p=0.03). 
PBMC of blood donors expressed moderate levels of BLyS and April and, 
among the three receptors, only BCMA was detectable. At day 0, SLE 
patients showed heterogeneous patterns of expression of the investigated 
molecules; however, after BLM treatment, 4/6 patients tended to 
normalize BLyS, April and BCMA expression resembling those of blood 
donors. Of note, these patients were those presenting the most significant 
upregulation of BAFFR at baseline. 
Conclusions: This pilot study demonstrates that BLM induces important 
effects on PBMC expression of BLyS, April and its receptors. Molecular 
studies may be useful to better explain the mechanism of action in the 
single patients and to identify new biomarkers that could help select 
patients more prone to respond to this specific therapy. 
 
BM8 Characterization of the Proinflammatory Profile of 
Synovial Fluid-Derived Exosomes of Patients With Gonarthrosis 
R. Domenis1, R. Zanutel1, A. Cifù1, C. Pistis1, P. Di Benedetto2, A. 
Causero1, M. Pozzi Mucelli3, F. Bassini3, M. Fabris2 
1University of Udine School of Medicine, Udine, Italy; 2Azienda Sanitaria 
Universitaria Integrata di Udine, Udine, Italy; 3Azienda per l’Assistenza 
Sanitaria n.3 Alto Friuli, Tolmezzo, Italy 
Background: Synovial fluid (SF)-derived exosomes have been poorly 
characterized and their role in joint inflammation has never been 
investigated thoroughly. Our goal was to characterize SF-derived 
exosomes of patients with gonarthrosis and to investigate their 
immuneregulatory properties. 
Methods: Exosomes were isolated from SF of seven patients with 
gonarthrosis by polymer precipitation (Exoquick), quantified by acetyl-CoA 
acetetylcholinesterase activity and validated by exosomes-specific 
tetraspanins expression by immunoblot and FACS. To evaluate their 
immunoregulatory properties, exosomes were further purified with affinity 
capture antibody-coupled magnetic beads and incubated with M1 
macrophages, differentiated from blood donor CD14+ monocytes, to 
investigate the expression of co-stimulatory molecules by flow cytometry 
and production of cytokines, chemokines and MMPs by multiplex ELISA. 
Results: SF-derived exosomes (1.3±1.4x1011/ml) expressed specific 
markers (CD9, CD63, CD81 TSG101) by immunoblot and FACS. After 
Exoquick isolation, contamination by immune complexes was detected. To 
avoid possible interference in functional experiments by immune 
complexes, we added a further isolation step. SF-derived exosomes 
significantly stimulated the production of several inflammatory cytokines 
and chemokines (IL1β, TNFα, IL16, CCL20, CCL15, CCCL1) and the 
release of specific metalloproteinases (MMP7 and MMP12) by M1 
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macrophages, although they did not influence the expression of CD80 and 
CD86 co-stimulatory molecules on M1 macrophages. 
Conclusions: We characterized exosomes isolated from SF of patients 
with gonarthrosis and demonstrated that they are functionally active in 
their ability to stimulate the release of proinflammatory cytokines and 
MMPs from M1 macrophages, suggesting that they may play a role in 
disease progression. 
 
BM9 MicroRNA: A Striking Player in Alzheimer’s Disease 
M. Akhtar1, L. Micolucci1, A. Giuliani1, E. Mensà1, M. Rippo1, F. Olivieri1, A. 
Procopio1 
1Università Politecnica delle Marche, Ancona, Italy 
Background: Alzheimer’s disease (AD) is a common and complex age-
related neurological disorder worldwide. Despite the advancements in 
understanding the genetic, molecular, and environmental factors of AD, 
there are no effective treatments to stop or reverse AD related symptoms. 
Early diagnosis of AD remains a big challenge as it takes a decade or 
more before the illness appears. Furthermore, post-mortem verification is 
often required. Therefore, there is an urgent need of biomarkers that can 
effectively detect early stage AD. MicroRNA (miRNA) is a class of non-
coding RNA (∼22-nt long) that regulates gene expression post-
transcriptionally. Accumulating evidence suggests that miRNA plays a 
crucial role in neural development and differentiation. About 70% of the 
currently identified miRNAs are reported to be expressed in the brain. In 
this study, we systematically evaluated the available literature to 
understand the role of miRNA in AD pathogenesis. 
Methods: The major biomedical databases were searched systematically 
to identify miRNA expression signatures in AD. Relevant articles were 
extracted by online searching using a combination of the following MeSH 
terms: microRNA or miRNA or miR and Alzheimer’s Disease. 
Results: We found that a number of miRNAs are deregulated in AD 
patients compared to the normal age-matched controls. 
Conclusions: Our data suggest that miRNA signatures may have 
potential to be considered as a screening tool as well as a therapeutic 
target for AD. 
 
BM10 Urinary Exosomes as Biomarkers in Prostate Cancer: A 
Pilot Study 
F. Calapà1, D. Lucchetti1, C. Fanali1, F. Carbone1, A. Calarco1, D. 
Pugliese1, F. Pinto1, V. Palmieri1, M. De Spirito1, P. Bassi1, A. Sgambato1 
1Università Cattolica del Sacro Cuore, Rome, Italy 
Background: Exosomes circulating in biological fluids largely mirror the 
molecular profile of the originating cells. Given the non-invasive nature of 
urine collection,analysis of urinary exosome content could be useful in the 
identification of new biomarkers in prostate cancer. This pilot study 
evaluated the expression of known prostate cancer genes (PSA, PCA3 
and PSMA) as potential exosomes biomarkers. 
Methods: mRNA and protein contents (PSMA, CD63, CD9) of urinary 
exosomes collected from 20 pre-and 14 post-radical prostatectomy 
patients and 8 healthy age-matched men were examined. The correct 
isolation of exosomes was confirmed by dynamic light-scattering, 
transmission electron microscopy, and Western-blot analysis. Western-
blot analysis, RT-PCR and nested RT-PCR were used to evaluate the 
expression of PSMA, PSA and PCA3 content, respectively. 
Results: Expression of PSA in urinary exosomes displayed 70% 
sensitivity, 62.5% specificity and an overall accuracy of 67.8% in 
identifying prostate cancer. PCA3 sensitivity, specificity and overall 
accuracy were 55%, 87.5%, and 64.3%, respectively. PSMA sensitivity, 
specificity, and overall accuracy were 76.5%, 57.1%, and 70.8%, 
respectively. These values were 85%, 87.5%, and 85.7%, respectively, 
when all three genes were simultaneously detected in extracted 
exosomes. Moreover, expression of PSA, PCA3, and PSMA were no 
longer detectable in a significant fraction of patients after surgery 
(p=0.0005, p= 0.032, p=0.0002, respectively). 
Conclusions: This pilot study suggests that urinary exosomes could be 
used as non-invasive  biomarkers for prostate cancer detection, with an 
overall accuracy comparable to the traditional PSA. Levels of urinary 
exosomes are strongly related to surgery and could be adopted into post-
operative surveillance. 
 
BM11 Identification of Double-strand Genomic DNA In Colon 
Cancer Exosomes: Is it a Potential Non-invasive Diagnostic Tool? 
F. Carbone1, D. Lucchetti1, P. Tomaiuolo1, F. Calapà1, C. Fanali1, A. 
Mazzari1, V. Palmieri1, M. De Spirito1, A. Crucitti1, A. Sgambato1 
1Università Cattolica del Sacro Cuore, Rome, Italy 
Background: Liquid biopsy offers a promising alternative for tumor 
characterization and disease monitoring. Exosomes shed by cancer cells 
are attractive for their content stability in biological fluids and ability to 
mirror the molecular profile of the originating cells. This study aimed to 
evaluate the possibility to identify exosomes-associated DNA from colon 
cancer cell lines and from plasma of colorectal cancer patients (CRC pts) 
and to analyze their potential use in clinical settings. 
Methods: Exosomes were isolated by ultracentrifugation from plasma of 
10 CRC pts and from the supernatant of human colon cancer cells and 
were characterized. Mutation analysis of KRAS in DNA extracted from 
exosomes was evaluated by real-time PCR and confirmed by PCR-RFLP. 
Results: We set  up the protocols  for DNA isolation from  exosomes and 
for the analysis of KRAS G12V mutation by HRM analysis. KRAS 
mutation was confirmed by PCR-RFLP  using MvaI endonuclease 
digestion. The analysis of exosomes DNA extracted from supernatant of 
colorectal cancer cells or from plasma of CRC pts confirmed that the 
isolated DNA displays the same mutational status of DNA extracted from 
cancer cell lines or from the corresponding primary tumors, respectively. 
Conclusions: This pilot study suggests that DNA extracted from 
exosomes can be useful for the analysis of KRAS mutational status in 
colorectal cancer patients. We are currently evaluating the possibility to 
detect mutations in other genes (i.e., BRAF). Further studies are 
warranted to evaluate the suitability of exosome extracted DNA as a non-
invasive diagnostic, predictive, and surveillance biomarker in colon cancer 
patients. 
 
BM12 Asymmetric Dimethylarginine (ADMA) In Asymptomatic 
Cerebral Small Vessel Disease 
A. Cifù1, N. Sanvilli1, N. Tanzi1, C. Pistis1, M. Fabris1, D.E. Fontana1, R. 
Giacomello1, F. Curcio1, G. Gigli1, F. Janes1 
1University Hospital of Udine, Udine, Italy 
Background: Cerebral small vessel disease (CSVD), detected as white 
matter hyperintensities (WMH) on brain MRI, could be a distinct 
pathological entity within cerebrovascular diseases. However, the several 
pathogenic hypotheses so far proposed were based on very 
heterogeneous clinical settings. Endothelial dysfunction seems to play a 
pivotal role but more studies are needed to clarify it. 
Methods: This is a pilot-case control study of young patients with CSVD. 
WMH severity was graded using the Fazekas score. Clinical history of 
patients and controls were negative for vascular and heart disease, 
classical vascular risk factors, autoimmune disorders, and coagulopathies. 
None of the patients reported family history of cerebrovascular disease. 
Blood samples were consecutively collected in the early morning and 
tested for inflammatory, endothelial, and prothrombotic markers. 
Results: 14 patients and 12 age- and sex-matched controls were 
recruited (mean age 52.6±5.9 yrs). Baseline clinical characteristics did not 
differ between the two groups. The mean Fazekas score in patients was 
2.9±0.86. Compared to controls, patients did not display higher levels of 
common inflammatory markers (C-reactive protein, fibrinogen, IL-6, IL10) 
and plasma prothrombotic factors (PAI, vWF, tPA, PAF-AH, 
homocysteine). In contrast, the levels of asymmetric dimethylarginine 
(ADMA), an endogenous inhibitor of nitric oxide, were significantly 
increased in patients compared to controls (122.2±33.7 µmol/l versus 
93.4±32.8 µmol/l; p=0.04). 
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Conclusions: Our pilot study suggests that ADMA, a known marker of 
endothelial dysfunction, may represent a new biomarker to identify 
asymptomatic CSVD, indicating the pathway of nitric oxide may be 
involved in endothelial dysfunction in this clinical setting. 
 
BM13 Platelet Activation Affects Pre-mRNA Maturation of a 
Group of Transcripts Useful as Markers of Acute Coronary 
Syndromes 
R. Tarallo1, G. Nassa1, G. Giurato1, G. Cimmino2, G. Bruno1, F. Rizzo1, L. 
Ricciardi1, A. Salvati1, G. Marchese3, P. Golino2, A. Weisz1 
1University of Salerno, Baronissi, Italy; 2Second University of Naples, 
Naples, Italy; 3Genomix4Life Srl, University of Salerno, Baronissi, Italy 
Background: Platelets represent a major player in the process of 
intravascular thrombus formation. Despite significant advancements in 
antithrombotic therapy, current strategies still fail to prevent thrombotic 
coronary events in a substantial number of patients, indicating that the 
complex mechanisms modulating platelet response during activation are 
not fully elucidated. The evidence that platelets are capable of de novo 
protein synthesis has raised the issue of whether and how these resident 
mRNAs are regulated in circulating platelets. Among the various 
mechanisms potentially involved, mRNA splicing may be potentially 
relevant. 
Methods: Purified platelet-rich plasma from healthy volunteers were 
collected and in vitro activated with collagen or thrombin receptor 
activating peptide. Transcriptome analysis by RNA-Seq and in silico intron 
retention analysis were applied to search for splicing events affected by 
platelet activation. HiRIEF LC-MS allowed platelet proteome 
characterization at deep coverage to investigate a possible correlation 
between splicing events and protein levels. 
Results: Extensive computational analysis following RNA-Seq revealed 
several splicing events occurring in activated platelets. By applying 
unbiased proteogenomics, we correlated intron retention events in 
quiescent platelets to exon-exon junctions frequency after activation. In 
this way we identified a set of transcripts presenting reduced intron 
retention and high peptide representation at exon-exon junctions in 
activated vs resting platelets. 
Conclusions: The observed results indicate that pre-mRNA maturation of 
platelet-specific transcripts could be monitored and used as marker of 
platelet activation in acute coronary syndromes.    
Acknowledgement: Research supported by MIUR (FIRB 
RBFR12W5V5_003), MOH (GR-2011-02347781), CNR (Flagship Project 
InterOmics) and Genomix4Life. 
 
BM14 Lactobacillus reuteri: Production and Characterization of 
Membrane Vesicles  for Future Health Applications 
R. Grande1, C. Celia1, A. Stringaro2, L. Di Marzio1, M. Di Marcantonio1, M. 
Colone2, M. Locatelli1, L. Savino1, V. Puca3, L. Hall-Stoodley4, P. 
Stoodley4, R. Muraro1, G. Mincione1 
1University "G.d'Annunzio" Chieti-Pescara, Chieti, Italy; 2Istituto Superiore 
di Sanità, Rome, Italy; 3University of L’Aquila, L’Aquila, Italy; 4The Ohio 
State University, Columbus, Ohio, USA 
Background: The probiotic Lactobacillus reuteri is effective against 
infantile colic, alleviation of eczema and Helicobacter pylori colonization. 
L.reuteri develops biofilm in vitro, producing factors that give health benefit 
to the host although the mechanism by which commensal bacteria 
communicate with the host remains unclear. The purpose of this study 
was to detect and characterize membrane vesicles (MVs), bilayer 
structures containing several molecules generated by bacteria, produced 
by L.reuteri  DSM 17938. 
Methods: The structure of MVs was evaluated by transmission and 
scanning electron microscope analysis. MVs were subsequently isolated 
by biofilm (bMVs) and planktonic (pMVs) phenotypes by 
ultracentrifugation and physicochemically characterized by dynamic light 
scattering (DLS) analysis. An enzymatic treatment was performed to 
determine MVs composition. eDNA was detected and quantified using the 
Quant-iTTMPicoGreendsDNA assay and NanoDropUV-VIS 
spectrophotometer. Proteins associated with MVs were extracted and 
quantified by BCA assay. 
Results: PicoGreen showed that eDNA was associated with MVs and that 
its concentration is higher in bMVs than in pMVs,  although an inverse 
correlation was found in the protein concentration, suggesting a different 
role of MVs in the two phenotypes. The enzymatic treatment showed that 
lipids and proteins represent the main structural components of MVs. The 
DLS analysis demonstrated that L.reuteri generates MVs with sizes in the 
nanometer range and a broad size distribution. 
Conclusions: L.reuteri produces MVs whose main components are lipids 
and proteins; eDNA is also associated to MVs. The biological activity and 
composition of MVs may represent the starting point for future applications 
in the development of vesicles-based therapeutic systems. 
 
BM15 Methylation Analysis of Protocadherin Genes in 
Pancreatic Adenocarcinoma 
M. Curia1, F. Fantini1, F. Tavano2, F. Di Mola3, R. Lattanzio1, M. Di 
Marcantonio1, L. Savino1, M. Piantelli1, P. Battista1, P. Di Sebastiano3, A. 
Cama1 
1University "G. d'Annunzio" of Chieti-Pescara, Chieti, Italy; 2Division of 
Gastroenterology and Research Laboratory, San Giovanni Rotondo, Italy; 
3Division of Surgical Oncology “SS Annunziata” Hospital, Chieti, Italy 
Background: Pancreatic cancer is one of the most lethal malignancies 
and somatic mutations of protocadherins have been identified. Some of 
them were recently identified as tumor-suppressor genes; in particular, 
PCDH10 is a functional tumor suppressor gene frequently silenced by 
methylation in multiple carcinomas. Our goal is to evaluate the prognostic 
significance of protocadherin methylation in pancreatic adenocarcinoma 
so we studied methylation in primary pancreatic cancers. Functional 
assays with a PCDH10 re-expressing pancreatic cancer cell line is in 
progress to characterize its biological effects in pancreatic tumorigenicity. 
Methods: 38 ductal pancreatic adenocarcinomas were recruited in “Casa 
sollievo della sofferenza” Hospital, S.Giovanni Rotondo. DNA was 
extracted from tumor tissue and treated with bisulfite solution. COBRA 
analysis and bisulfite genomic sequencing were used to determine the 
presence of methylated CpG in the promoter regions. A functional assay 
using AspC-1 and Capan-2 pancreatic cancer cell lines transfected with 
full length PCDH10 will assess the effect of PCDH10 on pancreatic cancer 
cell growth. 
Results: Cases were studied for PCDHAC2, PCDHGC5 and PCDH10 
methylation status and immunohistochemistry (IHC). Results showed no 
PCDHAC2 methylation pattern and ubiquitous methylation of PCDHGC5 
in all cases analysed. PCDH10 analysis showed a partial methylation 
pattern in 9/18 and no methylation in 9/18 cases analysed. IHC analysis 
detected PCDHAC2 expression in 6% of cases analysed and PCDHGC5 
in 30%. IHC of PCDH10 is in progress. 
Conclusions: The identification of aberrantly hypermethylated and 
silenced genes will have diagnostic, prognostic, and therapeutic 
applications. PCDH10 may be a potential target gene for cancer therapy. 
 
BM16 Primary Pleuro-Pulmunary Synovial Sarcoma: A Single-
Center 13-Year Experience 
S. Di Russo1, G. De Luca2, C. Moscatello1, M. Di Marcantonio1, G. 
Mincione1, A. Marchetti3, P. Battista1, F. Mucilli4 
1University of Chieti-Pescara, Chieti, Italy; 2Istitute of pathology, "S.S. 
Annunziata" Hospital, Chieti, Italy; 3University-Foundation, CeSI Biotech, 
Center of Predictive Molecular medicine, Chieti, Italy; 4"S.S. Annunziata" 
Hospital, Chieti, Italy 
Background: Primary pleural and pulmonary synovial sarcomas (PPSSs) 
are very rare and aggressive neoplasms that affect adults. The oncologic 
characteristics, treatment, and prognosis for PPSSs are not well defined 
because of a paucity of data. Dysregulation of Wnt/β-catenin and EGFR 
pathways leads to tumorigenesis with poor prognosis. We investigated the 
involvement of Wnt/ β-catenin and EGFR signaling in PPSSs. 
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Methods: This retrospective study identified seven PPSS cases at the 
Department of Thoracic Surgery, SS. Annunziata Hospital in Chieti from 
2002 to 2015. Paraffin tumour tissues were evaluated for protein and gene 
expression by IHC and RT-qPCR. 
Results: The retrospective study for PPSS reveals by IHC 5 biphasic and 
2 monophasic phenotypes with minimal focal epithelial component. 
Mesenchymal component shown vimentin expression in all PPSSs while 
CkAE1/AE3, EMA, E-cadherin and β-catenin were absent in the two 
monophasic PPSS. SYT–SSX1 fusion transcripts were found in 3 out of 7 
PPSSs.  Using one of the pleural normal tissues with a lower Ct value as 
a calibrator, RT-qPCR showed very strong expression in LEF1 trascripts 
in all tumors. APC increased in one pulmonary PPSS whereas the other 
PPSS showed a normal range. EGFR was overexpressed in all samples. 
Interestingly, gene expression indicate a normal range of ERB-b2 and 
ERB-b3 expression for one pleural monophasic sample, while ERB-b4 
was over expressed. 
Conclusions: Preliminary results confirmed the involvement of Wnt/β-
catenin and EGFR pathways in PPSSs and highlight unanswered 
questions, the solutions of which will be imperative in the rational 
exploration of these pathways in future molecular treatment strategies. 
 
BM17 Molecular Analysis of Base Excision Repair (BER) Genes 
in Breast and Ovarian Cancer Patients 
C. Moscatello1, F. Fantini1, M. Di Nicola1, A. Morgano1, I. Antonucci1, P. Di 
Gregorio2, P. Battista1, A. Cama1, M. Curia1 
1University of Chieti-Pescara, Chieti, Italy; 2“S.S. Annunziata” Hospital, 
Chieti, Italy, Chieti, Italy 
Background: The etiology of breast cancer (BC) is multi-factorial. The 
mammary tissue is particularly exposed to oxidative stress because of 
specific hormone metabolism. This state can produce oxidized DNA 
lesions such as 8-hydroxyguanine (8-oxoG), physiologically removed by 
the base excision repair (BER) pathway. A reduction of activities and/or 
transcript dosage imbalance in the BER genes may have a role in BC 
predisposition. 
Methods: DNA and RNA from peripheral blood mononuclear cells 
(PBMC) of 63 BC and/or ovarian cancer (OC) patients, previously 
screened for BRCA1/BRCA2, were studied for MUTYH and OGG1 
germline variants using dHPLC and sequencing; TaqMan assays were 
employed to test mRNA expression levels.  
Results: Forty-six patients presented with cancer family history, 28 of 
them showing vertical transmission of BC; 17 were BC/OC early onset 
without family history. No cases had a detectable pathogenic mutation in 
BRCA1/BRCA2 genes. Ten sequence variants were identified in MUTYH 
and OGG1. Importantly, 2/6 of MUTYH missense mutations were found in 
the same BC patient and not detected in 120 healty controls. Gene 
expression was analysed on 46 patients with available RNA and 40 
healthy donors selected according to similar gender and age. The MUTYH 
gene showed reduced expression in BC patients with and without 
evidence of direct genetic transmission compared to OC patients.  
Conclusions: Overall, significant reduced expression was observed in 
patient vs control group (p < 0.05) only for MUYH gene.  While not 
conclusive, this interesting finding suggests  clinical criteria for MUTYH- 
and OGG1-associated BC and OC phenotypes. 
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C1 A Novel SIRT Inhibitor Inducing a RIP1-Caspase 8-
Dependent Apoptosis 
V. Carafa1, F. Cuomo1, F. Baratta1, D. Rotili2, G. Cobellis1, A. Mai2, A. 
Nebbioso1, L. Altucci1 
1Seconda Università degli Studi di Napoli, Napoli, Italy; 2Università la 
Sapienza, Roma, Italy 
Background: The development and progression of cancer involves both 
epigenetic and genetic changes leading to the alteration of gene 
expression and cell phenotype [Sharma S et al. Epigenetics in cancer. 
Carcinogenesis. 2010]. Emerging evidences suggest the role of 
acetylation as a post-translational modification that plays a critical role in 
cell fate. The best known epigenetic enzymes in cancer therapy are 
histone deacetylases. In the last decade interest in Sirtuins as potential 
promising targets for cancer treatment has grown [Carafa V et al. Sirtuin 
functions and modulation: from chemistry to the clinic.Clin Epigenetics 
2016].     
Methods: We characterized a new SIRT inhibitor showing a multi-acting 
inhibition towards SirT1-2-4-5. The new molecule is inactive against HATs 
and HDACs. 
Results: The new molecule displays enhanced tumor-selective potential 
in vitro, in leukemic blasts ex vivo, and in vivo in both xenograft and 
allograft cancer models. PK and PD studies support its use in vivo. This 
SIRT inhibitor induces strong proliferation arrest and cell death in many 
cancer cells but is unable to induce death in normal cells. Gene 
expression analyses highlighted the induction of the death-receptor 
pathway, confirmed by the activation of both TRAIL and DR5 promoters. 
Conclusions: We defined a new specific death pathway in which 
Caspase8 and RIP1 have a functional role. Based on our findings, we 
hypothesize that Sirtuin modulation may play a key role in the induction of 
this cell death underscoring the action of SIRT1 in tumor cells.    
Acknowledgement:   We thank the Worldwide Cancer Research (AICR) 
for support (grant 15 1002). 
 
C2 Hybrid LSD1/JmjC Inhibitor as a Therapeutic Option in 
Cancers with Deregulated Hormone-Receptor Signaling 
R. Benedetti1, M. Conte2, A. Nebbioso2, P. Giovannelli2, D. Rotili3, A. 
Migliaccio2, A. Mai3, J. Martenz4, L. Altucci2 
1Seconda Università degli studi di Napoli, Napoli, Italy; 2Second University 
of Naples, Naples, Italy; 3Sapienza, University of Rome, Rome, Italy; 
4Faculty of Science, Nijmegen center for molecular life sciences, 
Nijmegen, Netherlands 
Background: The field of epigenetic-based drug discovery is in a 
transitional phase where the search for drugs is shifting from single-target-
oriented molecules to network-active compounds. In many cancers, 
lsyine-specific histone demethylase 1  (LSD1) and Junonji C (JmjC) are 
co-expressed and co-localize with hormone receptors (AR, ER, PML-
RAR), suggesting the potential use of hybrid molecules to target both 
enzymatic functions and to regulate hormone receptor signaling. 
Methods: We report  a novel “pan-KDM” inhibitor, obtained by coupling 
the chemical features of tranylcypromine with the 2OG competitive moiety 
(J Med Chem 2014, 57:42-55). The hybrid molecule displays unique 
features compared with scaffolds and well known single inhibitors. This 
compound inhibits LSD1 and JmjC enzymes, induces growth arrest and 
apoptosis in hormone responsive cells accompanied by strong increases 
in levels of H3K4me2/3, H3K9me2/3 and H3K27me3.  
Results: Treatment with the hybrid molecule reduces the level of ER (in 
MCF-7), AR (in LnCaP) and PML-RAR (in NB4) by both a transcriptional 
and non-trancriptional manner. The same treatment changes the 
methylation status of ER/AR/PML-RAR regulated promoter regions, 
affecting the transcription of several genes. In ex vivo blasts and breast 
cancers, the hybrid molecule reduces cell proliferation, such as in cellular 
models with acquired resistance to hormone stimuli (LnCaP C4-2) by 
rebalancing the epigenetic signature of histones. 
Conclusions: In these systems the multiple-target inhibitor may 
overcome potential mechanism(s) of resistance caused by redundancy 
and robustness of biological pathways, finding application in the treatment 
of resistant-to-therapy cancers (triple-negative breast cancers and 
cancers with acquired resistance). 
Acknowledgement: This project is funded by Blueprint Project Contract 
No. 28251 and PRIN2012ZNH9YH_002. 
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C3 Novel Mechanisms Involved in the Stimulatory Effects 
Exerted by Zinc in Breast Cancer Cells 
R. Lappano1, R. Lappano1, A. Pisano1, M. Santolla1, A. Vivacqua1, A. 
Belfiore2, M. Maggiolini1 
1University of Calabria, Rende, Italy; 2University of Catanzaro, Catanzaro, 
Italy 
Background: Zinc (Zn) is an essential element required for diverse 
cellular processes, including DNA and protein synthesis, enzyme activity 
and intracellular signaling; however, Zn has been also implicated in the 
progression of breast tumor. Estrogens stimulate the development of 
breast cancer mainly binding to and activating estrogen receptor (ER)α 
and ERβ that regulate the expression of genes involved in cell 
proliferation, migration, and survival. In addition, the G protein estrogen 
receptor, namely GPER, has been shown to mediate estrogen action in 
diverse types of normal and malignant cells. 
Methods: To ascertain whether zinc chloride (ZnCl2) might trigger the 
transduction signaling mediated by GPER, we performed co-
immunoprecipitation studies, luciferase assays, gene expression 
experiments, immunoblotting and cell cycle analysis, and proliferation and 
migration assays in SkBr3 breast cancer cells that lack the classical ERs. 
Results: We found that GPER is involved in the ZnCl2 dependent 
activation of both epidermal growth factor receptor (EGFR) and insulin-like 
growth factor receptor I (IGF-IR) transduction pathways as well as 
downstream effectors like ERK and AKT. Moreover, ZnCl2 stimulated a 
functional interaction of GPER with EGFR and IGF-IR toward gene 
transcription and biological responses such as cell-cycle progression, 
proliferation, and migration of the SkBr3 breast cancer cells. 
Conclusions: Our data provide novel insights into the molecular 
mechanisms through which GPER may contribute to the stimulatory 
effects exerted by zinc in cancer cells toward breast tumor progression. 
 
C4 Effects of m-TOR Inhibitor Everolimus on Human Breast 
Cancer Cells 
L. Taglieri1, F. De Luliis1, A. Giuffrida1, S. Scarpa1 
1Sapienza University, Rome, Italy 
Background: Breast cancer is a heterogeneous disease, divided into 4 
categories based on the receptor profile: luminal A, luminal B, basal-like, 
and HER2-like. Luminal A/B correspond to the hormone-responsive breast 
cancer phenotypes and their therapy consists of anti-hormonal molecules; 
however, resistance to these agents may occur. Considering that the 
signaling pathway of steroid hormones is mediated by PI3k/Akt and that 
the mammalian target of rapamycin (mTOR) is a downstream mediator of 
Akt, some mTOR inhibitors, such as everolimus, were developed to 
overcome the resistance to anti-hormonal therapy. Unfortunately not all 
hormone-sensitive breast cancer cells have a good responsiveness to 
everolimus in vitro. 
Methods: Two human breast cancer cell lines were utilized: BT-474 
(luminal B) and MCF-7 (luminal A). Apoptosis was analyzed by Western 
blot of PARP, BAX/Bcl2 and caspase 8/9 and by caspase 3 
immunofluorescence and FACS analysis of annexin V/propidium iodide. 
Resistance was analyzed by Western blot of survivin. 
Results: We chose BT-474 and MCF-7 among other Lumninal A/B 
cancers because the first responded to everolimus with apoptosis and the 
second was not sensitive. At the same time everolimus upregulated 
survivin, an anti-apoptotic protein, in MCF-7 and downregulated survivin in 
BT-474. Inhibiting this upregulation of survivin on MCF-7 with the 
utilization of YM155, the apoptotic response to everolimus was replaced. 
Conclusions: These data demonstrate that the pro-apoptotic response of 
hormone-sensitive breast cancer cells to everolimus can be limited by the 
over-expression of survivin and that the forced diminution of survivin can 
sensitize tumor resistant cells to everolimus-induced apoptosis. 
 
C5 Ligand-Activated PPARγ Downregulates CXCR4 Gene 
Expression through a Novel Identified PPAR Response Element and 
Inhibits Breast Cancer Progression 
D. Rovito1, G. Gionfriddo1, I. Barone1, C. Giordano1, F. De Amicis1, M. 
Lanzino1, S. Catalano1, D. Bonofiglio1, S. Andò1 
1University of Calabria, Cosenza, Italy 
Background: SDF-1 and its cognate receptor CXCR4 play a key role in 
mediating breast cancer cell invasion. Therefore, drugs able to inhibit 
CXCR4 activation may add critical tools to reduce tumor progression, 
especially in the most aggressive form of breast cancer disease. PPARγ, 
a member of the nuclear receptor superfamily, has been found to 
downregulate CXCR4 expression in several cancer cells, however the 
molecular mechanism underlying this effect is not fully understood. 
Methods: CXCR4 expression was evaluated by RT-PCR, immunoblotting 
and immunofluorescence in different breast cancer cells and in cancer-
associated fibroblasts (CAFs) treated with PPARG ligand BRL. Transient 
transfections, DNA-affinity-precipitation-assay, chromatin 
immunoprecipitation (ChIP) and re-ChIP assays were performed to 
identify a PPAR response element (PPRE) within the CXCR4 promoter. 
Migratory promoting activities were analyzed by wound 
healing/transmigration/invasion assays. 
Results: We found that ligand-activated PPARγ downregulated CXCR4 
transcriptional activity through the recruitment of SMRT corepressor onto 
a newly identified PPRE within the CXCR4 promoter. As a consequence, 
BRL significantly inhibited cell migration and invasion in a PPARG-
dependent manner. According to the ability of CAFs to secrete high levels 
of SDF-1, BRL reduced migratory promoting activities and affected 
CXCR4 pathways induced by CAF-derived conditioned media. CAFs 
exposed to BRL showed a decreased CXCR4 expression, a reduced 
motility and invasion along with a phenotype characterized by an altered 
morphology. 
Conclusions: Our findings provide novel insights into the role of PPARγ 
in inhibiting breast cancer progression and further highlight the utility of 
PPARγ ligands for future therapies aimed at targeting both cancer and 
surrounding stromal cells in breast cancer patients. 
 
C6 Targeting Breast Cancer-associated Fibroblasts with 
Farnesoid X Receptor Ligands as a Novel Treatment Strategy for 
Breast Cancer 
I. Barone1, V. Vircillo1, C. Giordano1, R. Tarallo2, A. Rinaldi2, G. Bruno2, D. 
Bonofiglio1, S. Catalano1, S. Andò1 
1University of Calabria, Rende, Italy; 2University of Salerno, Salerno, Italy 
Background: Breast cancer-associated fibroblasts (CAFs) play multiple 
roles in tumor initiation and promotion. Early studies have shown that 
activation of nuclear Farnesoid X Receptor (FXR) in mammary epithelial 
cancer cells exerts an oncosuppressive role. However, the detailed 
functions of this receptor in CAFs remain to be elucidated. 
Methods: Human CAFs were isolated from biopsies of primary breast 
tumors (n=4). FXR expression was evaluated by realtime RT-PCR, 
immunofluorescence and immunoblotting.  FXR functional role in CAFs 
was tested by evaluating the effects of the selective FXR agonist GW4064 
in MTT, wound healing and transmigration assays. RNA sequencing was 
used to compare the transcriptomes of vehicle- and GW4064-treated 
CAFs. Ingenuity pathway analysis (IPA) was used to calculate the 
activation z-score of molecular canonical pathways. FXR impact on tumor-
promoting abilities of CAFs was assessed in coculture experiments with 
human estrogen receptor-positive MCF-7 and -negative SkBr3 breast 
cancer cells using soft-agar growth assays. 
Results: We found FXR mRNA and protein expression in CAFs. GW4064 
treatment significantly decreased CAF motility without affecting 
proliferation. Quantitative transcriptome analysis revealed 1182 
differentially expressed genes in response to GW4064 treatment. IPA 
evidenced a marked reduction in the activity of RhoA signaling, regulation 
of actin-based motility by Rho and signaling by Rho Family GTPases, 
(activation z-score: -1, -0.8, -0.8, respectively). Finally, MCF-7 and SkBr3 
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cells cocultured with GW4064-treated CAFs showed reduced anchorage-
independent growth. 
Conclusions: The present and our previous studies propose FXR ligands 
as potential pharmacological tools that, targeting both cancer and 
activated stromal cells, may represent a more effective approach to treat 
breast cancer patients. 
 
C7 High-density Lipoproteins Inhibit Oxidative Stress-
Induced Prostate Cancer Cell Proliferation 
M. Ruscica1, M. Botta1, N. Ferri2, C. Songia1, G. Franceschini1, L. 
Calabresi1, P. Magni1, M. Gomaraschi1 
1Università degli Studi di Milano, Milan, Italy; 2Università degli Studi di 
Padova, Padua, Italy 
Background: Oxidative stress plays a role in the pathogenesis and the 
progression of prostate cancer (PCa). Reactive oxygen species (ROS) are 
normally generated during cell metabolism and PCa cells generate a 
higher amount of ROS proportionally to an aggressive phenotype. High-
density lipoprotein (HDL) particles are known to prevent atherosclerosis 
through different mechanisms, including their antioxidant properties. Thus, 
the aim was to assess in two human PCa cell lines (LNCaP-androgen 
dependent, and PC3-androgen independent) whether antioxidant 
properties of HDL were able to reduce oxidative stress and the related cell 
proliferation. 
Methods: HDL isolation from plasma of healthy human volunteers, RNA 
isolation, qPCR, cell proliferation and cell cycle analysis. 
Results: H2O2 induced oxidative stress in LNCaP (62.6%) and PC3 
(27.7%) cells. This effect was counteracted by HDL. A 72-h treatment with 
5M H2O2 increased LNCaP (25%) and PC3 (43%) cell growth. HDL pre-
treatment abolished H2O2-driven LNCaP and PC3 cell proliferation. 
LNCaP cells seeded at 10% FBS (control) resulted in 82% of cells in G0-
G1 phase, 3% in S phase and 15% in G2-M phase. H2O2 increased G2 
phase (25%), whereas concomitant treatment with HDL restored a 
condition similar to the control. PC3 cells (control, 5%FBS) showed 64% 
of cells in G0-G1 phase, 4% in S phase and 32% in G2-M phase. H2O2 
treatment increased G2 phase up to 52%, whereas the addition of HDL 
resulted in cell-cycle phase distribution similar to the control. 
Conclusions: HDL exerts antioxidant activities on androgen-dependent 
and castration-resistant PCa cell lines, thus limiting cell proliferation 
induced by ROS. 
 
C8 Crosstalk Between NF-κB and Shh Pathways in Prostate 
Cancer 
D. Vecchiotti1, D. Verzella1, D. Capece1, M. Fischietti1, B. Di Francesco1, 
M. Di Vito Nolfi1, S. Meschini2, A. Tessitore1, E. Alesse1, F. Zazzeroni1 
1University of L'Aquila, L'Aquila, Italy; 2Istituto Superiore Di Sanita', Rome, 
Italy 
Background: Prostate cancer (PCa) is the most commonly diagnosed 
cancer in men. Common genomic alterations in PCa involve  AR and PI3K 
pathways, rearrangements of ETS and loss of function of  NKX3.1. In 
addition, constitutive activation of both NF-κB transcription factor and 
Hedgehog (Hh) pathway were suggested to play a role during the 
development and progression of PCa. This project aimed to investigate 
the  crosstalk between NF-κB and Hh pathways in prostate cancer. 
Methods: PCa cell lines and BPH-1 were cultured in standard conditions. 
RelA silencing was performed by lentiviral infection of pLentiLox3.7-
human RelA shRNA. NF-κB-p65, Shh and Gli1 IHC was performed on 
prostate cancer-normal tissue array (CA3; SuperBioChips Tissue). 
Immunofluorescence, Western blots, Q-PCRs, MTS assay, NF-κB-DNA-
binding assay (TransAMTM) were performed following standard protocols. 
Results: Strong correlation between NF-κB activation and Shh and Gli1 
expression was observed. Hyperactivation of both NF-κB and Hh 
pathways were shown in androgen-independent PC-3 and Du145 cell 
lines, which correlate with the higher proliferative rate of these cell lines 
compared to androgen-dependent cell lines. Knockdown of RelA 
significantly decreased Gli1 levels but had no effect on SHh expression. 
As expected, a significant reduction of proliferative capacity was observed 
in RelA knockdown cell lines. 
Conclusions: We demonstrated a close relationship between Gli1 and 
NF-κB in human PCa. Knockdown of NF-κB subunits resulted in 
decreased GLI1 expression, indicating that NF-κB is a regulator of Gli1 
expression. Further experiments are needed to demonstrate whether NF-
κB regulates Gli1 at a transcriptional or post-transcriptional level. 
 
C9 The Role of KCTD11 Tumor Suppressor Gene in Prostate 
Cancer 
B. Di Franceso1, D. Verzella1, M. Fischietti1, D. Vecchiotti1, D. Capece1, V. 
Mastroiaco1, A. Tessitore1, F. Zazzeroni1, A. Gulino2, E. Alesse1 
1University of L'Aquila, L'Aquila, Italy; 2University of Rome, La Sapienza, 
Rome, Italy 
Background: The loss of tumor suppressor genes seems to be an 
important event in the onset of prostate cancer (PCa). An increased 
frequency of loss of heterozygosity (LOH) in the 17p13 locus suggests 
that the loss of genes located in this region may have an important role in 
PCa progression. Interestingly, KCTD11 maps to 17p13.2 and its 
expression was reduced in several human cancers by either LOH and 
methylation. KCTD11 was shown as an inhibitor of the sonic-
hedgehog/patched/Gli-1 pathway and as an hypoxia-regulated gene. 
Methods: KCTD11 IHC analysis was performed on cancer-normal tissue 
array (CA3; SuperBioChips Tissue Array). Human prostate cancer cell 
lines were cultured in standard conditions. KCTD11 overexpression was 
obtained by retroviral infection. qPCR, proliferation assay, Western blot 
and LOH analyses were performed following standard protocols. Cell 
cultures in hypoxic conditions were performed using a Galaxy 48R New 
Brunswich incubator. 
Results: Nuclear KCTD11 expression was strongly reduced in primary 
prostate cancer and this event correlated with overexpression of proteins 
acting on the Hedgehog pathway, such as Gli1 and Patch1. Low levels of  
KCTD11  mRNA have been also observed in PCa cells; conversely 
ectopic overexpression of  KCTD11 led to growth arrest. Notably, hypoxia 
significantly induced KCTD11 gene expression. 
Conclusions: Our study demonstrates that KCTD11 as well as negatively 
regulated downstream effectors belonging to Hedgehog signaling play a 
role in the pathogenesis of prostate cancer. All together, these results 
underline KCTD11 as a possible diagnostic and therapeutic marker in 
prostate cancer. 
 
C10 HDAC4 and HDAC6 Protect Glioblastoma Cells from 
Radiotherapy-Induced Cell Death 
G. Gravina1, F. Marampon1, A. Colapietro1, S. Pompili1, A. Vetuschi1, R. 
Sferra1, E. Di Cesare1, C. Festuccia1 
1University of L'Aquila, L'Aquila, Italy 
Background: Glioblastoma (GBM) radioresistance restricts the curative 
potential of radiotherapy  (RT) and HDACs inhibitors have been shown to 
affect GBM radioresistance through unknown molecular mechanisms. 
Methods: HDAC4 or HDAC6 expression in U87MG p53WT and U251MG 
p53MT GBM cell lines was silenced by HDAC4- or HDAC6-shRNA. 
Radiation response and related molecular networks were investigated 
using in vitro experimental assays. HDAC4 and HDAC6 levels were 
assessed immunohistochemically on paraffin-embedded tumor samples 
from 31 GBM patients subjected to temozolomide and radiotherapy 
combined treatment. 
Results: In vitro experiments show that silencing HDAC4 or HDAC6 
radiosensitized GBM cells by promoting DNA double-strand break (DSBs) 
accumulation, preventing RT-induced DNA-PKcs or -ATM nuclear 
translocation and finally promoting U251MG apoptosis- or U87MG 
autophagy-mediated RT-induced cell death. Silencing HDAC4 
predisposed GBM cells to RT-induced p21WAF1/CIP1-mediated cellular 
senescence in a p53WT dependent manner. Furthermore, silencing 
HDAC4 or HDAC6 reduced GBM stemness potential. HDAC-4 positivity 
was found in 29 (93.5%) out of 31 GBM lesions, 22 (70.9%) showed  high 
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and 7 (22.6%) low HDAC4 expression. HDAC6 positivity was found in 30 
(96.7%) out of 31 GBM lesions, 22 (70.9%) showed high and 8 (25.8%) 
low HDAC6 expression. By analyzing retrospective data of these patients, 
we found that high intensity of HDAC4 and/or HDAC6 
immunohistochemical staining was shown to predict poor prognosis. 
Conclusions: Altogether, these observations suggest that HDAC4 and 
HDAC6 are guardians of RT-induced DNA damages and stemness, thus 
promoting radioresistance and  represent potential prognostic markers 
and therapeutic targets for GBM. 
 
C11 NGF Sensitizes TrkA SH-SY5Y Neuroblastoma Cells to 
TRAIL-Induced Apoptosis 
L. Gneo1, P. Ruggeri1, L. Cappabianca1, A.R. Farina1, A.R. Mackay1 
1University of L'Aquila, L'Aquila, Italy 
Background: APO2L/TRAIL is a promising chemotherapeutic agent with 
pro-apoptotic action on tumour but not non-transformed cells. 
Neuroblastoma (NB) originates from neuroblasts transformed at different 
stages along the sympatho-adrenal lineage, blocked in differentiation and 
selected for apoptosis-resistance by oncogene activation, onco-
suppressor inactivation and physiological apoptosis protection 
mechanism(s), the characterization of which are critical for developing 
novel pro-apoptotic therapeutic strategies. Therapeutic TRAIL application 
in NB, however, has been hampered by observations of TRAIL resistance 
in NB models. Here we characterize a novel mechanism for sensitizing 
SH-SY5Y NB cells to TRAIL-induced apoptosis, involving nerve growth 
factor (NGF) and its receptor TrkA. 
Methods: cFLIP, Bcl-xL and dominant negative NF-κB expression; siRNA 
cFLIP and Mcl-1 knockdown; RT-PCR; tumour growth in soft agar; TRAIL-
activated TRAIL-receptor complex purification; apoptosis and death 
assays; immunoprecipitation-Western blotting. 
Results: Non-transfected, control and TrkA-transfected SH-SY5Y cells 
expressed all components for TRAIL-induced apoptosis but exhibited 
cFLIP-dependent TRAIL-resistance. NGF sensitized TrkA but not non-
transfected or control-SH-SY5Y cells to TRAIL-induced type II apoptosis 
through the intrinsic pathway.   NGF induced TrkA binding of cFLIP and 
reduced cFLIP recruitment to TRAIL-receptor complexes, consistent with 
cFLIP sequester.  NGF effects were temporary and eventually prevented 
by NGF-stimulated Mcl-1 expression but optimised by siRNA Mcl-1 
knockdown. 
Conclusions: This novel pro-apoptotic immunological dimension for 
NGF/TrkA in sensitizing NB cells to TRAIL-induced apoptosis identifies 
TrkA as a novel competitive regulator of TRAIL-induced apoptosis, 
depends  upon TrkA sequester of cFLIP, helps to explain TrkA association 
with better prognosis in NB, and provides a potential pro-apoptotic 
therapeutic strategy for NGF, TRAIL, and MCL-1 inhibitor use in TrkA 
expressing NB. 
 
C12 Lack of Glutamine Synthetase Marks Glutamine 
Auxotrophy of Human Oligodendroglioma Cells 
M. Chiu1, C. Sabino1, R. Andreoli1, G. Taurino1, M.G. Bianchi1, O. 
Bussolati1 
1University of Parma, Parma, Italy 
Background: Besides protein synthesis, the amino acid glutamine plays 
several other metabolic roles, such as precursor of other non essential 
amino acids or, in several tumor cells, anaplerotic substrate and mTORC1 
activator. Glutamine synthetase (GS, coded by GLUL) catalyzes the 
synthesis of glutamine and may play important regulatory roles. 
Oligodendroglioma (OD) is a rare brain tumor often characterized by GS 
negativity. Here we investigate GS expression and the metabolic role of 
glutamine in cultured OD cells. 
Methods: Human OD cell lines Hs683 and HOG were grown at 4 mM 
glutamine. Intracellular metabolite content was measured with LC-MS/MS. 
Radiolabeled leucine was used for protein synthesis evaluation and 
radiolabeled glutamine for transport. Transient expression of GS was 
obtained with pCMV-GLUL vector. 
Results: OD cells had a negligible expression of GS, even upon 
glutamine starvation. This condition severely reduced cell glutamine and 
glutamate (but not the anaplerotic substrate α-ketoglutarate), hindered 
protein synthesis, activated caspase-3, and caused massive cell death. 
However, mTORC1 was inhibited in HOG but not in Hs683 cells. The 
inhibition of SNAT1/2 glutamine transporters lowered intracellular 
glutamine and leucine, inhibited mTORC1, and hindered cell proliferation. 
Non-essential amino acids, but not α-ketoglutarate, partially rescued 
viability of glutamine-deprived cells. Upon glutamine starvation, viability 
and protein synthesis were partially restored by GLUL transfection. 
Conclusions: In GS-negative OD cells glutamine starvation is markedly 
cytotoxic. Cytotoxicity is neither due to anaplerosis failure nor to mTORC1 
inhibition but, rather, to protein synthesis suppression, partially relieved by 
GS expression. Thus, human OD may exemplify a glutamine-auxotroph 
tumor. 
 
C13 Glutathione is a Key Player in the Multidrug Resistance 
of Neuroblastoma 
R. Colla1, R. Colla1, N. Traverso1, A. Izzotti1, C. De Ciucis1, A. Pulliero1, M. 
Pronzato1, C. Domenicotti1, B. Marengo1 
1University of Genova, Genova, Italy 
Background: The availability of antioxidants is recognized as one of the 
critical factors that are able to make cancer cells resistant to therapies. 
Several studies have demonstrated that chemoresistant phenotypes 
display high levels of glutathione (GSH), which is crucial to maintain 
reactive oxygen species (ROS) under the cytotoxic limit preventing cancer 
cell death. 
Methods: HTLA-230, a human MYCN-amplified neuroblastoma cell line, 
was chronically treated with etoposide at a concentration that in vitro 
mimics the clinically-used dose. The selected cells (Etopo-R) were 
exposed to higher doses of etoposide or doxorubicin and their multidrug 
resistance (MDR) was tested. In order to investigate the role of GSH in 
MDR, Etopo-R were pre-treated with buthionine sulfoximine (BSO, a 
GSH-depleting agent) or N-acetylcysteine (NAC, able to promote GSH 
biosynthesis). Cell response was evaluated in terms of cell viability, 
tumorigenicity, and oxidative status (ROS production, GSH levels, and 
activity of GSH-related enzymes). 
Results: Etopo-R cells are highly tumorigenic and acquire MDR, 
becoming less sensitive than parental cells to etoposide or doxorubicin. 
They are characterized by up-regulation of catalase and glutathione-S-
transferase activity, have higher levels of GSH and over-express γ-
glutamylcysteine ligase, a crucial enzyme in GSH biosynthesis. Treatment 
of Etopo-R cells with BSO markedly reduces their tumorigenic potential 
that is instead enhanced by the exposure to NAC. 
Conclusions: Collectively, our results demonstrate that GSH and GSH-
related responses are crucially involved in the acquisition of MDR of 
neuroblastoma cells.  We propose this antioxidant molecule as a 
therapeutic and predictive target (Grants from Genoa University). 
 
C14 c-Myc Sustains Transformed Phenotype and Promotes 
Radioresistance of Embryonal Rhabdomyosarcoma Cell Lines 
F. Marampon1, G. Gravina1, C. Festuccia1, A. Colapietro1, P. Sanità1, S. 
Delle Monache1, F. Marampon1 
1University of L'Aquila, L'Aquila, Italy 
Background: We have previously reported that the MEK/ERK pathway 
sustains in vitro and in vivo transformed phenotype and radioresistance of 
embryonal rhabdomyosarcoma (ERMS) cell lines. Furthermore, we found 
that aberrant MEK/ERK signaling activation promotes c-Myc oncoprotein 
accumulation. 
Methods: In this study, the role of c-Myc in sustaining the ERMS 
transformed and radioresistant phenotype is characterized. RD and 
TE671 cell lines conditionally expressing MadMyc chimera protein, c-Myc-
dominant negative, and shRNA directed to c-Myc were used. 
Results: Targeting c-Myc counteracted in vitro ERMS adherence and in 
suspension, growth motility and the expression of pro-angiogenic factors. 
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c-Myc depletion decreased MMP-9, MMP-2, u-PA gelatinolytic activity, 
neural cell adhesion molecule sialylation status, HIF-1α, and VEGF, and 
increased TSP-1 protein expression levels. Rapid but not sustained 
targeting c-Myc radiosensitized ERMS cells by radiation-induced 
apoptosis, DNA damage and impairing the expression of DNA repair 
proteins RAD51 and DNA-PKcs, thereby silencing affected ERMS 
radioresistance. c-Myc sustains ERMS transformed phenotype and 
radioresistance by protecting cancer cells from radiation-induced 
apoptosis and DNA damage, while promoting radiation-induced DNA 
repair. 
Conclusions: These data suggest that c-Myc targeting can be tested as a 
promising treatment in cancer therapy. 
 
C15 MEKs/ERKs/c-Myc Pathway Sustains EphA2 Receptor 
Signaling: Effect of Targeting on Growth Arrest, Myogenic 
Differentiation, and Onco-Phenotype Reversal in 
Rhabdomyosarcoma Cells 
A. Colapietro1, G. Gravina1, C. Ciccarelli1, C. Dominici2, F. Maggiorini2, C. 
Festuccia1, F. Marampon1 
1University of L'Aquila, L'Aquila, Italy; 2University of Rome “Sapienza, 
Rome, Italy 
Background: Expression of EphA2 receptor is frequently aberrant in a 
variety of malignancies and correlates with poor prognosis. EphA2 acts as 
a tumor promoter through a ligand ephrin-independent mechanism, which 
requires phosphorylation of EphA2 on serine 897 (S897). The 
RAS/MEKs/ERKs/c-Myc axis sustains  in vitro and in vivo growth potential 
and counteracts differentiation of RAS-constitutive-active embryonal 
rhabdomyosarcoma (ERMS) cell lines. 
Methods: The aim of this study was to investigate the role of EphA2 
signaling in sustaining ERMS cell lines RD and TE671 oncogenic 
phenotype and its relationship with the RAS/MEKs/ERKs/c-Myc axis. A 
new synthesized antagonist of S897-EphA2 phosphorilation and selective 
shRNAs were used for the in vitro experiments. The EphA2 protein levels 
of 33 microdissected ERMS patient samples were evaluated by Western 
blotting. 
Results: We demonstrate that EphA2 ligand ephrin-independent signaling 
inhibition induced G2/M growth arrest, reversal of anchorage-independent 
growth, and rescued the myogenic program by inducing myogenin 
expression and the acquisition of the myogenic-like phenotype in ERMS 
cells.  
Conclusions: These results suggest that EphA2 is a key downstream 
target of the MEK/ERK/c-Myc signaling pathway in the regulation of 
rhabdomyosarcomagenesis. 
 
C16 Endogenous Lysyl Oxidase in Tumor Progression and 
Collagen Stiffness: Study Performed In Human Clear Cell Renal Cell 
Carcinoma Primary Cell Cultures 
B. Torsello1, C. Bianchi1, G. Bovo2, V. Cassina1, S. De Marco1, C. 
Meregalli1, S. Bombelli1, P. Viganò3, G. Strada3, R.A. Perego1 
1School of Medicine and Surgery, Milano-Bicocca University, Monza, Italy; 
2Anatomo-Pathology Unit, San Gerardo Hospital, Monza, Italy; 3Urology 
Unit, Bassini ICP Hospital, Milano, Italy 
Background: In human clear cell renal cell carcinoma (ccRCC), VHL 
gene inactivation leads to stabilization of hypoxia inducible factors (HIFs). 
The lysyl oxidase gene  (LOX), a HIF-1α target, codes the inactive 
proenzyme (Pro-Lox) which, secreted and proteolysed, produces the 
active enzyme (Lox) and the pro-peptide (Lox-PP). Lox, increasing 
extracellular matrix stiffness by collagen crosslinking, promotes tumor 
progression and metastasis. Lox and Lox-PP can reenter the cells where 
Lox promotes cell proliferation and invasion, while Lox-PP acts as tumor 
suppressor. We performed, for the first time in ccRCC, a detailed study of 
endogenous LOX using ccRCC primary cell cultures. 
Methods: 24 ccRCC patients enrolled. Primary cell cultures were 
obtained from tumor and matched normal renal cortex samples. Protein 
expression was evaluated by Western blot, IHC, IF. LOX silencing was 
performed by siRNA. Apoptosis, proliferation, migration, invasion, 
adhesion assays were performed. Collagen stiffness was measured by 
atomic force microscopy. 
Results: Conditioned media of ccRCC cells, which overproduced and 
secreted active Lox, increased collagen matrix stiffness associated with 
activation of FAK/SRC signaling and a more invasive phenotype. The lack 
of Lox-mediated crosslinking action prevented matrix stiffness increment. 
The absence of endogenous LOX heavily impaired the invasion capacity 
of ccRCC cells on collagen. The oncosuppressive action of Lox-PP was 
not prevailing in ccRCC. 
Conclusions: In ccRCC cells endogenous LOX overexpression, favored 
by constitutive HIF-1α, plays a major action in tumor progression, 
promoting cellular adhesion, migration, and collagen matrix stiffness. 
These findings could indicate new therapeutic strategies by targeting 
selectively the different LOX peptides in ccRCC.    
Acknowledgement: Supported by A.G.S. Onlus 
 
C17 Keap1/Nrf2 Pathway In Kidney Cancer: Frequent 
Methylation of Keap1 Gene Promoter In Clear Renal Cell Carcinoma 
F. Fabrizio1, M. Costantini2, M. Copetti1, A. la Torre1, A. Sparaneo1, A. 
Fontana1, M. Poeta3, M. Gallucci4, S. Sentinelli4, P. Graziano1, P. 
Parente1, V. Pompeo4, L. De Salvo4, G. Simone4, R. Papalia4, F. Picardo2, 
T. Balsamo1, G.P. Flammia2, D. Trombetta1, A. Pantalone2, K. Kok5, L. 
Muscarealla1, V. Fazio1 
1IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy; 
2University Campus Bio-Medico, Roma, Italy; 3Biotechnology and 
Biopharmaceutics, University of Bari, Bari, Italy; 4Regina Elena National 
Cancer Institute, Roma, Italy; 5University of Groningen, Groningen, 
Netherlands 
Background: The Keap1/Nrf2 pathway is a master regulator of the 
cellular redox state through the induction of several antioxidant defence 
genes implicated in chemotherapeutic drug resistance of tumor cells. An 
increasing body of evidence supports a key role for the Keap1/Nrf2 
pathway in kidney diseases and renal cell carcinoma (RCC), but data 
concerning the molecular basis and the clinical effect of its deregulation 
remain incomplete. 
Methods: Here we present a molecular profiling of the KEAP1 and 
NFE2L2 genes in five different renal cell carcinoma histotypes by 
analysing 89 tumor/normal paired tissues: clear cell renal carcinoma 
(ccRCC); oncocytoma; papillary renal cell carcinoma type 1 (PRCC1); 
papillary renal cell carcinoma type 2 (PRCC2); and chromophobe cell 
carcinoma. 
Results: A tumor-specific DNA methylation of the KEAP1 gene promoter 
region was frequently found only in ccRCC subtype (18/37, 48.6%) and a 
direct correlation with mRNA levels was confirmed by in vitro 5-
azacytidine treatment. Analysis of an independent data set of 481 ccRCC 
tumors corroborates these findings and reveals a significant correlation in 
multivariate analysis of epigenetic KEAP1 silencing with the stage, 
Fuhrman grade and overall survival in ccRCC. 
Conclusions: For the first time, our molecular results present the 
epigenetic silencing of KEAP1promoter as the possible leading 
mechanism for modulation of KEAP1 expression in ccRCC and 
corroborate the driver role of Keap1/Nrf2 axis deregulation with a potential 
new function as an independent epigenetic prognostic marker in RCC. 
 
C18 Wnt Signaling Inhibitors as Promising Biomarkers of 
Osteolytic Bone Metastasis 
M.G. Marazzi1, E. Galliera1, L. Drago1, G. Banfi2, G.V. Simona1, A. 
Luzzati2, M.M. Corsi Romanelli1 
1Università degli Studi di Milano, Milan, Italy; 2IRCCS Galeazzi Orthopedic 
Institute, Milan, Italy 
Background: Despite the clinical importance of bone metastases, little is 
known about their onset and progression and current diagnostic tools lack 
the sensitivity and specificity required for clear early diagnosis. Growing 
understanding of the interaction between cancer and bone has led to the 
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identification of innovative diagnostic tools. An emerging family of 
molecules with a pivotal role in bone tumor progression and metastasis is 
the Wnt gene family. This study investigated the diagnostic potential of the 
two Wnt signaling inhibitors, sclerostin and DKK-1, to improve the 
detection of osteolytic bone metastases. 
Methods: We measured sclerostin and DKK-1, MMP-2, MMP-9, the bone 
resorption marker TRAP5b, and the metastatic marker survivin in 15 
healthy patients, in 20 patients with primary tumors, and in 20 patients 
with bone metastases. The normal distribution was verified by KS 
normality. Statistical analysis of ANOVA and correlations were performed 
by PRIMS 3.0. 
Results: Sclerostin and DKK-1 were clearly higher in primary tumor 
patients and even higher in metastatic patients compared to controls. 
DKK-1 and sclerostin were positively correlated with bone resorption 
parameters and this link was particularly strong in metastatic patients. A 
good correlation of survivin was found with DKK-1, and correlation was 
even higher with sclerostin in metastatic patients, definitely confirming the 
importance of these two Wnt signaling  inhibitors as diagnostic markers of 
bone metastases. 
Conclusions: The close correlations with metastatic markers and bone 
resorption markers makes sclerostin and DKK-1 new promising 
biomarkers in the diagnosis of bone osteolytic metastases. 
 
C19 A Rare Case of Carcinosarcoma Ex Pleomorphic 
Adenoma of the Parotid Gland with No History of Long-standing or 
Recurrent Pleomorphic Adenoma 
F.A. De Los Reyes1, S.C. Yañez1 
1UERM Memorial Medical Center, Quezon City, Philippines 
Background: The aim of this report is to describe a rare case of 
carcinosarcoma ex pleomorphic adenoma involving the left parotid gland 
with no history of a long standing pleomorphic adenoma, or a recurrent 
pleomorphic adenoma, and to describe its morphology and important 
immunohistochemistry findings. 
Methods: The histopathologic findings of the left parotid gland are 
correlated with the clinical history and ancillary procedure, and surgical 
pathology staging, including assessment of the draining lymph nodes. 
Immunohistochemistry studies, assessment of proliferative capacity, and 
possible treatment target were also done. The tumor is also compared 
with other reported cases with the same diagnosis. 
Results: Carcinosarcoma ex pleomorphic adenoma contains features of 
the two tumors under malignant mixed tumors, which are carcinosarcoma 
and carcinoma ex pleomorphic adenoma. Immunohistochemistry studies 
were done to document the epithelial and mesenchymal areas for both 
malignant and benign sections from the tumor. Immunohistochemistry 
studies were done to classify the epithelial component, consisting of 
adenocarcinoma, not otherwise specified, and sarcoma component 
consisting of myxoid and mesenchymal chondrosarcoma. 
Conclusions: Approximately ten cases of carcinosarcoma ex 
pleomorphic adenoma have been documented in scientific publication, 
even less with the background of no recurrent or prolonged untreated 
pleomorphic adenoma. The case contributes to the fund of knowledge for 
diagnosis and improvement of quality of care. 
 
C20 IGF-I/IGF-IR Transduction System Involves GPER and 
DDR1 in the Stimulation of Mesothelioma and Lung Cancer Cells 
S. Avino1, P. De Marco1, F. Cirillo1, R. Lappano1, M. Perri1, A. Belfiore2, M. 
Maggiolini1 
1University of Calabria, Rende, Italy; 2University Magna Graecia of 
Catanzaro, Catanzaro, Italy 
Background: The insulin-like growth factor-I (IGF-I)/IGF-I receptor (IGF-
IR) transduction system cooperates with various pathways toward the 
stimulation of cancer growth and resistance to antitumor agents. In this 
regard, it has been recently reported that IGF-IR-mediated signaling 
triggers a functional crosstalk with the G protein estrogen receptor 
(GPER) and the tyrosine kinase receptor, collagen discoidin domain 
receptor 1 (DDR1), in different types of malignant cells, leading to 
important biological responses like proliferation and migration. 
Methods: Real- time PCR, immunoblotting analysis and gene silencing 
experiments were performed to ascertain the regulation of GPER and 
DDR1 at both mRNA and protein levels upon IGF-I treatment in IST-MES1 
mesothelioma and A549 lung cancer cells. Luciferase assays were also 
performed to evaluate the ability of IGF-I to transactivate promoter 
constructs like GPER and its target genes such as CTGF and EGR1. 
Chemotactic motility and migration were determined as biological 
responses to IGF-I stimulation. 
Results: We found that IGF-I induces GPER expression through the IGF-
IR/ERK/p-38 transduction signaling in both IST-MES1 and A549 cells. 
Next, we ascertained that in these cells IGF-I triggers the expression of 
GPER and DDR1 target genes like CTGF, EGR1, MATN-2, FBN-1, 
NOTCH 1 and HES1, stimulating chemotaxis and cell migration as 
biological counterpart. 
Conclusions: Our findings provide new insights on the mechanisms by 
which the IGF-I/IGF-IR system exerts a stimulatory action in 
mesothelioma and lung cancer cells, thus suggesting novel potential drug 
targets to be considered in these aggressive malignancies. 
 
C21 A Knowledge-Base Approach and Bioinformatic Analysis 
to Highlight the Role of MicroRNAs in the Pathogenesis of Malignant 
Mesothelioma 
L. Micolucci1, M. Akhtar1, A. Giuliani1, E. Mensà2, M. Rippo1, R. Lazzarini1, 
F. Olivieri1, A. Procopio1 
1Università Politecnica delle Marche, Ancona, Italy; 2Italian National 
Research Center on Aging (INRCA-IRCCS), Ancona, Italy 
Background: MicroRNAs (miRNAs) are endogenous, non-coding, small 
RNAs able to modulate gene expression at the post-transcriptional level 
with a fundamental role in multiple cellular processes and regulatory 
pathways. Aberrantly expressed miRNAs are correlated to the 
pathogenesis of numerous cancers including malignant mesothelioma 
(MM). MM is an asbestos-related lethal cancer, poorly responsive to 
current treatments. Recently a systematic review and qualitative meta-
analysis identified a pool of high-confidence MM-associated miRNAs 
(mesomiRs) with potential clinical relevance. Herein we aimed to define 
the role of mesomiRs on the pathogenetic mechanism underling MM 
tumorigenesis. 
Methods: A data mining approach and bioinformatic analysis on 
mesomiRs were combined to predict their role in the disruption of key 
pathways in the pathogenesis of MM. The results obtained were 
integrated with multiple sources of biological data to build the pathways 
and the global network. 
Results: We have developed a knowledge base of the molecular 
constituents of pathways and networks whose members, both miRNAs 
and proteins, are mutated in MM. MesomiRs appear strongly involved in 
multiple pathways deregulated in cancer, such as signaling pathways 
regulating pluripotency of stem cells, apoptosis, cell cycle, PI3K-Akt, p53, 
TGF-β, FoxO signaling pathways, focal adhesion and adherens junction. 
Together, we demonstrated the ability of our approach to prioritize miRNA 
targets and to identify relevant deregulated pathways. These findings may 
provide a new rationale for new therapeutic approach and drug discovery. 
Conclusions: In this study, we present a reliable method to consolidate a 
bridge between aberrant microRNA expression and MM pathogenesis as 
a basis for further investigations. 
 
C22 Expression of p60-CAF-1 (Chromatin Assembly Factor-1) 
in Patients with Oral Squamous Cell Carcinoma (OSCC) 
L. Postiglione1, G. Ilardi1, G. Di Spigna1, E. Abete1, D. Russo1, F. Merolla1, 
M. Romano1, A. Sangermano2, E. Varriale2, M. Mascolo1, S. Staibano1 
1University of Naples "Federico II", Naples, Italy; 2Dia-Chem Srl - 
Molecular Biology, Naples, Italy 
Background: Head and neck squamous cell carcinoma (HNSCC) is the 
sixth most common human cancer, and is a major cause of cancer-related 
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mortality. HNSCC represents a major current public health problem. Oral 
squamous cell carcinoma (OSCC) represents the majority of HNSCC. 
P60-CAF-1 (chromatin assembly factor 1)-protein is a highly efficient 
epigenetic regulator of cell replication and DNA-repair in eukaryotic cells.  
We have evaluated the expression of the p60-CAF-1 protein both by IHC, 
on formalin-fixed, paraffin-embedded (FFPE) tumor tissues samples and 
in peripheral blood samples by ELISA assay. 
Methods: We collected tissue samples from 9 patients who underwent 
surgery for OSCC of the tongue, floor and palate, and normal control 
tissue.   The protein-expression study was performed by 
immunohistochemistry on FFPE tumor tissues using anti-CAF-1 p60 
antibody.   ELISA assay was determined using:  primary antibody; HRP 
conjugated secondary antibody; substratum TMB activity. 
Results: CAF-1/p60 protein was found overexpressed on all OSCC tumor 
tissue samples; the same samples showed high protein levels as detected 
by ELISA assay. The results observed by ELISA were: controls (as mean 
± S.D.) 29,5±8,5 U.I./ml; patients (as mean ± S.E.) 50,2±4,7 U.I./ml. 
Conclusions: Preliminary results are the basis to expand the study of 
further cases with a prolonged follow-up. We can assume that elevated 
blood levels of p60-CAF-1 protein may correspond to more aggressive 
tumors with an unfavorable outcome. Such a protein-expression profile 
could constitute the basis for a novel prognostic and predictive algorithm 
to be used in addition to the standard diagnostic protocols for OSCCs. 
 
C23 Institution of Head and Neck Paraganglioma Cell Lines 
and Effects of Drugs Interfering with Tumor Metabolism 
R. Florio1, L. De Lellis1, V. di Giacomo1, M. Gallorini1, A. Natale1, M. Di 
Marcantonio1, F. Verginelli1, D. Verzilli1, R. Mariani Costantini1 
1University of Chieti, Chieti, Italy 
Background: Head and neck paragangliomas (HN-PGLs) are relatively 
rare tumors that cause important morbidity. At present, surgery is the only 
therapeutic option. HN-PGLs are often linked to germline mutations in 
succinate dehydrogenase genes (SDHx), encoding mitochondrial complex 
II subunits involved in the tricarboxylic acid cycle. No commercial cell line 
is available. 
Methods: HN-PGLs cell lines were established from two patients carrying 
germline SDHx mutations to test molecules active on tumor metabolism. 
Viability in treated and untreated cells was tested by MTT. Effects of 
treatments on cell cycle and apoptosis were analyzed by flow cytometry 
and Western blot. Clonogenic ability and cell migration after treatment 
were also examined. 
Results: Since both HN-PGL cell lines derived from patients with germline 
defects in a gene encoding an SDHx enzyme we tested the effects of 
three drugs active on tumor metabolism: the pyruvate kinase inhibitor 
dichloroacetate (DCA), the antagonist of the PPARA nuclear receptor 
GW6471, and the antidiabetic drug metformin. DCA and GW6471 affected 
viability of both HN-PGL cell lines and reduced clonogenic activity. 
Treatment with DCA or GW6471 induced apoptosis in both HN-PGL cell 
lines. However, the effect of the two drugs on cell cycle was different. Also 
metformin appears to drastically affect viability of both cell lines. 
Conclusions: The establishment of HN-PGL cell lines provides the 
opportunity to study pathophysiology and therapeutic molecules in this 
rare tumor. DCA, GW6471, and metformin are active in HN-PGLs, 
providing a rationale for testing the antitumor effect of these and additional 
metabolic drugs as single agents or in combination. 
 
C24 Glutamine Addiction and Low Expression of Glutamine 
Synthetase Underlie Glutamine Dependence of Human Multiple 
Myeloma Cells: A New Attractive Therapeutic Strategy 
M. Chiu1, M. Bolzoni1, F. Accardi1, C. Sabino1, M.G. Bianchi1, R. Andreoli1, 
R. Vescovini1, I. Airoldi2, G. Missale3, N. Giuliani1, O. Bussolati1 
1University of Parma, Parma, Italy; 2 Istituto Giannina Gaslini, Genova, 
Italy; 3University-Hospital of Parma, Parma, Italy 
Background: Glutamine supports the growth of several types of cancers 
through glutaminolysis-dependent anaplerosis. However, glutamine 
metabolism has never been investigated in multiple myeloma (MM), 
although hyperammonemia, an indicator of sustained glutaminolysis, was 
described in relapsed/refractory MM patients. 
Methods: 64 patients with plasma cell dycrasias were included in this 
study together with human myeloma cell lines (HMCLs: RPMI 8226, 
OPM2, JJN3, KMS-12-BM, XG1). NH4+ was assessed in bone marrow 
(BM) plasma with a biochemical assay. Amino acid BM plasma content 
was determined by HPLC. Either glutamine-free incubation or the 
glutaminolytic enzyme L-asparaginase from E. chrysanthemi was used for 
glutamine starvation. Intracellular metabolites were measured with LC-
MS/MS. L-[4,5-3H] glutamine was used for transport studies. Stable 
ASCT2 silencing was obtained with an anti-SLC1A5 shRNA vector. SCID-
NOD mice were injected subcutaneously with ASCT2-silenced or 
scramble transfected JJN3 cells. 
Results: MM patients have higher BM plasma NH4+ and glutamate, but 
lower glutamine than patients with indolent monoclonal gammopathies. 
Both CD138+ cells from patients and HMCLs exhibited glutamine-
dependent NH4+ production. High glutaminase and low-to-absent 
glutamine synthetase expression were observed in HMCLs and in CD138+ 
cells. In HMCLs, glutamine starvation decreased intracellular glutamine, 
glutamate and α-ketoglutarate, inhibited mTORC1, and triggered 
apoptosis. Furthermore, silencing of the ASCT2 transporter significantly 
impaired glutamine uptake and MM cell growth, along with JJN3 tumor 
growth in rodents. 
Conclusions: MM cells show features of glutamine-addiction,and, due to 
low expression of glutamine synthetase, their proliferation depend upon 
glutamine uptake. Glutamine availability and metabolism may therefore 
constitute novel therapeutic targets in MM. 
 
C25 ErbB Receptors and BER Pathways in Human Gastric 
Tumours: Molecular Implication of Oxidative Stres. 
L. Savino1, M. Di Marcantonio1, C. Moscatello1, G. Aceto1, P. Raimondi2, 
A. Cichella2, R. Cotellese1, P. Innocenti1, G. Mincione1, R. Muraro1 
1University "G.d'Annunzio" Chieti-Pescara, Chieti, Italy; 2Unit of General 
and Laparoscopic Surgery, SS Annunziata Hospital, Chieti, Italy 
Background: Deregulation and cross-talk of intracellular signals have 
been shown to be the driving forces in cancers. In this study, ErbB and 
BER pathways in neoplastic gastric tissues and cells, as a molecular 
signature for tumor progression, were investigated. 
Methods: ErbBs and BER molecular signaling genes and proteins were 
evaluated in the gastric carcinoma cell line AGS in basal condition and 
after single or combined treatments with H2O2, EGF and LY294002 and in 
primary gastric carcinoma tissues by RT-qPCR and Western blot. 
Results: Increased levels of pEGFR and pMAPK were detected in AGS 
cells after treatments with H2O2, although EGFR expression did not show 
any significant change. In addition, H2O2 treatment downregulated pAKT, 
as compared to control or EGF-treated cells. PARP-1 expression was 
decreased after H2O2 treatment, while OGG1 protein and gene expression 
decreased with LY294002 treatment, suggesting an Akt-dependent 
mechanism. An upregulation of ErbB2 gene expression was observed 
after EGF treatment, while ErbB4 expression increased with H2O2 and 
LY294002. Nrf2 and APE1 gene expression levels were reduced by H2O2 
and LY294002 combined treatments. Data on gastric tissues showed that 
EGFR, highly expressed in intestinal-type, diffuse-type gastric carcinomas 
and their normal counterparts, was not phosphorylated in all cases. In 
contrast, diffuse-type carcinomas showed increased pMAPK, pAKT and 
OGG1 expression, as compared to control tissues. ErbB2 and Mutyh gene 
expression levels were higher in intestinal-type than in diffuse-type 
carcinomas, while ErbB4 showed an opposite expression pattern. 
Conclusions: These data indicate that oxidative stress modify EGFR and 
BER signaling, suggesting an integrated role between these pathways. 
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C26 Two Simultaneous and Very Uncommon PI3KCA 
Mutations in a Liver Metastasis from a Colorectal Cancer Patient with 
Aggressive and Resistant Disease 
A. Tessitore1, G. Bruera1, V. Mastroiaco1, K. Cannita2, A. Cortellini2, A. 
Dalmas3, F. Zazzeroni1, C. Ficorella1, E. Ricevuto1, E. Alesse1 
1University of L'Aquila, L'Aquila, Italy; 2S.Salvatore Hospital Medical 
Oncology Unit, L'Aquila, Italy; 3S.Salvatore Hospital Pathology Unit, 
L'Aquila, Italy 
Background: Colorectal cancer (CRC) is a widespread tumor. 
KRAS/NRAS genotype drives metastatic CRC treatment with targeted 
therapies. The prognostic and predictive significance of other genes 
(PIK3CA, BRAF) is under investigation. Here, we describe a CRC patient 
carrying a KRAS and two very uncommon PIK3CA mutations in liver 
metastasis. 
Methods: Primary CRC and metastatic liver tumor samples were 
collected from an early-onset patient with synchronous metastases, 
treated with first-line intensive triplet chemotherapy plus bevacizumab 
(FIr-B/Fox). KRAS/NRAS (exons 2, 3, 4), BRAF (exon 15), PI3KCA 
(exons 9, 20) were analyzed by direct sequencing. PTEN, Akt and S473p-
AKT were examined by immunohistochemistry. 
Results: The KRAS exon 2 c.34G>A, G12S mutation was detected in 
primary tumor and liver metastasis. Two PIK3CA exon 9 mutations on the 
same allele (c.1633G>C, E545Q; c.1645G>C, D549H) were detected only 
in the latter sample. Interestingly, the c.1633G>C mutation was reported 
with very low frequency in databases; on the contrary, the c.1645G>C 
mutation was never described in CRC, although it was reported in just two 
samples from hepatocellular and cervical carcinoma. 
Immunohistochemistry analysis revealed PTEN expression and 
differences in Akt and p-AKT expression between primary and metastatic 
samples. The patient showed aggressive and resistant disease (7 months 
PFS, 15 months OS). 
Conclusions: A KRAS and two rare PI3KCA mutations, one never 
reported in CRC, are described in liver metastasis from a patient with very 
aggressive disease. Differences were detected in Akt and p-Akt 
expression by comparing primary tumor/metastasis, leading to the 
hypothesis of a functional role of these rare PI3KCA mutations in cancer 
aggressiveness. 
 
C27 Magnesium Homeostasis Goes Awry in Chemoresistance 
A. Cazzaniga1, L. Locatelli1, A. Sargenti2, V. Trapani3, S. Castiglioni1 
1Università degli Studi di Milano, Milano, Italy; 2Università Alma Mater di 
Bologna, Bologna, Italy; 3Università Cattolica del Sacro Cuore Roma, Italy 
Background: Chemoresistance is one of the most significant factors 
impeding the progress of cancer therapy. In addition to the over-
expression of P-glycoprotein (P-gp), other biochemical mechanisms seem 
to contribute to render cancer cells resistant to anti-cancer drugs. Since 
neoplastic cells accumulate magnesium partly through the upregulation of 
the magnesium transporter TRPM7, we focused on magnesium 
homeostasis in a model of chemoresistance, i.e., colon carcinoma LoVo 
cells sensitive (LoVo-S) or resistant (LoVo-R) to doxorubicin. 
Methods: We performed real-rime PCR and Western blot to study the 
expression of TRPM7 and MagT1 in LoVo-S and -R. We silenced TRPM7 
and MagT1 and evaluated cell proliferation by a cell counter and 
sensitivity to doxorubicin by MTT assay. Total Magnesium content was 
assessed using the fluorescent chemosensor DCHQ5. Magnesium influx 
in Mag–Fluo-4-loaded cells was performed by live confocal imaging. 
Results: In LoVo-R we found higher intracellular concentration of total 
magnesium but lower influx capacity than in LoVo-S. Interestingly, the 
distribution of magnesium is different in the two cell types. Moreover, in 
LoVo-R we detected lower levels of TRPM7, involved in the transport of 
divalent cations, and higher amounts of another transporter, MagT1, 
which is highly specific for magnesium. Silencing TRPM7 in LoVo-S 
retarded cell proliferation and also induced the cells to shift their 
phenotype into a resistant one. Silencing MagT1 in LoVo-R markedly 
inhibited cell growth without affecting the sensitivity to doxorubicin. 
Conclusions: We conclude that in LoVo cells drug resistance is 
associated with alteration of magnesium homeostasis. 
 
C28 Biological Function of Oncogenic KRAS In Promoting 
Angiogenesis 
S. Delle Monache1, A. Calgani1, K. Cannita2, C. Ficorella2 
1University of L'Aquila, L'Aquila, Italy; 2S. Salvatore Hospital, University of 
L'Aquila, L'Aquila, Italy 
Background: Ras functions and activation of its signaling pathways is an 
important mechanism by which human cancer develops. Constitutive 
activation of the RAS pathways occurs through mutational activation of the 
RAS oncogene. Among the three RAS genes (HRAS, KRAS and NRAS) 
KRAS seems to be the most predominantly involved in tumour 
progression because of its molecular nature. It has been demonstrated 
that distinct KRAS mutations associate with specific metabolic phenotypes 
showing a distinct angiogenic profile. Although the relationship between 
KRAS and VEGF has been demonstrated, the biological role of KRAS in 
VEGF production by tumour cells is still not clarified. 
Methods: Using KRAS mutant colon cancer cell lines (SW480 and 
LS174T) and wild-type colon cancer cell line SW48, we first evaluated the 
production of VEGF by a specific ELISA assay. Moreover, to elucidate the 
function of oncogenic KRAS in promoting angiogenesis we analysed the 
effect of conditioned media (CM) derived from SW480, LS174T and SW48 
cell lines on the ability to induce tubule formation of HUVEC. By Western 
blotting analysis we also compared the Ras-activated signaling pathways 
in these cancer cell lines. 
Results: Our preliminary results suggest that oncogenic KRAS 
significantly promotes the production of VEGF from SW480 and LS174T 
cells lines. In vitro biological assays also showed that upregulated VEGF 
secretion in CM of SW480 and LS174T with respect to SW48 enhances 
the tube formation ability of HUVEC. 
Conclusions: In conclusion, our study established a direct role of KRAS 
in promoting angiogenesis in colon cancer cell lines. 
 
C29 Wnt Gene Expression in Polyposis and Colorectal Cancer 
F. Fantini1, G. Fabietti1, L. Falcone1, C. Moscatello1, C. Efthymatis2, M. 
Neri2, R. Valanzano3, G. Aceto1, A. Cama1, M. Curia1 
1University " G. d'Annunzio" of Chieti-Pescara, Chieti, Italy; 2U.O.D. 
Gastroenterologia ed Endoscopia Digestiva P.O. SS. Annunziata Hospital, 
Chieti, Italy; 3Unit of Surgery, Careggi University Hospital, Florence, Italy 
Background: Transcript dosage may influence transcriptome. To 
elucidate the role of altered gene expression in colorectal polyposis we 
analyzed APC gene expression. 
Methods: Patients with familial and sporadic polyps were enrolled 
following inclusion (age≥18 years) and exclusion (inflammatory bowel 
diseases) criteria. Donors with no family history of cancer were recruited 
as controls.We planned to recruit 20 familial adeomatous polyposis (FAP) 
cases, 50 cases of sporadic polyps, 50 cases of colorectal cancer, 50 
healthy controls. 
Results: We analyzed APC expression in colon tumour tissues and 
adjacent mucosa from 20 patients with FAP, 20 cases with sporadic 
polyps, and in normal colonic mucosa from 20 healthy controls. RT-qPCR 
results showed a reduced expression in colon tumour tissues (0.13 
2−DCT) as compared to adiacent mucosa (0.34 2−DCT). APC expression 
in adiacent colonic mucosa was higher also compared to healthy control 
colonic mucosa. The differences in APC expression between colon 
tumour tissues and adiacent mucosa in familial and sporadic cases were 
statistically significant in the familial group (p=0.0054). We also correlated 
APC expression with age. In patients the expression levels tend to 
decrease more rapidly with age (R2=0.473). In contrast, the control group 
had a constant APC expression trend in life. Correlation with sex showed 
that APC reduced expression is more evident in men than women (0.11 vs 
0.22 2-ΔcT). 
Conclusions: This study showed that the APC gene expression is lower 
in colon tumor tissue compared to adjacent mucosa but expressed more 
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in adjacent mucosa compared to mucosa of control subjects. APC seems 
to restore cellular homeostasis in human colonic epithelium. 
 
C30 NaBu-induced Differentiation Affects the Release of 
Exosomes from HT29 Colon Cancer Cells and their Ability to 
Modulate the Behavior of Recipient Cell 
D. Lucchetti1, F. Calapà1, C. Fanali1, F. Carbone1, V. Palmieri1, M. De 
Spirito1, A. Sgambato1 
1Università Cattolica del Sacro Cuore, Rome, Italy 
Background: Exosomes are extracellular vesicles involved in intercellular 
communication and largely mirror the molecular profile of the originating 
cells. We previously reported that NaBu-induced differentiation of HT29 
colon cancer cells is associated with a reduced expression of CD133. This 
study aimed to analyze the role of exosomes in the differentiation process. 
Methods: Exosomes were prepared using differential centrifugations. 
MicroRNA and mRNA expression levels were evaluated by RT-PCR. Cell 
proliferation was assessed by MTT assay and confirmed with ECIS 
system and cell motility was assessed using the scratch test and 
confirmed by confocal microscopy. 
Results: NaBu-induced differentiation was associated with an increase in 
the release of exosomes and in their expression of CD133 compared to 
untreated cells. HT29 cells differentiation and the decrease of cellular 
CD133 expression levels was prevented by blocking multivescicular body 
maturation with NH4Cl. Exosomes released from differentiated cells 
carried specific microRNAs at levels higher than those isolated by 
untreated cells. Exosomes released from differentiating cells increased 
the proliferation and the motility rate of both normal and cancer cells, 
increased the colony-forming efficiency of cancer cells, and prevented 
NaBu-induced differentiation of recipient HT29 cells. Such effects were 
associated with an increased phosphorylation of both Src and Erk proteins 
and with an increased expression of genes involved in EMT. 
Conclusions: Release of exosomes is affected by differentiation of colon 
cancer cells. Exosomes might be used by differentiating cells to remove 
cellular components that are no longer necessary but might continue to 
exert their effects on recipient cells. 
 
C31 Rapid Detection of CNV Alterations, Point Mutations and 
Gene Fusions Using the Next-Generation Sequencing Oncomine 
Focus Assay 
D.M. Oliveira1, A. Rizzuto1, T. Mirante1, L. Elia1, C. Mignogna1, D. 
Malanga1 
1Università degli Studi "Magna Graecia" di Catanzaro, Catanzaro, Italy 
Background: Next-generation sequencing (NGS) provides tools to 
identify with high accuracy and sensibility alterations in attractive 
therapeutic targets. The OncomineTM Focus Assay allows simultaneous 
analysis of DNA and RNA, detecting SNVs, indels, CNVs and gene 
fusions in 52 cancer relevant genes. Identification of druggable players 
involved in cancer progression  can provide new therapy options to 
improve clinical outcome. 
Methods: We obtained RNA and DNA from 82 tumors of the 
gastrointestinal tract: 30 gastric and 52 colorectal carcinoma (CRC). 
These samples were sequenced in the PGM sequencer (Ion Torrent) 
using the OncomineTM Focus Assay and results were analysed using Ion 
Reporter™ Software. Sanger sequencing was used to validate SNV, FISH 
or real-time PCR were used to confirm CNV alterations. 
Results: We validated experimentally the NGS data and confirmed the 
alterations identified. As expected KRAS mutations were the most 
frequent alterations among CRC tumors; ERBB2 amplification or 
missense mutations were more frequent among gastric tumors. 
Interestingly we found FGFR1 amplification in two CRC patients, 
confirmed by real-time PCR. In our cohort no specific fusions were found 
but 3 samples presented 3’to 5’imbalance in the RET gene. 
Conclusions: Using Oncomine TM  Focus Assay we were able to rapidly 
identify SNVs, CNVs and gene fusions in key targetable genes with high 
accuracy, demonstrating that it can have an impact in clinical oncology. 
The identification of FGFR1 amplification and possible RET aberrations 
indicated by the 3'/5' imbalance assay in CRC could provide new therapy 
options for the cancer patients harbouring these alterations. 
 
C32 miRNA Expression Profiling of Mouse Colon Cancer 
Stem Cells: A Tumour-Specific Signature Traceable along Colorectal 
Cancer Progression with Prognostic Value in Human Colon Cancer 
M. De Robertis1, M. Poeta2, C. Fusilli3, L. Loiacono3, T. Mazza3, M. 
Sanchez4, L. Marchionni5, M. Diodoro6, E. Pescarmona6, E. Signori7, G. 
Lamorte3, J. Garcia-Foncillas8, V.M. Fazio1 
1University Campus Bio-Medico of Rome, Rome, Italy; 2University of Bari, 
Bari, Italy; 3IRCCS “Casa Sollievo della Sofferenza", San Giovanni 
Rotondo, Italy; 4Istituto Superiore di Sanità, Rome, Italy; 5Sidney Kimmel 
Comprehensive Cancer Center, Johns Hopkins University, Blatimore, 
Maryland, USA; 6Regina Elena National Cancer Institute, Rome, Italy; 
7Institute of Translational Pharmacology, National Research Council 
(CNR), Rome, Italy; 8Oncohealth Institute, FIIS-Fundacion Jimenez Diaz, 
Madrid, Spain 
Background: The definition of cancer stem cells (CSC) still lacks 
conclusive experimental evidence. Colorectal cancer (CRC) EphB2 cells 
have been correlated to stem-like properties and tumor malignancy. Here, 
we investigated a panel of miRNA involved in the self-renewal and cell 
fate during cancer development using murine CRC EphB2 sorted cells 
and tissue of mouse/human CRC and public dataset (TCGA). 
Methods: FACS-isolated CD44+ EphB2high cells of the CRC AOM/DSS 
murine model were analyzed by gene expression and IHC analysis (Lgr5, 
Ascl2, krt20) to characterize the stem-like/differentiation phenotype. 
miRNAs expression profiling was performed using TaqMan Low Density 
Arrays (LifeTechnologies) both on sorted cells and whole tissue samples 
of AOM/DSS model containing dysplastic ACFs, microadenoma, 
adenoma, carcinoma. Single real-time PCR for selected miRNAs were 
performed on 60 FFPE human samples and further validated in The 
Cancer Genome Atlas (TCGA) stage I–IV CRC (n=130) to determine their 
potential prognostic role. 
Results: The analysis of miRNA expression pattern in the EphB2high 
sorted stem-like cells in comparison to miRNAs of CRC murine whole 
tissue showed a significant cancer stemness signature in the 
initiation/progression steps. EphB2 stemness-related miRNAs, which 
orchestrate cell cycle, apoptosis, tumorigenesis, progression and 
metastasis, were further analyzed in human samples at different phases 
(ACF, adenoma, adenocarcinoma) revealing a pattern similar to the 
murine model. 
Conclusions: These data provide a comprehensive miRNA signature 
implicated in the regulation of tumorigenesis, stemness, and cell fate 
determination that could be exploited for diagnosis and therapeutic 
design, and could be proposed as novel CRC prognostic biomarkers. 
 
C33 Testing of Novel Peroxisome Proliferator-Activated 
Receptor Antagonists in Colorectal and Pancreatic Cancer Cell Lines 
L. De Lellis1, A. Ammazzalorso1, R. Florio1, F. Verginelli1, B. De Filippis1, 
M. Fantacuzzi1, L. Giampietro1, C. Maccallini1, R. Amoroso1, A. Cama1 
1G. d’Annunzio University, Chieti, Italy 
Background: PPARs are ligand-activated transcription factors that are 
often deregulated in tumors, where these receptors modulate cell 
proliferation, differentiation, survival and lipid metabolism. PPAR isoforms 
play a pleiotropic role in tumors because they may act as tumor 
suppressors or oncoproteins depending on cancer type. Here, we 
explored the antiproliferative activity of a series of novel PPAR 
antagonists synthetized in our laboratories of medicinal chemistry. 
Methods: The activity of novel molecules on PPARα/PPARγ was 
investigated by a Gal4-PPAR transactivation assay in HEK-293 cells. 
Expression of carnitine palmitoyl transferase 1 (CPT1A), a key gene 
controlled by PPARα and PPARγ involved in fatty acid transport in 
mitochondria, was analyzed by qPCR. Effects of novel antagonists on 
viability in different tumor cell lines were evaluated using MTT. In 
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particular, HT-29 and SW480 colorectal cancer cell lines, together with 
Capan-2 and AspC-1 pancreatic cancer cell lines were selected based on 
their expression of both PPARα/PPARγ  (Expression Atlas Database). 
Results: The novel molecules showed an antagonistic behavior on 
PPARα and PPARγ, and were able to repress CPT1A expression. 
Preliminary experiments were conducted incubating the four cell lines with 
novel compounds at 75 uM to evaluate their activity on cell viability. 
Interestingly, one of the tested compounds significantly reduced viability in 
the colorectal and pancreatic cancer cell lines examined. Based on these 
results, we further characterized its dose-dependent cytotoxic effects. 
Conclusions: This study shows that inhibiting PPARα/PPARγ activities 
reduces viability of the colorectal and pancreatic cancer cells tested, 
suggesting an oncogenic role of these nuclear receptors in these cell 
lines. 
 
C34 Search for Key Targets in the Biology of Pancreatic 
Cancer 
S. Veschi1, L. De Lellis1, R. Florio1, G. Mincione1 
1"G. d'Annunzio" University of Chieti-Pescara, Chieti, Italy 
Background: Patients with pancreatic cancer have an average survival of 
less than a year. Hence, there is an urgent need to find more effective 
therapeutic approaches to treat this deadly disease. Clinical trials based 
on traditional chemotherapy combined with erlotinib, an EGFR inhibitor, 
reported benefit in pancreatic cancer patients. Our purpose is to identify 
key targets in the biology of pancreatic cancer using non-cancer drugs. 
These can be exploited in a treatment strategy based on combination with 
erlotinib. We are testing the potential anticancer activity in pancreatic cell 
lines of nelfinavir, an HIV protease inhibitor, and nitroxoline, an antibiotic 
active on biofilm infections. 
Methods: KRAS oncogene mutated pancreatic cancer cell lines AsPC-1 
and Capan-2 were treated with increasing concentrations of erlotinib, 
nelfinavir and nitroxoline. In our preliminary experiments we evaluated the 
effect of treatments on cell viability by MTT assay.  
Results: Erlotinib, nitroxoline, and nelfinavir affected viability of both 
human pancreatic cancer cell lines. Combined treatments with these and 
other non-cancer drugs will be tested and the effects on cell cycle, 
apoptosis and other key pathophysiological features of pancreatic cancer 
will be analyzed. 
Conclusions: Successful treatment of advanced human pancreatic 
tumors may require simultaneous targeting of several distinct signaling 
cascades including those driven by KRAS and EGFR. In our preliminary 
studies erlotinib, nitroxoline, and nelfinavir appear to be interesting drug 
candidates for new combined treatment strategies in pancreatic cancer. 
The sensitivity of the tumor to these agents suggests that they affect key 
targets in the biology of pancreatic cancer. 
 
C35 miR-182 Dysregulation in a Diet-Induced NAFLD-NASH-
Hepatocellular Carcinoma Mouse Model 
V. Mastroiaco1, A. Tessitore1, G. Cicciarelli1, R. Sferra1, A.Vetuschi1, F. 
Del Vecchio1, D. Verzella1, M. Fischietti1, V. Davide1, B. Di Francesco1, F. 
Zazzeroni1, E. Alesse1 
1University of L’Aquila, L’Aquila, Italy 
Background: Nonalcoholic fatty liver disease (NAFLD) is a frequent liver 
disorder. It can progress through the more severe nonalcoholic 
steatohepatitis (NASH), fibrosis and, lastly, hepatocellular carcinoma 
(HCC). miRNAs are small non-coding RNAs acting as regulators of gene 
expression at the post-transcriptional level. In this study, a mouse model 
was used to investigate the effects of high-fat (HF) and low-fat/high-
carbohydrate (LF-HC) diets on miRNA expression during liver damage 
progression. 
Methods: C57BL/6J mice were HF or LF-HC diet fed for 3, 6, 12, and 18 
months. Control mice were standard diet fed. Hepatic tissues were 
collected. Histological analyses were performed. TaqMan RT-qPCR was 
used to analyze miRNAs in liver tissues. Target gene protein products 
were examined by immunoblotting. 
Results: Progressive liver damage was observed in HF and LF-HC mice. 
Tumors were detected in HF after 12 and 18 months and in LF-HC after 
18 months. Molecular analysis showed several miRNAs differentially 
expressed during the disease progression and in tumors. Among them, 
miR-182 showed early dysregulation, being overexpressed in HF vs LF-
HC fed mice after 3 months. The trend was maintained in HF after 6, 12 
and 18 months and, in particular, in tumors compared to peritumoral 
tissues. The transcription factor FOXO1, a miR-182 target, was analyzed 
by immunoblotting and found ipo-expressed. 
Conclusions: miRNA expression was evaluated in livers from mice HF or 
LF-HC diet fed during the progression of liver damage up to HCC. miR-
182 was upregulated in HF tissues and HF/LF-HC tumors. The expression 
of its target FOXO1 decreased and the role of this will be discussed. 
 
C36 New Bioinformatics Approach to Identify Target Genes 
for Dysregulated MicroRNAs in a Chemically-Induced Hepatocellular 
Carcinoma Mouse Model 
F Del Vecchio1, F. Gallo1, A. Di Marco1, V. Mastroiaco1, P. Caianiello1, F 
Zazzeroni1, E. Alesse1, A. Tessitore1 
1University of L’Aquila, L’Aquila, Italy 
Background: Hepatocellular carcinoma (HCC) is an aggressive tumor. 
miRNAs are non-coding RNAs acting in post-transcriptional gene 
regulation, whose dysregulated activity plays a role in cancer. A single 
miRNA can exert its action on hundreds of putative target genes. We used 
a chemically-induced HCC mouse model to identify miRNA differential 
expression during the progression of hepatic damage up to HCC. In this 
context, we generated an original bioinformatic approach to predict 
putative target genes and protein networks involved in 
hepatocarcinogenesis. 
Methods: C57BL/6J mice were treated with diethylnitrosamine (DEN) and 
sacrificed after 3, 6, and 11 months. miRNA expression related to controls 
was evaluated. Dysregulated miRNAs were analyzed by bioinformatics 
prediction tools (miRanda, TargetScan, PITA and Rna-22) to identify 
target genes. Genemania software was then exploited for enrichment 
annotation analysis and protein construction network. Immunoblotting was 
used to validate target genes’ expression. 
Results: Bioinformatics tools globally identified 15 putative target genes 
of four upregulated miRNA (miR-125a-5p, miR-27a, miR-182, miR-193b) 
subjected to analysis. The protein product of one among them (ankyrin-G) 
was further validated by immunoblotting to assess the strength of the 
approach. Enrichment annotation analysis highlighted 26 significant 
functional clusters putatively involved in DEN-induced HCC, and a 
network including links between selected miRs, targets, and possible 
interactions among them and other proteins was built. 
Conclusions: We combined the results of microRNA expression analysis 
from an in vivo HCC mouse model with a new bioinformatics approach. 
Interactions between miRs, target genes and related proteins putatively 
involved in HCC initiation and progression were identified. 
 
C37 Defective Chromosome Segregation Causes DNA 
Damage and  Structural Chromosome Abnormalities In Human 
Hepatocellular Carcinoma 
M. Lulli1, S. Madiai1, T. Mello1, K. Rombouts2, A. Galli1, V. Carloni1 
1University of Florence, Florence, Italy; 2UCL Institute for Liver and 
Digestive Health, London, United Kingdom (Great Britain) 
Background: High levels of genomic instability appear to correlate with 
progression of hepatocellular carcinoma (HCC). The more common form 
of genomic instability in HCC is chromosomal instability, resulting in 
ongoing numerical and structural chromosomal aberrations yielding a 
heterogeneously tumor cell population that has the ability to undergo 
selective evolution, mainly represented by drug resistance and immune-
system escape. Chromosomal instability per se is an important factor of 
DNA damage sustaining numerical and structural chromosome 
aberrations but the underlying causes and mechanisms are unknown. 
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Methods: We screened proteins known to be activated in the presence of 
DNA damage by using an animal model of diethylnitrosamine-induced 
HCC expressing karyotypic alterations and we identified the DNA damage 
response checkpoint kinase Chk2. Next, specimens obtained from 
patients with primary HCC were evaluated for the expression of Chk2 and 
pathological analysis was carried out. To assess the functional role of 
Chk2 in HCC, gain and loss-of- function studies were performed in vitro. 
Results: We demonstrated that defective chromosome segregation 
induced DNA damage and numerical and structural chromosome 
aberrations. Overexpression and activation of the DNA damage response 
protein Chk2 and its mislocalization within the mitotic spindle carried on 
chromosomes missegregation self-perpetuating DNA damage. 
Immunohistochemical studies identified the expression of Chk2 in a 
subset of patients with HCC. 
Conclusions: These findings propose Chk2 as a putative biomarker that 
can be used to detect chromosomal instability and DNA damage in HCC 
providing a valuable support not only for prognosis but also for identifying 
patients who are likely to have a response to therapy. 
 
C38 Identification of Specific PIWI-interacting Small 
Noncoding RNA (piRNA) Expression Patterns During 
Hepatocarcinogenesis 
F. Rizzo1, A. Rinaldi1, E. Coviello1, A. Sellitto2, D.G. Cracas1, L. Ricciardi1, 
L. Di Tommaso3, M. Roncalli3, R. Tarallo1, A. Weisz1 
1University of Salerno, Baronissi, Italy; 2University of Salerno, 
Genomix4Life, Baronissi, Italy; 3Humanitas University, Rozzano, Italy 
Background: Hepatocellular carcinoma (HCC) is the most frequent 
primary liver malignancy, mostly occurring in the context of chronic liver 
diseases leading to cirrhosis, more often beginning with development of 
premalignant lesions, characterized by low- (LGDN) and high-grade 
(HGDN) dysplastic nodules. P-element induced Wimpy testis (PIWI)-
interacting RNAs (piRNAs) represent a large family of small noncoding 
RNAs, 23-35 nucleotide-long, first identified in fruitfly germline cells by 
their ability to interact with PIWI proteins and thereby exert epigenetic 
silencing of retrotransposons. The piRNAs are now also known as post-
transcriptional regulators in somatic tissues, including stem and cancer 
cells, where piRNAs and piRNA-like molecules have been shown to 
influence key cellular processes. 
Methods: We applied small RNA sequencing to search for liver piRNAs 
and to profile their expression patterns in cirrhotic nodules (CNs), LGDN, 
HGDN, early HCC and progressed HCC (pHCC), analyzing 55 nodules 
from 17 patients. 
Results: We identified an expression signature of 58 piRNAs and 67 
novel piRNA-like molecules that clearly discriminates HCC from matched 
CNs, correlating also to clinicopathological characteristics of HCC. This 
result was confirmed by functional analysis of predicted piRNA target 
mRNAs. Interestingly, 24 piRNAs showed specific expression patterns in 
dysplastic nodules compared  to cirrhotic liver and/or pHCC. 
Conclusions: These results demonstrate that the piRNA pathway is 
active in human liver, where it is likely to represent a new player in the 
molecular events that characterize hepatocellular carcinogenesis, from 
early stages to pHCC. Furthermore, they suggest that piRNAs might 
represent new disease biomarkers, potentially useful for differential 
diagnosis of dysplastic and neoplastic liver lesions. 
 
C39 FGF2 in Human Melanoma Progression: The Antithetical 
Functions of Different Isoforms 
E. Andreucci1, F. Bianchini1, A. Biagioni1, M. Del Rosso1, L. Papucci1, N. 
Schiavone1, L. Magnelli1 
1University of Florence, Florence, Italy 
Background: Aberrant fibroblast growth factor 2 (FGF2) expression is 
correlated with different types of human cancer, included melanoma, 
where it is thought to contribute to its development and progression. An 
alternative translational process gives rise to five FGF2 isoforms with 
specific localization and functions: a low molecular weight (LMW, 18 KDa) 
and four high molecular weight (HMWs, 22, 22.5, 24, 34 KDa) isoforms. 
Alternative translation of FGF2  mRNA is regulated by an internal 
ribosome entry site (IRES) that controls the expression of all the isoforms 
except for the 34 KDa HMW, which depends instead on the canonical 
cap-dependent mechanism. To date, very extensive studies have been 
performed on LMW FGF2, while HMWs isoforms have to be better 
investigated. 
Methods: To disclose the differential contribution of FGF2 isoforms in 
melanoma progression, we forced the expression of IRES-dependent 
isoforms- LMW (18 KDa) and HMWs (22, 22.5, 24 KDa)- in human 
melanoma cells. We then evaluated their biological roles by studying 
migration, anoikis resistance, homing, chemoresistance and tumor 
angiogenesis. 
Results: We demonstrated that while LMW FGF2 expression confers 
stem-like traits and a pro-angiogenic profile to melanoma cells, HMWs 
isoforms are involved in the migratory processes and in the maintenance 
of tumor perfusion, when endothelial cell-driven angiogenesis is lacking, 
by promoting vasculogenic mimicry. 
Conclusions: This comparative study shows the differential contribution 
of FGF2 isoforms in melanoma progression, pointing out that, even 
behaving in specific/antithetical manners, they cooperate in different steps 
of metastatic cascade, providing melanoma cells with higher malignancy 
and aggressiveness. 
 
C40 Involvement of ζ-Crystallin in Acidic Microenvironment of 
Melanoma 
M. Lulli1, R. Loffredo2, A. Lapucci1, L. Papucci1, S. Capaccioli1, N. 
Schiavone1 
1University of Florence, Florence, Italy; 2University of Trento, Trento, Italy 
Background: Most cancer cells, including those of melanoma, rely on 
aerobic glycolysis, which causes a chronic acidification of tumor 
microenvironment. In turn, acidosis induces a metabolic shift toward 
glutaminolysis and increases the apoptotic threshold of cancer cells, 
favoring malignant progression and onset of drug-resistant phenotypes. 
Bcl-2 gene expression undergoes an intricate post-transcriptional 
regulation. Among the regulators of Bcl-2 mRNA fate, we identified ζ-
Crystallin (CryZ) and highlighted its alteration in leukemia cells. Beside 
Bcl-2, CryZ regulates the expression of glutaminase (GLS) and glutamate 
dehydrogenase (GDH), two major genes of glutaminolysis. Furthermore, it 
has been demonstrated that aspirin-like analgesics are potent inhibitors of 
CryZ enzymatic activity. 
Methods: Biomolecular effects of exogenous modulation, per se or in 
combination with targeted therapies, have been analyzed in A375 and 
MeWo melanoma cells exposed to extracellular acidosis. In addition, the 
role of acetylsalicylic acid (ASA) and salicylic acid (SA) on CryZ binding 
activity to mRNA targets has been investigated. 
Results: We demonstrated that: 1) acidosis induced the expression of 
CryZ; 2) inhibition of p38 pathway prevented acidosis-mediated CryZ 
upregulation; 3) acidosis conferred CryZ-dependent resistance to 
vemurafenib; 4) besides Bcl-2, CryZ associates with the anti-apoptotic 
Bcl-xL mRNA; 5) ASA and SA impaired the binding of CryZ to Bcl-2, Bcl-
xL and GLS mRNAs. 
Conclusions: We disclosed a role of CryZ as an important pH-responsive 
element that confers a cytoprotective effect on melanoma cells. In 
addition, the evidence that ASA and SA impaired CryZ binding to its 
mRNA targets could lay the basis for development of innovative post-
transcriptional therapeutic tools. 
 
C41 Subpopulation of Acidic Melanoma Cells as a New Target 
of Metformin 
S. Peppicelli1, A. Toti1, E. Giannoni1, F. Bianchini1, F. Margheri1, M. Del 
Rosso1 
1University of Florence, Florence, Italy 
Background: Proliferating cancer cells exhibit an increased glycolysis 
regardless of oxygen tension, a phenomenon known as the Warburg 
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effect. Further, an abnormal vasculature can result in regional variation in 
oxygenation implying a dynamic change in metabolism of tumor cells from 
an aerobic to an anaerobic type of glycolysis. These metabolic programs 
lead to a change in tumor microenvironment pH, which reduces to 
acidosis, conferring a new adaptive aspect to cancer cells. 
Methods: A375 human melanoma cells were cultivated under acidic 
conditions, either obtained by enriching culture media with protons or 
lactic acid. Acidic cells were evaluated for epithelial-to-mesenchymal 
transition (EMT) program and metabolism. Metformin, a biguanide 
commonly used for type 2 diabetes, was used as mitochondrial complex I 
inhibitor. 
Results: We found that melanoma cells exposed to an acidic extracellular 
microenvironment, show a profile associated with a shift to EMT and an 
oxidative phosphorylation (Oxphos) metabolism. In particular, lactic 
acidosis contributed to EMT profile of acidic melanoma cells stimulating 
motility, and a-cyano-4-hydroxycinnamate treatment inhibited lactate-
induced migration. Metformin addition to acidic medium reduced EMT 
profile, such as N-cadherin expression and invasiveness, and Oxphos 
metabolism. As we may expect, metformin promoted AMPKα expression 
and phosphorylation in acidic melanoma cells. In addition, when 
metformin concentration increased to 10 mM, it induced a striking 
inhibition of proliferation and colony formation of acidic cells. 
Conclusions: These findings disclose a new potential rationale for 
metformin addition to therapy of advanced melanoma, e.g., targeting 
acidic cells, a most likely drug resistant subset population. 
 
C42 Tumor-tropic Endothelial Colony Forming Cells (ECFCs) 
Loaded with Near-infrared Sensitive Gold Nanoparticles: A “Cellular 
Stove” Approach to the Photoablation of Melanom. 
A. Laurenzana1, A. Chillà1, F. Margheri1, A. Biagioni1, G. Margheri2, A. 
Zoppi3, S. Trigari4, F. Bianchini1, L. Calorini1, G. Fibbi1, M. Del Rosso1 
1University of Florence, Florence, Italy; 2National Research Council, 
Florence, Italy; 3Plasmatech italia, PIsa, Italy; 4Italian Research Council, 
Florence, Italy 
Background: One of the major challenges in cancer treatment is to 
selectively deliver cytotoxic drugs to the tumor site while avoiding potential 
side effects to non-diseased organs. Nanoparticles (NPs) are perfect tools 
for local drug delivery or drug targeting. Even though during the last 
decade multifunctional nanoparticles have been developed to improve the 
accumulation of therapeutic drugs in tumor tissues, the massive uptake of 
NPs by tumor tissues is still a significant challenge. 
Methods: Gold (Au) nanoparticles were prepared by chemical reduction 
of HAuCl4. Transmission electron microscopy and ICP analysis were 
performed to estimate gold uptake.  Capillary morphogenesis and Boyden 
chamber assay were performed to evaluate the migration properties. In 
vitro and in vivo photothermal treatment were conducted with a laser 
diode emitting at 808 nm wavelength with light intensities, namely 1, W 
cm−2. 
Results: We propose a promising strategy to deliver therapeutic chitosan-
coated gold nanoparticles to tumor cells as hidden cargo of endothelial 
colony forming cells (ECFCs) endowed with an innate tumor-tropism. 
Remarkably, ECFC gold enrichment doesn’t affect cell viability and 
preserves the endothelial lineage characteristics such as capillary 
morphogenesis and cell migration. We demonstrate that heavily Au-doped 
ECFCs are able to efficiently warm up the tumor environment, and kill the 
cancer cells via hyperthermic heating both in vitro as well as in vivo. 
Conclusions: The therapeutic impact of these results are relevant for the 
control of melanoma, which is one of the most aggressive skin cancers, 
notorious for its high multidrug resistance, easy to relapse and low 
survival rate. 
 
C43 Impact of KSRP on Post-transcriptional Deregulation of 
IL-8, IL-1b, TNF-α, CXCR2 and IL-1R Expression and Consequently 
on Cell Motility and Invasiveness in Melanoma Cells 
I. Granucci1, R. Loffredo2, F. Di Gesualdo1, S. Capaccioli1, M. Lulli1 
1University of Florence, Florence, Italy; 2University of Trento, Trento, Italy 
Background: The pleiotropic far upstream element binding protein 2 or 
KH-type splicing regulatory protein (KSRP) is considered a checkpoint of 
inflammation since it regulates the expression of several inflammatory 
cytokines, binding to their mRNAs and committing them to exosome-
mediated degradation. Deregulation of this post-transcriptional control of 
gene expression is at the basis of a variety of pathological processes. 
Genes coding cytokines and cytokine receptors frequently undergo post-
transcriptional regulation: their altered expression generates a crosstalk 
between cancer cells and microenvironment, promoting cancer onset and 
progression.  Having observed that KSRP RNA targets identified so far - 
IL-1β, IL-6, IL-8, iNOS, TNF-α, β-catenin and let7 family - are deregulated 
in invasive melanoma, we have hypothesized that KSRP could play a key 
role in melanoma progression. 
Methods: Biomolecular effects of positive or negative exogenous 
modulation of KSRP expression on human melanoma cell lines (A375, 
A375-M6, MeWo and M21) were analyzed. 
Results: Here, we report the following evidence: 1) KSRP lowers 
expression of IL-8, IL-1β and TNF-α, already known as KSRP targets, by 
destabilizing their mRNAs; 2) KSRP binds the mRNAs of CXCR2 and IL-
1R, two KSRP targets unraveled so far, and reduces their expression by 
lowering their mRNA stability; 3) KSRP overexpression causes a marked 
decrease of cell motility and invasiveness, and lowers the apoptosis 
threshold in response to UV irradiation. 
Conclusions: Our results strongly suggest that KSRP could contribute to 
melanoma progression. The evidence reported here could be the basis for 
future studies aimed to modulate KSRP in melanoma by interfering with 
the multiple factors promoting onset and progression of this severe 
malignancy. 
 
C44 Quercetin Induces Primary Effusion Lymphoma Cell 
Death through Inhibition of Multiple Cell Signaling Pathways 
M. Granato1, C. Rizzello1, M. Gilardini Montani1, M. Vitillo2, R. Santarelli1, 
R. Gonnella1, G. D'Orazi, A. Faggioni1, M. Cirone1 
1"La Sapienza" University, Rome, Italy; 2"San Filippo Neri" Hospital, ASL 
Roma 1, Rome, Italy; 3Regina Elena National Cancer Institute, Rome, Italy  
Background: Quercetin is a bioflavonoid widely distributed  in the plant 
kingdom, with anti-inflammatory and anti-cancer properties.Quercetin has 
been reported to inhibit several cancer-related pathways including 
PI3K/Akt, mTOR and STAT3. Since these pathways are hyperactivated in 
primary effusion lynphoma (PEL), a B-cell lymphoma associated with the 
oncogenic virus KSHV, we investigated whether quercetin would reduce 
their activation and induce PEL cell death. Moreover, since these 
pathways may regulate the release of cytokines such as IL-10 and IL-6, 
which are essential for PEL cell growth, we next explored the effect of 
quercetin tratment on their secretion. 
Methods: Western blot analysis was used to evaluate the expression and 
phosphorylation of P13K/Akt/mTOR and STAT3, and cytokine release 
was analysed by chemiluminescence (IMMULITE 1000, SIEMENS).Cell 
survival was investigated by tripan-blue exclusion assay. 
Results: We found that quercetin treatment reduced PI3K/ Akt, mTOR 
and STAT3 phosphorylation in PEL cells, downregulating the expression 
of the pro-survival cellular proteins such as c-FLIP, cyclin D1 and c-MYC. 
These effects resulted in the induction of a strong cytotoxicity against PEL 
cells, also due to a reduction of IL-6 and IL-10 release. These cytokines 
are indeed essential for PEL survival. 
Conclusions: The results obtained in this study indicate that quercetin 
may represent an ideal molecule for the treatment of this aggressive B-cell 
lymphoma, for which an effective therapy has not been found yet. 
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C45 HDAC4 Silencing Sensitizes Resistant Chronic Myeloid 
Leukemia Cells to Imatinib Mesylate Treatment 
E. Tirrò1, C. Romano1, M. Pennisi1, N.L. Parrinello1, L. Manzella1, F. 
Stagno1, F. Di Raimondo1, P. Vigneri1 
1University of Catania, Catania, Italy 
Background: The combination of imatinib (IM) with histone deacetylase 
(HDAC) inhibitors sensitizes both chronic myeloid leukemia (CML) cells 
and CD34+ progenitors of IM-resistant patients to apoptosis.  The aim of 
this study was to determine if inactivation of BCR-ABL affects the 
expression and the activity of HDAC in CML cells to evaluate a 
therapeutic role for HDAC inhibitors in IM-resistant patients. 
Methods: HDAC activity was evaluated employing a fluorescent assay kit. 
HDAC4 silencing was achieved by shRNA lentiviral infection. The effects 
of drugs were analysed by proliferation and apoptosis assays. 
Results: IM treatment of CML cells increased total HDAC activity as 
compared to untreated cells. The same results were observed on BCR-
ABL-transduced HL-60 cells; no difference was detected in the empty 
vector transduced control.  An immunoblot analysis revealed that 
variations in HDAC activity after IM treatment were associated with an 
increase in HDAC4 expression. Interestingly, HDAC4 silencing reduced 
HDAC activity after exposure to IM.    K562-R and LAMA84-R resistant to 
IM displayed higher HDAC4 expression as compared to their IM-sensitive 
counterpart. Indeed, HDAC4 silencing restored IM response and 
determined an increase of apoptosis.  We also found that the combination 
of IM and apicidin, an HDAC4 inhibitor, enhanced the apoptotic rate of IM-
resistant CML cells.  Experiments performed employing IM-resistant 
CD34+ progenitors demonstrated that the two-drug association 
determined a significant increase in cell death. 
Conclusions: Results suggest that BCR-ABL negatively modulates 
HDAC activity mostly by reducing HDAC4 expression. Furthermore, 
strategies aimed at reducing HDAC4 levels may represent a potential 
therapeutic option for CML patients unresponsive to IM. 
 
C46 High BCR-ABL/GUSIS Levels at Diagnosis are Associated 
with Unfavorable Responses to Standard Dose Imatinib 
L. Manzella1, S. Stella1, F. Stagno1, E. Tirrò1, M. Massimino1, C. Romano1, 
M. Pennisi1, A. Cupri1, S. Forte2, A. Antolino3, C. Caracciolo4, L. Nocilli5, S. 
Impera6, C. Musolino7, D. Turri8, M. Russo9, C. Tomaselli10, M. Rizzo11, M. 
Musso12, F. Morabito13, L. Levato13, F. Di Raimondo1, P. Vigneri1 
1University of Catania, Catania, Italy; 2IOM Ricerca srl Viagrande, Catania, 
Italy; 3Maria Paternò-Arezzo Hospital, Ragusa, Italy; 4University of 
Palermo, Palermo, Italy; 5Papardo Hospital, Messina, Italy; 6ARNAS 
Garibaldi Hospital, Catania, Italy; 7University of Messina, Messina, Italy; 
8Cervello Hospital, Palermo, Italy; 9San Vincenzo Hospital, Taormina, 
Italy; 10Civico Hospital Palermo, Palermo, Italy; 11Sant’ Ella Hospital, 
Caltanisetta, Italy; 12La Maddalena Hospital, Palermo, Italy; 13Division of 
Hematology, Cosenza, Italy 
Background: The approval of second-generation tyrosine kinase 
inhibitors (TKIs) for the first line treatment of chronic myeloid leukemia 
(CML) has generated a need for early molecular parameters associated 
with inadequate responses to imatinib mesylate (IM). We correlated BCR-
ABL transcripts at diagnosis with the outcome (defined according to the 
2013 European Leukemia Net recommendations) of 272 newly diagnosed 
CML patients receiving IM 400 mg/day. 
Methods: BCR-ABL transcripts were measured from peripheral blood 
samples at diagnosis using real-time quantitative PCR (qPCR). 
Determinations were performed twice on the same sample using either 
ABL or glucuronidase-beta (GUS) as reference genes. BCR-ABL values 
were reported on the international scale (IS). 
Results: With a median follow-up of 60 months, 65.4% of patients 
achieved an optimal response, 5.6% presented a response defined as 
“warning,” 22.4% failed IM, and 6.6% switched to a different TKI because 
of intolerance to the drug. We applied ROC curves to define BCR-
ABL/GUSIS expression that would separate patients likely or unlikely to 
achieve multiple endpoints, namely: optimal response (OR), failure-free 
survival (FFS), event-free survival (EFS), transformation-free survival 
(TFS) and overall survival (OS). We found that high BCR-ABL/GUSIS 
levels at diagnosis were associated with inferior probabilities of OR 
(p<0.001), FFS (p<0.001) and EFS (p<0.001). Elevated BCR-ABL/GUSIS 
levels were associated with higher rates of disease transformation to the 
accelerated phase or blast crisis (p=0.029) but not with OS (p=0.132). 
Conclusions: BCR-ABL transcripts at diagnosis employing GUS allow 
the identification of CML patients unlikely to benefit from standard dose IM 
that should be considered for alternative forms of treatment. 
 
C47 BCR-ABL1 Doubling Time and Halving Time May Predict 
CML Response to Tyrosine Kinase Inhibitors 
S. Stella1, M. Pennisi1, F. Stagno2, S.R. Vitale1, A. Antonio3, C. 
Caracciolo4, L. Nocivi5, S. Impera6, C. Musolino7, F. Morabito8, M. Rizzo9, 
L. Manzella1, F. Di Raimondo2, P. Vigneri1 
1University of Catania, Catania, Italy; 2Division of Hematology, Ferrarotto 
Hospital, Catania, Italy; 3Maria Paternò-Arezzo Hospital, Ragusa, Italy; 
4Division of Hematology, University of Palermo, Palermo, Italy; 5Division of 
Hematology, Papardo Hospital, Messina, Italy; 6Division of Oncology and 
Hematology, ARNAS Garibaldi Nesima, Catania, Italy; 7University of 
Messina, Messina, Italy; 8Division of Hematology, Cosenza, Italy; 9Division 
of Hematology, Sant'Elia Hospital, Caltanissetta, Italy 
Background: With the advent of imatinib (IM), patients with chronic 
myeloid leukemia (CML) are monitored by qPCR to evaluate treatment 
response and provide interventions for patients failing the therapy. We 
determined whether BCR-ABL1 doubling times could distinguish 
inconsequential rises in BCR-ABL1-transcripts from resistance to the 
treatment and investigated if BCR-ABL1 halving-times could identify 
patients with deep molecular responses. 
Methods: We examined 377 CML pts. 315 received IM as first-line 
treatment and the remaining received 2G-TKIs. 
Results: We classified 315 IM-treated patients into three groups: subjects 
that failed IM (n=34); subjects that lost a previously achieved MR3 but 
maintained a complete cytogenetic response (CCyR) (n=77); and subjects 
with a confirmed rise in their BCR-ABL-transcripts without MR3 loss 
(n=204). Short doubling-times were observed in patients failing IM (34.85 
days). Long doubling times were found in subjects losing a MR3 with 
CCyR and in individuals with a rise in BCR-ABL-transcript with a loss of 
MR3 (52 vs 60.5 days). Doubling times in individuals failing 2G-TKIs as 
second-line treatment were shorter than those observed for IM-resistant 
patients (28.5 vs 34.8). Halving times were lower in subjects with MR3 
after 6 months of IM as compared to individuals without MR3 (21.7 vs 
42.7). After 12 months of IM, short halving times occurred in patients with 
MR3 as compared to individuals without MR3 (30.6 vs 97.3). Similar results 
were found in patients receiving 2G-TKIs as first-line therapy.  
Conclusions: Doubling time is a tool that records differences in CML 
kinetics according to the clinical context and distinguishes patients failing 
TKIs. Halving times may identify patients with deep molecular responses. 
 
C48 The Metabolically-Modulated Stem Cell Niche:   An 
Energy Restriction Model for Leukaemia Stem Cell Resistance to 
Therapy 
P. Dello Sbarba1, S. Bono2, G. Cheloni2, M. Lulli2, M. Poteti2, I. Tusa2, E. 
Rovida2 
1Università degli Studi di Firenze, Firenze, Italy; 2UniFI, Firenze, Italy 
Background: The concept of stem cell niche was introduced in 1978 to 
model sites suited to host haematopoietic stem cells (HSC) and favour 
their self-renewal, restraining clonal expansion and differentiation 
commitment. Studies of the effects of low oxygen tension on HSC 
maintenance in vitro led us to hypothesize that in vivo HSC niches are 
located within tissue areas where oxygen tension is physiologically lower 
than elsewhere. We found that HSC are adapted to survive, and selected, 
in low oxygen, where they are capable to cycle, and that low oxygen, in 
turn, steers cycling towards HSC self-renewal. 
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Methods: We then focused on leukaemia stem cells (LSC) of chronic 
myeloid leukaemia (CML). CML is triggered by a well-identified 
oncogenetic mechanism, the expression of the constitutively-active 
BCR/Abl tyrosine kinase, and brilliantly treated with its inhibitors (TKi). 
However, TKi are extremely effective in inducing remission of disease, but 
unable, in the majority of cases, to prevent relapse. 
Results: We found that metabolic restrictions (oxygen/glucose shortage), 
while suppressing BCR/Abl protein, do not abolish LSC potential, which is 
thereby refractory to TKi. 
Conclusions: Thus, metabolically-adapted LSC are excellent candidates 
to sustain TKi-resistant minimal residual disease (MRD) of CML and the 
related risk of relapse. Current work is directed (a) to establish the role of 
other “metabolic” players, such as low pH and availability of glutamine, in 
the definition of LSC microenvironment and in the maintenance of MRD of 
CML, as well as (b) to determine the sensitivity of metabolically-adapted 
LSC to non-TKi drugs. 
 
CELL DEATH, TISSUE INJURY AND REPAIR 
 
CDIR1 Crosstalk at the Mouse Neuromuscular Junction during 
Neurotoxin-Induced Degeneration and Regeneration of Motor Axon 
Terminals 
M. Rigoni1, E. Duregotti2, S. Negro1, M. Scorzeto1, B. Dickinson3, C. 
Chang4, C. Montecucco5 
1University of Padua, Padua, Italy; 2Dept. of Biomedical Sciences, Padua, 
Italy; 3University of Chicago, Chicago, Illinois, USA; 4University of 
California, Berkeley, California, USA; 5University of Padova, Padua, Italy 
Background: The neuromuscular junction (NMJ) is the site of 
transmission of the nerve impulse to the muscle. This finely tuned 
synapse relies on at least three components: the motor neuron, the 
muscle fiber, and Schwann cells, which assist nerve recovery after injury. 
The molecular mechanisms underlying peripheral neuroregeneration are 
not fully understood. 
Methods: We have set up an innovative experimental model to study the 
crosstalk that takes place at the neuromuscular junction among its three 
main components during motor axon terminal degeneration and 
regeneration. Animal neurotoxins are used here to induce an acute and 
reversible nerve terminal degeneration, to detect signaling molecules 
released by degenerating nerve and pathways that become activated in 
perisynaptic Schwann cells and muscle cells. 
Results: We have identified several molecules through which the 
damaged nerve terminal communicates with nearby cells, activating 
signaling pathways in Schwann cells that promote nerve regeneration. 
Among these messengers, mitochondrial hydrogen peroxide appears to 
be crucial at the initial stages of regeneration, because its inactivation by 
catalase delays the functional recovery of the damaged neuromuscular 
junction in vivo. 
Conclusions: We are currently investigating, by transcriptomic analysis of 
the NMJ at different stages of the degeneration and regeneration process, 
the retrograde signals generated at the NMJ that could stimulate nerve 
regrowth. These findings may provide important indications about the 
pharmacological treatment of traumatized patients. 
 
CDIR2 TGF-β1 Production is Modulated by Arg Tyrosine Kinase 
in High Glucose Treated Human Renal Tubular Cells 
C. Bianchi1, B. Torsello1, C. Meregalli1, S. De Marco1, G. Bovo2, R. Brivio3, 
G. Strada4, S. Bombelli1, R. Perego1 
1School of Medicine and Surgery, Milano-Bicocca University, Monza, Italy; 
2Anatomo-Pathology Unit, San Gerardo Hospital, Monza, Monza, Italy; 
3Clinical Pathology Unit, San Gerardo Hospital, Monza, Italy; 4Urology 
Unit, Bassini ICP Hospital, Milano, Italy 
Background: Renal tubular cells subjected to hyperglycemia are involved 
in tubular interstitial fibrosis development observed in diabetic 
nephropathy (DN) through mechanisms still unclear. It has been described 
that tubular cells under high glucose (HG) condition overproduce TGF-β1 
involved in epithelial mesenchymal transition (EMT) and renal interstitial 
fibrosis development. The non-receptor tyrosine kinase Arg protein is 
involved in some aspects of the EMT process through RhoA/ROCK 
pathway, which is also involved in TGF-β1 secretion by HG treated tubular 
cells. Our study investigated the involvement of Arg tyrosine kinase in the 
production of TGF-β1 induced in well-characterized human primary 
tubular cell cultures by treatment with HG. 
Methods: Human primary tubular cell cultures established from normal 
renal cortex and cultured in control (100 mg/dl glucose) or in HG medium 
(450 mg/dl glucose) were used. Arg, TGF-β1 precursor, and phospho-
p190RhoGAP were evaluated by Western blot; secreted TGF-β1 by 
ELISA; ROS by fluorescent oxidized DCF quantification; GTP-bound 
RhoA by G-LISA kit. Arg silencing was performed by siRNA. 
Results: Primary tubular cells under HG condition overproduced ROS 
that downregulated Arg tyrosine kinase, and overexpressed and secreted 
TGF-β1 that activated fibroblasts. A further TGF-β1 expression increase 
was induced in HG condition with Arg silencing. In the HG treated cells 
ROS-dependent Arg kinase downregulation induced RhoA activation 
through p190RhoGAP modulation. 
Conclusions: These data evidence a novel specific involvement of Arg 
kinase in the regulation of TGF-β1 expression in tubular cells under HG 
conditions and provide cues for new translational approaches in DN.  
Acknowledgement: Supported by A.G.S. Onlus 
 
CDIR3 Role of p110δ PI3K in Carotid Restenosis 
A. Bilancio1, M. Oliviero1, M. Donniacuo1, A. Boscaino2, I. Marino1, F. 
Rossi1, A. Migliaccio1, B. Rinaldi1 
1II University of Naples, Naples, Italy; 2AORN" Cardarelli" Naples, Naples, 
Italy 
Background: Restenosis is a narrowing of arterial lumen that occurs 
upon  endothelial arterial damage and represents a limiting long term 
success of intervention in the arteriopathy disease. Accumulating 
evidence indicates that recruitment of inflammatory cells at the site of 
arterial injury is a critical step in the pathogenesis of restenosis. 
Methods: Several signaling pathways are involved in pathogenesis of 
intima hyperplasia, including phosphoinositide 3- kinase (PI3K).  PI3K is a 
lipid kinase family that controls many biological cellular functions such as 
proliferation, growth, differentiation, migration. Class IA PI3K is divided 
into three isoforms. Although p110α and p110β are ubiquitously 
expressed, p110δ is restricted in white blood cells.  To investigate the role 
of p110δ PI3K in the pathogenesis of restenosis we used mice in which 
p110δ PI3K has been (p110δD910A/D910A) catalytically inactivated and in 
which we performed an arterial injury. 
Results: p110δD910A/D910A mice show defects in proliferation and 
differentiation of B- and T-lymphocytes (Okkenhaug, Bilancio, et al: 
Science. 2002, 297:1031-1034; Ali, Bilancio, et al: Nature 2004, 431:1007-
1011; Bilancio et al: Blood 2006,107:642-650) and in migration of 
macrophages (Papakonstantis, Zwaenepoel, Bilancio, et al: Journal of 
Cell Science. 2008,121:4124-4133). p110δD910A/D910A mice were subjected 
to arterial injury and monitored for 30 days. In this work, we report that 
p110δ inactivation abolishes inflammatory cell recruitment in an in vivo 
model of arterial injury resulting in strong inhibition of restenosis 
Conclusions: This approach might have great pharmacological interest 
because it allows the use of an isoform-specific inhibitor of PI3K to 
prevent restenosis. 
 
CDIR4 DDB2 Mutant Protein Unable to Interact with PCNA 
Influences Cell Cycle Progression 
O. Cazzalini1, P. Perucca1, I. Guardamagna1, R. Mocchi1, S. Sommatis2, 
E. Prosperi3, L. Stivala1 
1Università di Pavia, Pavia, Italy; 2UB-CARE - Spinoff dell'università di 
Pavia, Pavia, Italy; 3Istituto di Genetica Molecolare (IGM) del CNR, Pavia, 
Italy 
Background: DNA damage binding protein 2 (DDB2) is a protein involved 
in the early step of DNA damage recognition of the nucleotide excision 
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repair (NER) process. Recently, it has been suggested that DDB2 may 
play a role in DNA replication, based on its ability to promote cell 
proliferation. We have previously demonstrated that DDB2 binds the 
proliferating cell nuclear antigen (PCNA), a molecular platform 
coordinating the activity of several factors during NER; moreover, it also 
interacts with PCNA in the absence of DNA damage. However, whether 
and how this interaction influences cell proliferation is not known. In this 
research, we have addressed this question by using HEK293 cell clones 
stably expressing DDB2Wt protein, or a mutant form (DDB2Mut) unable to 
interact with PCNA due to a mutation in PCNA interacting protein 
sequence (PIP-box). 
Methods: For the interaction between the investigated proteins, 
fluorescence microscopy, cytofluorimetric analysis and Western blot 
techniques were carried out. Clonogenic assays and BrdU incorporation 
were performed to analyse HEK293 cell proliferation. 
Results: We show that overexpression of the DDB2Mut protein provides a 
proliferative advantage over the wild-type form, by shortening cell cycle 
length. In particular, an increase in the number of S-phase cells, together 
with a different progression throughout this phase, and a reduction in 
p21CDKN1A protein levels have been observed in the DDB2Mut cells. 
Conclusions: The results show that mutation in the PIP-box of DDB2 
determines a cell cycle perturbation, suggesting that this effect is 
dependent on DDB2-PCNA interaction. 
 
CDIR5 The Dynamic Adaptation of Macrovascular Endothelial 
Cells to Microgravity 
A. Cazzaniga1, L. Locatelli2, S. Castiglioni2 
1Università di Milano, Milano, Italy; 2Università degli Studi di Milano, 
MILANO, Italy 
Background: After hundreds of space missions it is evident that long 
duration space flight activates responses that might result in potential 
hazard for the astronauts. It is well known that microgravity markedly 
impacts on the performance of the cardiovascular system. Since 
endothelial cells are responsible for vascular integrity, we studied the 
adaptive response of human macrovascular endothelial cells to 
microgravity. 
Methods: Human endothelial cells were isolated from the umbilical vein 
and propagated in vitro. Microgravity was simulated by the rotating wall 
vessel. Reactive oxygen species (ROS) were detected by dichloro-
dihydro-fluorescein diacetate (DCFH) assay. A stress protein array was 
performed and validated by western blot. 
Results: We found that early after exposure to weightlessness these cells 
synthesize higher amounts of HSP70 than controls. HSP70 returns to 
basal level after 4 days, when paraxonase-2, HSP27 and sirtuin-2 
gradually increase and peak at day 10. In parallel, thioredoxin interacting 
protein (TXNIP) is upregulated after 10 days in real and simulated 
microgravity. TXNIP is a stress responsive protein that inhibits thioredoxin 
activity, thus generating oxidative stress, and is known to be involved in 
mechanotransduction. However, we detected a transient rapid increase of 
ROS only after a few hours in microgravity, while at later time points ROS 
generation dropped to control levels. 
Conclusions: Adaptation to microgravity is a dynamic process. Indeed, 
different stress proteins are involved at different times after exposure to 
microgravity to allow endothelial cells to adapt to the mechanical stress 
determined by microgravity. 
 
CDIR6 Is Methadone Really Safe in Opioid Maintenance 
Treatment? 
A. Colatutto1, G. Ceschiat2, S. Zago1, F. Curcio1 
1University Hospital of Udine, Udine, Italy; 2University of Udine, Udine, 
Italy 
Background: Opioids are frequently associated with fatal poisonings due 
to their ability to cause respiratory and cardiovascular depression, and 
among the numerous reports  published on fatal poisoning, methadone is 
the most frequently found. Because toxicological analysis is the most 
informative diagnostic tool after autopsy, we decided to review the 
toxicological analysis of 150 deaths in the Medical Legal Institute of the 
University of Udine. 
Methods: Between 2012 and 2015 over 150 blood samples were 
analyzed first by screening test by ILAB 650 (Instrumentation Laboratory 
IL., Freemont CA, USA). Screening test was performed by cloned enzyme 
donor immunoassay (CEDIA Technology) and positive samples were 
subsequently analysed by gas chromatography mass spectrometry 
(GC/MS), (Agilent Technology 4400, Varian BV, Middelburg, the 
Netherlands). 
Results: Among 150 fatalities, 25 deaths (16,6%) were related to fatal 
opioid intoxication, and among these 13 deaths (50%) were due to 
methadone poisoning. Methadone concentrations were from 0.1 to 3.5 
μg/mL., according to Clarke’s (0-33 μg/mL). 
Conclusions: The number of fatal opioid poisonings is increasing in 
Europe and methadone is the drug most involved. The profile of 
methadone intoxication is related to accidents in over 90% of deaths and 
suicide in 6% of cases. The median concentration of methadone in fatal 
cases does not differ from therapeutic concentrations. In spite the 
paramount progress of laboratory technology over recent decades it is still 
difficult to assess a clearcut correlation between blood methadone 
concentration and therapeutic effect. Forensic toxicology does not 
possess methods to prove that death has been caused by poisoning. 
 
CDIR7 Retinoic Acid Impairs Neuronal Response to Oxidative 
Stress: Role of Nrf2-Dependent Responses 
M. Nitti1, S. Piras1, A.L. Furfaro2, L. Brondolo1, U.M. Marinari1, M.A. 
Pronzato1 
1University of Genoa, Genoa, Italy; 2Giannina Gaslini Institute, Genoa, 
Italy 
Background: The generation of reactive oxygen species (ROS) derived 
from NADPH oxidase (NOX) by modulating redox balance favors neuronal 
differentiation induced by all-trans retinoic acid (ATRA) [Nitti M. et al, Cell 
Signal 2010]. In this work, the ability of neuronal cells to balance ATRA-
induced ROS generation has been investigated and the Nrf2-dependent 
antioxidant system was evaluated. 
Methods: SH-SY5Y neuroblastoma cells were differentiated  for 4 or 7 
days with 10μM retinoic acid. Cell viability after exposure to 100-500μM 
H2O2 was measured by trypan blue exclusion test. Gene and protein 
expression were detected by RT-PCR and Western blotting. Nrf2 binding 
to DNA was checked by ChIP analysis. 
Results: Cell treatment with H2O2 decreased cell viability significantly 
more in the differentiated cells than in the undifferentiated ones.  The 
expression of GCLM and GCLC, key enzymes in the synthesis of GSH, 
was not modified by H2O2 treatment both before and after cell 
differentiation. However, after H2O2 treatment heme oxygenase 1 (HO-1) 
expression as well as Nrf2 binding to the HO-1 promoter was significant 
reduced in differentiated cells in comparison to the undifferentiated ones. 
In addition, exposure to bilirubin prevented cell death induced by H2O2 in 
differentiated cells. 
Conclusions: Our data show that neuronal differentiation induced by 
ATRA impairs Nrf2/HO-1  activation and reduces the availability of 
endogenous bilirubin, thus decreasing cell adaptation to oxidative stress. 
 
CDIR8 Atomic Force Microscopy (AFM) Investigation  of the 
Mechnism of Transmissible Cytotoxicity by a Protein Isolated from 
Cerebrospinal Fluid of a Neurological Patient: A Protein Misfolding 
Hypothesis 
A. Alessandrini1, M. Portolani1, U. Muscatello2 
1Università di Modena e Reggio Emilia, Modena, Italy; 2CNR-Istituto 
Nanoscienze-S3, Modena, Italy 
Background: A cytotoxic protein fraction was  originally isolated from glial 
and epithelial cell cultures inoculated with aliquots of cerebrospinal fluid 
from a neurological patient. The cytotoxicity thus generated is 
transmissible to other cell cultures with remarkable efficiency and is 
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maintained through repeated  passages. Analytical,ulstrastructural and 
immunological analyses excluded the presence in the fraction of virus-like 
particles and of prion proteins. The cytotoxicity is resistant  to denaturation 
by physical and chemical agents. In the advanced stages, the process 
results in intracellular accumulation of protein fibrils.In view of all these 
observations, the hypothesis was advanced that this cytoxic fraction is the 
result of a process of  protein misfolding that propagates by transmitting 
the protein misfolded state to other cell cultures. 
Methods: We investigated with atomic force microscopy (AFM) the 
relative frequency  of protein monomeric, dimeric and low-n-oligomeric 
forms present in the cytotoxic fraction compared to that in the control. In 
fact, the misfolded proteins first come together to form dimers and  low n-
oligomers during fibrillogenesis, The use of AFM allows imaging of 
individual proteins and protein aggregates at high resolution, thus 
permitting determination of the frequency of specific structural forms of 
protein present in a sample. 
Results: Statistical analysis of AFM images revealed that the frequencies 
of dimers and of  low n-oligomer forms are significantly higher in the 
cytotoxic fraction than in the control. 
Conclusions: These observations substantiate the above hypothesis that 
the cytoxic fraction under study is the result of a protein misfolding 
process, capable of  being transmitted to other cell cultures. 
 
INFLAMMATION AND IMMUNOPATHOLOGY 
 
INIM1 Epicardial Adipose Tissue Increase as a Potential 
Mediator of Cardiac Fibrosis through ST2 Overexpression in CAD 
and Non-CAD Patients 
E. Vianello1, A. Sigruner2, P. Giubbilini3, G.V. Simone1, L. Tacchini1, G. 
Schmitz2, M.M. Corsi Romanelli1, E. Dozio1 
1University of Milan, Milan, Italy; 2University of Regensburg, Regensburg, 
Germany; 3IRCCS Policlinico San Donato, Milan, Italy 
Background: In coronary artery diseases (CAD) chronic hemodynamic 
sheer induces cardiac remodeling evolving in tissue fibrosis. The newer 
cytokine implicated in this process is ST2, an interleukin-1 receptor with 
two main isoforms, ST2L and soluble ST2 (sST2). The natural ST2L 
ligand is interleukin-33 (IL-33) and its binding has cardioprotective 
properties including cardiac fibrosis prevention. This mechanism is 
blocked by sST2, the receptor decoy of ST2L and its overexpression can 
inhibit ST2/IL-33 signaling. Different tissues can express ST2, including 
adipose tissue. Since EAT shares the microcirculation with myocardium 
our aim is to verify: first if EAT can produce ST2, and then whether 
increased EAT thickness can be associated to ST2 overexpression in 
CAD and non-CAD patients. 
Methods: We collected EAT and subcutaneous adipose tissue (SAT) 
biopsies from 22 CAD patients who underwent bypass surgery and 10 
non-CAD patients who underwent valvular replacement. All patients were 
stratified according to median EAT thickness value (8mm). ST2 and IL-33 
expression were assayed using microarray technology. ST2 level was 
determined by Western blotting analysis. 
Results: ST2 protein level was higher in EAT than SAT. CAD and non-
CAD patients with EAT thickness >8mm have higher expression of ST2 
gene than CAD and non-CAD patients with EAT thickness<8mm. IL-33 
expression was similar intra and inter CAD and non-CAD groups. 
Conclusions: Our results demonstrated that EAT mass increase is 
associated to ST2 expression and production in CAD and non-CAD 
patients and may be related to induction of cardiac fibrosis. 
 
INIM2 Characterization of the Proinflammatory Profile of 
Synovial Fluid-Derived Exosomes of Patients with Gonarthrosis 
R. Domenis1, R. Zanutel1, A. Cifù1, C. Pistis1, P. Di Benedetto2, A. 
Causero2, M. Pozzi3, F. Bassini3, M. Fabris2, K. R. Niazi4 
1University of Udine, Udine, Italy; 2ASUI Udine, Udine, Italy; 3AAS n.3 Alto 
Friuli, Tolmezzo, Italy; 4NantBioScience Inc., Culver City, California, USA 
Background: Synovial fluid (SF)-derived exosomes have been poorly 
characterized and their role in joint inflammation has never been 
investigated thoroughly. The purpose of this study is to characterize SF-
derived exosomes of patients with gonarthrosis and to investigate their 
immunoregulatory properties. 
Methods: Exosomes were isolated from SF of seven patients with 
gonarthrosis by polymer precipitation (Exoquick), quantified by acetyl-
CoA-acetetylcholinesterase activity, and validated by tetraspanins 
expression by immunoblot and FACS. To evaluate their immunoregulatory 
properties, exosomes were further purified with affinity capture antibody-
coupled magnetic beads and incubated with M1 macrophages, 
differentiated from blood donor CD14+ monocytes, and the production of 
cytokines, chemokines and MMPs and expression of co-stimulatory 
molecules were investigated by FACS and multiplex ELISA. 
Results: SF-derived exosomes (1.3±1.4x1011/ml) expressed the specific 
exosomal markers (CD9, CD63, CD81, TSG101) by immunoblot and 
FACS. After isolation with Exoquick, a relevant contamination by immune-
complexes was detected. To avoid possible interference in functional 
experiments by immune complexes, we added a magnetic bead isolation 
step. SF-derived exosomes significantly stimulated the production of 
several inflammatory cytokines and chemokines (IL1β, TNFα, IL16, 
CCL20, CCL15, CCCL1) and the release of specific metalloproteinases 
(MMP7 and MMP12) by M1 macrophages, although they did not influence 
the expression of CD80 and CD86 co-stimulatory molecules. 
Conclusions: In this study, we characterized exosomes isolated from SF 
of patients with gonarthrosis and demonstrated that they are functionally 
active in their ability to stimulate the release of proinflammatory cytokines 
and MMPs from M1 macrophages, suggesting that they may play a role in 
disease progression. 
 
INIM3 Biological Properties of Wine Grape Polyphenols on 
Human Dermal Blood Endothelial Cells 
M. Savio1, S. Di Francesco1, R. Borroni2, G. Borroni1, L. Stivala1 
1University of Pavia, Pavia, Italy; 2Policlinico San Matteo IRCCS, Pavia, 
Italy 
Background: The role of cutaneous microvasculature is crucial for both 
inflammatory and neoplastic diseases of the skin. The antioxidant, 
antiproliferative and antiinflammatory properties of wine grape 
polyphenols are widely recognized on blood vessels of the main 
circulatory system; however, little is known about their functions on the 
cutaneous microvasculature.   We sought to analyze the biological effects 
of selected wine grape polyphenols on primary human dermal blood 
endothelial cells (HDBECs). 
Methods: Primary HDBECs (Promocell, Germany) were incubated for 24 
hours respectively with Epicatechin, Quercitin3-glucoside and Malvidin3-
glucoside chloride (Phytolab, Germany), dissolved in dimethylsulphoxide. 
Cells were then irradiated with either UVA or UVB as proinflammatory 
stimulus. Cytotoxicity was assessed by MTT assay and trypan blue dye, 
DNA damage was determined by H2AX histone phosphorylation; levels of 
ICAM-1 were measured by ELISA. Production of reactive oxygen species 
(ROS) was investigated by flow cytometry analysis. 
Results: At the concentrations tested, none of the polyphenols exerted 
cytotoxic effects, although they significantly prevented UV-induced cell 
death, as observed mainly after UVA exposure. Similarly, UVA-induced 
DNA damage was decreased after treatment with each polyphenol, as 
compared to control. Dose-dependent inhibition of ROS production and 
ICAM-1 expression were also observed on UVA-irradiated HDBECs. 
These findings suggest that polyphenols exert an anti-inflammatory effect 
on HDBECs through their ability to interfere with ROS and cytokine 
release. 
Conclusions: Polyphenols derived from wine grape could be candidate 
antioxidants and anti-inflammatory compounds for skin diseases with 
involvement of the blood microvasculature. 
 
SIPMeT / SIPMeL Abstracts 
S24   ajp.amjpathol.org  ■  The American Journal of Pathology 
INIM4 Elevated Plasma Platelet-Activating Factor 
Acetylhydrolase Activity is Significantly Associated with High Risk 
Anti-phospholipid Antibody Antigenic Specificities 
M. Fabris1, A. Cifù1, C. Pistis1, R. Giacomello1, M. Siega-Ducaton2, E. 
Tonutti2, F. Curcio1 
1University Hospital of Udine, Udine, Italy; 2University of Udine, Udine, 
Italy 
Background: Elevated plasma platelet-activating factor acetylhydrolase 
(PAF-AH) activity was associated with increased risk of cardiovascular 
events. Our goal was to study the association between PAF-AH activity 
and the presence of different anti-phospholipid antibodies (aPL) antigenic 
specificities. 
Methods: Plasma PAF-AH activity was measured in 72 female patients 
(50±15 yrs) positive for at least one anti-phospholipid antibody in a 
context of thrombotic events or risk of thrombosis and in 21 age/sex 
matched blood donors (BDs). aPL antibodies (anti-
phosphatidylserine/prothrombin IgG/IgM antibodies - aPS/PT, anti-β2-
glycoprotein I IgG/IgM antibodies - aB2GpI, lupus anticoagulant - LAC), 
were analyzed by diagnostic methods. 
Results: PAF-AH activity was significantly more elevated in patients than 
in BDs (18.6±4.7 vs 13±2.4 nmol/min/ml; p<0.0001). Patients presenting 
only aB2GpI+ antibodies or only aPS/PT+ antibodies did not express 
different PAF-AH activity (17.8±3.4 vs 16.5±3.5 nmol/min/ml), although 
patients positive for both aB2GpI and aPS/PT antibodies showed 
significantly more elevated PAF-AH levels (20.9±5.6; p=0.03 versus 
aB2GpI+ and p=0.008 versus aPS/PT+). LAC+ showed higher PAF-AH 
plasmatic activity than LAC-negative patients (p=0.035). Patients 
disclosing IgG or IgM positive aPS/PT antibodies did not differ 
significantly, although aB2GpI IgG+ patients disclosed higher PAF-AH 
activity than aB2GpI IgM+ patients (21.8±6.4 vs 18.2±3.4 nmol/min/ml; 
p=0.07). Accordingly, aB2GpI IgG+ patients were more frequently 
associated to aPS/PT+ antibodies than aB2GpI IgM+ patients (85% vs 
35%; p=0.0006). 
Conclusions: PAF-AH activity is particularly elevated in patients showing 
both aB2GpI (especially IgG isotype) and aPS/PT antibodies, supporting 
the prominent role of this aPL pattern in anti-phosholipid antibody 
syndrome and possibly identifying PAF-AH as a factor involved in the 
pathogenic process. 
 
INIM5 Antioxidant Effects of Extra Virgin Olive Oil Polyphenol 
Extracts on PBMCs 
G. Accardi1, G. Adamo1, A. Aiello1, G. Candore1, C. Gambino1, G. Ghersi1, 
A. Procopio2, C. Caruso1 
1University of Palermo, Palermo, Italy; 2University Magna Grecia of 
Catanzaro, Roccelletta di Borgia, Italy 
Background: The traditional Mediterranean diet is characterized by the 
use of extra virgin olive oil (EVOO), which plays a key role in the 
prevention of age-related diseases and in the attainment of longevity due 
to the high levels of phenols. In fact, in particular oleuropein and 
hydroxytyrosol phenols seem to have the capacity to scavenge ROS and 
to act as anti-inflammatory molecules. Thus, they can positively affect the 
pathogenesis of age-related diseases, characterized by a low-grade 
inflammation and accumulation of ROS. The aim of the study was to 
establish the antioxidant activity of oleuropein, hydroxytyrosol and 
derivates, using human peripheral blood mononuclear cells (PBMCs) as 
an in vitro cellular screening system. 
Methods: We tested the two native molecules and their paracetylated 
derivates on PBMCs. The cells were cultured and incubated with three 
polyphenol concentrations (1, 10 and 100 mM). ROS production was 
detected by Synergy-HT plate-reader (Ex/Em 488/528nm), after treatment 
with 20mM of 2’,7’ –dichlorofluorescin diacetate. 
Results: Preliminary results demonstrate that the paracetylated 
molecules work in a dose-dependent manner, scavenging the ROS. This 
is in agreement with the datum that peracetylation of oleuropein and 
hydroxytyrosol may improve the ability to permeate the cellular 
membrane, hence performing the antioxidant action. 
Conclusions: The use of supplements is widely popular but the real 
effects on humans are not always tested. Their application in terms of 
potentiation of therapies or prevention is interesting but, because they are 
chemical molecules, it is important, to first well characterize all their 
possible effects using human ex vivo models. 
 
INIM6 The Crosstalk Between Fibronectin-Elicited Signals and 
the Receptor for the Colony-Stimulating Factor 1 (CSF-1R) Sustains 
Macrophage Migration 
E. Rovida1, G. Digiacomo1, I. Tusa1, M. Bacci1, M. Cipolleschi1, P. Dello 
Sbarba1 
1University of Florence, Florence, Italy 
Background: Integrins, following binding to proteins of the extracellular 
matrix, including fibronectin (FN), regulate several biological functions 
including migration. Besides activation of adaptor molecules and kinases, 
integrins can transactivate receptor tyrosine kinases (RTK) in the absence 
of growth factors. Colony stimulating factor-1 receptor (CSF-1R) is a RTK 
that supports the survival, proliferation, and motility of 
monocytes/macrophages, which are essential components of innate 
immunity and cancer development. Macrophage interaction with FN is 
recognized as an important aspect of host defense and wound repair. The 
aim of the present study was to investigate a possible crosstalk between 
FN-elicited signals and CSF-1R in macrophages. 
Methods: We used the BAC1.2F5 and J774 murine macrophage cell lines 
and human primary macrophages derived from peripheral blood of healthy 
donors. Cell migration was assessed using 48-well modified Boyden 
chambers. 
Results: FN induced migration in BAC1.2F5 and J774 cells as well as in 
human primary macrophages. Adhesion to FN determined 
phosphorylation of the focal adhesion kinase (FAK) and Src family kinases 
(SFK) and activation of the FAK/SFK complex as witnessed by paxillin 
phosphorylation. SFK activity was necessary for FAK activation and 
macrophage migration. Moreover, FN-induced migration was dependent 
on FAK in either murine macrophage cell lines or human macrophages. 
FN also induced CSF-1R and β1 integrin interaction and FAK-dependent 
CSF-1R phosphorylation. FN-induced CSF-1R phosphorylation was 
functional to migration. Indeed, genetic or pharmacological inhibition of 
CSF-1R prevented FN-induced macrophage migration. 
Conclusions: Our results identified a new SFK-FAK/CSF-1R signaling 
pathway that mediates FN-induced migration of macrophages. 
 
INIM7 CD161++CD8+ Mucosal-Associated Invariant T Cells 
(MAIT) are Reduced in Peripheral Blood of Healthy Elderly People 
M. Bulati1, S. Buffa1, G. Candore1, D. Lio1, C. Caruso1, G. Colonna-
Romano1 
1University of Palermo, Palermo, Italy 
Background: MAIT cells represent the most abundant innate-like T cell 
population in humans involved in anti-bacterial immunity. These cells have 
been associated with numerous diseases, such as bacterial infections and 
many proinflammatory diseases. Reduced number of circulating MAIT 
cells have been demonstrated in different autoimmune pathologies, as 
well as in HIV-infected patients. It is known that elderly people are 
characterized by a chronic, low-grade, proinflammatory status associated 
with the remodeling of the immune system. These changes are strictly 
associated with the increased susceptibility to infectious disease, other 
than chronic inflammatory diseases, of elderly people. In the present 
study, we investigated the percentage and the absolute number of 
circulating MAIT cells in healthy elderly people compared with young 
subjects. 
Methods: Peripheral blood mononuclear cells were isolated from whole 
blood of 25 healthy elderly and 20 young subjects. To characterize the 
phenotype of MAIT lymphocytes, extracellular labelling was performed 
with anti-CD8-FITC, CD161-PE and CD3-ECD. Cells were acquired on an 
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Epics XL-MCL (BeckmanCoulter) four-colour flow cytometer and analyzed 
with FlowJo software (TreeStar). 
Results: The results obtained show a significant decrease, both in 
percentage and in absolute number, of CD161++CD8+ MAIT cells in the 
elderly compared to young subjects. 
Conclusions: The age-related reduction of MAIT cells could be due to the 
chronic proinflammatory status of elderly people. Moreover, the reduction 
of these cells could explain the impaired ability of elderly subjects to 
respond to bacterial infections, e.g. S. pneumonia, which is one of the 
causes of morbidity and mortality in elderly people. 
 
INIM8 Immunomodulatory Effect on CXCL10 of Selen-
methionine in Association with Myo-Inositol in Patients with 
Euthyroid Autoimmune Thyroiditis 
L. Rossi1, P. Fallahi2, S. Ferrari2, I. Ruffilli2, G. Elia2, F. Ragusa2, A. 
Antonelli2 
1University Hospital of Pisa, Pisa, Italy; 2University of Pisa, Pisa, Italy 
Background: Different experimental researches and clinical trials have 
shown that myo-inositol and phosphatidylinositol(s) are involved in 
physiological and pathological conditions of the thyroid.   The IFN-γ-
inducible protein 10 (CXCL10, or IP-10) was initially identified as a 
chemokine induced by IFN-γ. Determination of high level of CXCL10 in 
peripheral fluids is considered a marker of a Th1 orientated immune 
response. The immune-modulating effect of selenomethionine in 
association with myo-inositol in patients with euthyroid autoimmune 
thyroiditis (AT) has been evaluated. 
Methods: We evaluated 21 consecutive Caucasian patients with newly 
diagnosed euthyroid chronic AT. All patients were treated with 
selenomethionine plus myo-inositol (600 mg/83 mg) tablets, twice per day, 
for 6 months. A complete thyroid assessment was done before the 
treatment and after 6 months. Serum CXCL10 levels were assayed by a 
quantitative sandwich immunoassay using a commercially available kit. 
Results: After treatment, thyroid-stimulating hormone (TSH) levels 
significantly declined compared to basal values, particularly in patients 
with an initial TSH value in the high normal range (2.1<TSH<4.0), 
suggesting that the combined treatment can reduce the risk of a 
progression to hypothyroidism in subjects with autoimmune thyroid 
diseases (AITD). After treatment, antithyroid autoantibody levels declined, 
as did CXCL10 levels, confirming its immunomodulatory effect. 
Conclusions: We first show an immunomodulatory effect of 
selenomethionine in association with myo-inositol in patients with 
euthyroid AT. Further researches are necessary to extend the 
observations in large population, to evaluate the effect on quality of life, 
and to study the mechanism of the effect on chemokines. 
 
INIM9 CD3+CD56+cells, a Novel Regulatory Subset, Modulates 
the Effector Function of Human CD8+ T Cells: Implication for Type 1 
Diabetes 
M. Santopaolo1, V. Rubino2, S. de Simone3, A. Palatucci4, A. Giovazzino5, 
G. Terrazzano4, G. Matarese6 
1Università di Napoli Federico II, Naples, Italy; 2Università Federico II, 
Naples, Italy; 3Consiglio Nazionale delle Ricerche, Naples, Italy; 
4Università degli Studi di Potenza, Potenza, Italy; 5Università degli Studi di 
Napoli, Naples, Italy; 6Università degli Studi di Napoli “Federico II, Naples, 
Italy 
Background: Orchestration of immune response is a complex 
phenomenon aimed to maintain tissue homeostasis. The key role of 
regulatory populations in the prevention of autoimmunity and immune 
mediated diseases has been largely shown. A number of observations 
indicate that normal peripheral blood contains a small population of 
lymphocytes that express both CD56 and CD3 phenotypic markers, which 
usually characterize human natural killer (NK) and T (CD3) cells, 
respectively. The biological hallmarks and functional characteristics of 
CD3+CD56+ cells are not completely understood; experimental evidence 
associated this cell subset with different pathophysiological conditions. 
Methods: CD3+CD56+ cells were isolated from peripheral blood 
mononuclear cells (PBMCs) of human healthy subjects (HS) and type 1 
diabetes subjects (T1D), by high-performance cell sorting. The phenotype 
and functional activity of human CD3+CD56+ cells was assayed by 
cytofluorimetric analysis. 
Results: We found that flow-sorted CD3+CD56+ cells inhibited 
proliferation, cytoxicity and interferon (IFN)-γ production of activated CD8+ 
T cells, both in autologous and allogeneic conditions. Furthermore, it has 
been observed that down-modulation of CD8+ T cell activity was not 
dependent on FAS-FASL-mediated apoptosis and required cell-cell 
contact. Finally, absolute cell numbers and suppressive capability of 
CD3+CD56+ cells were reduced in T1D compared with HS. 
Conclusions: Our data unveil a novel lymphocyte subset with regulatory 
properties that specifically modulate CD8+ T cell response, which numbers 
and function were impaired in T1D. The comprehension of the precise 
cellular and molecular mechanisms that lead to suppressive activity of 
CD3+CD56+ cells may contribute to the understanding of their role in the 
pathophysiology of T1D. 
 
INIM10 Role of Annexin A1 (ANXA1) in the Modulation of Immune 
Response and Inflammation During Multiple Sclerosis  
A. Colamatteo1, E. Maggioli2, S. Cassano3, M. Galgani3, G. Matarese4, E. 
Solito2 
1Università degli Studi di Salerno, Baronissi, Italy; 2Queen Mary University 
of London, London, United Kingdom (Great Britain); 3Consiglio Nazionale 
delle Ricerche, Napoli, Italy; 4Università degli Studi di Napoli "Federico II", 
Napoli, Italy 
Background: Annexin A1 (ANXA1) is an endogenous anti-inflammatory 
molecule, whose activity is mediated by glucocorticoids. It is mainly a 
cytoplasmic molecule but can be either membrane-associated and 
secreted as soluble factor. It exerts its anti-inflammatory action by limiting 
neutrophil extravasation and blocking monocyte migration via α4β1 
integrin. ANXA1 also regulates blood-brain barrier (BBB) integrity in brain 
microvascular endothelial cells, and its expression is selectively lost in 
BBB of multiple sclerosis (MS) subjects. While the role of ANXA1 in innate 
immunity is well known, its action on the modulation of adaptive immune 
response is not completely understood. 
Methods: ANXA1 expression in Treg and T conv cells from MS and 
healthy subjects was measured by Western blot and flow cytometry. 
Migratory capacity of Treg and T conv cells, from MS and healthy 
subjects, was tested using a transmigration assay with normal and human 
brain microvascular endhotelial cells silenced for ANXA1. 
Results: We found that ANXA1 intracellular levels were significantly lower 
both in Treg and Tconv cells from MS compared to healthy subjects, also 
upon T cell receptor (TCR) activation. Moreover, we observed an impaired 
expression of ANXA1 levels in Th17 cells from MS compared to healthy 
subjects. Finally, Treg and Tconv cells from MS subjects showed a higher 
degree of adhesion and migration compared to healthy subjects and this 
condition is exacerbated on endhotelium lacking of ANXA1. 
Conclusions: Together these findings suggest that the differential 
expression of ANXA1, in Treg and Tconv cells, could have relevance to 
the resolution of inflammation in MS subjects. 
 
INIM11 Association of Uncoupling Protein Polymorphisms with 
Oxidative Stress and Implications for Atherosclerosis in Systemic 
Lupus Erythematosus Patients 
C. Gambino1, G. Accardi1, A. Aiello1, B. Gioia1, M. Midiri1, G. Guggino1, C. 
Schinocca1, C. Carru2, C. Caruso1, G. Candore1 
1University of Palermo, Palermo, Italy; 2University of Sassari, Sassari, Italy 
Background: Uncoupling proteins (UCPs) are a family of inner 
mitochondrial membrane carriers, implicated in inflammation and 
atherogenesis through the control of reactive oxygen species production. 
In this study we investigate the association between genetic variants in 
the UCP1, UCP2, and UCP3 genes with the presence of carotid plaque 
and oxidative stress in systemic lupus erythematosus (SLE) patients. 
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Methods: To date, 48 SLE patients and 29 age/sex-matched healthy 
individuals were enrolled. All samples were genotyped for the following 
SNPs, UCP1 -3826 A/G, UCP2 -866 G/A, UCP2 Ins/Del, and UCP3 -
55C/T using RFPL-PCR. Plasma oxidative stress was evaluated 
measuring plasma levels of malondialdehyde (MDA) and thiols by laser-
induced fluorescence capillary electrophoresis. Carotid plaque was 
evaluated using echo-colour-Doppler examination. 
Results: Statistical analyses of the SNPs showed no significant difference 
in genotype and allele frequencies between cases and controls. Increased 
risk for carotid plaque has been observed in SLE patients (p< 0.05), but it 
seems to not correlate with UCP SNPs. Oxidative stress data showed 
higher levels of MDA, cysteine, and taurine in SLE patients compared to 
controls (p< 0.05). Particularly, the increase of MDA is associated with the 
mutated allele G of  UCP1 gene (p= 0.035). 
Conclusions: In our case-control study, we observed no significant 
associations between genetic variants in UCP genes and SLE 
pathogenesis. In contrast, we found that UCP1 -3826 A/G polymorphism 
is associated with increased levels of MDA in SLE. Several  studies 
suggest MDA as a predictor of cardiac events; further studies are needed 
to confirm our observations. 
 
INIM12 ANA Testing and Anti-DFS70 Antibody Detection in 
Clinical Practice: Experience with DFS70-Ko HEp2 
D.E. Fontana1, E. Tonutti1, F. Pesente1, N. Bizzaro1, N. Blasone1, M. 
Carletti1, L. Meroi1, S. Milloch1, F. Curcio1, M. Fabris1 
1University Hospital of Udine, Udine, Italy 
Background: When an ANA pattern suggestive of anti- DFS70 antibodies 
(dense fine speckled) is detected, it should be confirmed. Several 
confirmation methods are available, including a new ANA-IIF using HEp2 
cells knocked-out for the DFS70 antigen (DFS70-Ko) and mixed at 1:9 
ratio with normal HEp2 cells. The aim of this study is to evaluate the 
possibility of using this test as a first level ANA screening test. 
Methods: We performed the ANA test using the IMMCO HEp2 DFS70-Ko 
ANA-IIF method in 3 different series of sera: 90 previously tested positive 
for anti-DFS70 by chemiluminenscent immunoassay (CLIA, BioFlash, 
INOVA); 108 high positive for the most common rheumatic disease-
associated autoantibodies; and 131 consecutive routine samples 
screened for ANA on HEp2 INOVA. 
Results: The HEp2 DFS70-Ko test enabled recognition of anti-DFS70 
antibodies in 85/90 (94.5%)  DFS70 CLIA-positive sera. The 131 sera with 
defined antibody specificity displayed their expected HEp2 pattern, both 
on the standard and DFS70-Ko subtrates. We found an elevated 
concordance (95.5%) between ANA results on Inova and on IMMCO 
DFS70-Ko HEp2 cells. 3/5 suspected DFS70 sera on Inova were 
confirmed by IMMCO. 
Conclusions: The IMMCO HEp2 DFS70-Ko method could be used for 
routine ANA screening as it presents sensitivity and specificity comparable 
to the standard HEp2 substrate, keeping the expression of autoantibody 
markers intact. Moreover, it offers an excellent opportunity allowing the 
simultaneous identification and confirmation of the presence of anti-
DFS70 antibodies. This could prove to be extremely important regarding 
organization, turnaround time, and laboratory economy. 
 
INIM13 LPS Adsorption to Titanium Dioxide Nanoparticles Shifts 
the Proinflammatory Transduction Pathways Triggered by 
Endotoxin: A Biomimetic Effect of the Complex 
M.G. Bianchi1, M. Allegri1, A.L. Costa2, S. Ortelli2, M. Blosi2, A. Pagliaro1, 
M. Chiu1, E. Bergamschi1, O. Bussolati1 
1University of Parma, Parma, Italy; 2CNR, Faenza, Italy 
Background: Engineered nanoparticles (NP) have been recently 
proposed as powerful tools for immunomodulating approaches although 
they may also cause unwanted inflammatory responses. We recently 
observed that TiO2 NPs synergize TLR4-dependent proinflammatory 
effects of LPS in macrophages (Bianchi et al., Toxicol Res 2015, 4:385-
398). Our task is to identify which TLR4-dependent inflammatory 
pathways are triggered by the LPS-NP complex. 
Methods: Raw 264.7 (murine) cells were treated with TiO2 NP (20 nm, 80 
µg/cm2) and LPS O55:B5 (0.5 ng/ml) alone or in combination. The 
endpoints evaluated were Nos2, Tnf and Ifnbeta1 expression (RT-PCR), 
MAPK and IRF-3 phosphorylation (Western blot). MyD88 adaptor function 
was inhibited with specific peptides. 
Results: Compared with LPS or NPs alone, co-incubation with TiO2 NPs 
and LPS potentiated either NF-κB- (Tnf, Nos2) or TRIF-dependent 
(Ifnbeta1) gene expression, changing also the kinetics of induction. The 
phagocytosis inhibitor cytochalasin B partially hindered the LPS-
dependent induction of Ifnbeta and Nos2, but abolished the synergistic 
effect. NP-LPS complex increased IRF-3 phosphorylation and nuclear 
translocation more than LPS alone. MyD88 adaptor inhibition reduced the 
LPS-NP dependent overstimulation of Nos2 and Ifnbeta1 and prevented 
the LPS-dependent induction of Nos2 but not that of Ifnbeta1. LPS-NP co-
treatment mainly involved p38 phosphorylation, but LPS alone had a 
prevalent effect on JNK and ERK1/2. 
Conclusions: The synergistic effect of TiO2 NP and LPS on macrophage 
activation is attributable to the endosomal targeting of the complex, which, 
due to NP aggregation, may assume bacteria-like shape and size and 
become endowed with biomimetic properties. 
 
INIM14 Induction of Arginase Pathway in Human Monocytes: 
Does Celiac Disease Matter? 
A. Barilli1, F. Gaiani1, F. Ingoglia1, R. Visigalli1, L. Raucci1, G. de'Angelis1, 
V. Dall'Asta1 
1University of Parma, Parma, Italy 
Background: Celiac disease (CD) is an immunomediated enteropathy, 
involving both adaptive and innate responses against ingested gluten in 
susceptible individuals. We have demonstrated that the activation of the 
arginase metabolic pathway in murine macrophages by gluten peptides 
contributes to the modulation of intestinal permeability in vitro. The aim of 
this study is to verify 1) whether a comparable gluten-driven induction of 
arginase also occurs in human monocytes; 2) if the activation of arginase 
pathway by gluten corresponds to the onset of an inflammatory phenotype 
in immune cells; and 3) if the expression of genes belonging to this 
pathway could be used as serological marker of CD. 
Methods: Circulating monocytes were isolated from blood samples 
collected from 15 CD patients on gluten-free diet, 15 naïve patients and 
15 healthy controls. After treatment with enzymatically digested gluten 
(PTG), the expression of arginase and of the proinflammatory marker IL1β 
was measured in all samples. 
Results: An induction of arginase transcript was observed in PTG-treated 
monocytes, confirming data obtained in murine cells; a concomitant 
increase of IL1β also occurred, indicating the inflammatory effect of the 
treatment. However, no significant difference was detected between 
healthy or pathological samples, neither CD nor CD_GF. Hence, neither 
arginase nor IL1β in circulating monocytes appear to be good candidates 
for diagnosis of CD, being equally expressed in all groups. 
Conclusions: In human monocytes, gluten activates arginase pathway 
and increases IL1β mRNA, confirming the onset of an inflammatory 
phenotype. However, these genes  do not appear to be good candidates 
for diagnosis of CD. 
 
INIM15 Human Macrophage Differentiation Induces an Increase 
of Carnitine Transport 
F. Ingoglia1, R. Visigalli1, B. Rotoli1, A. Barilli1, V. Dall'Asta1 
1University of Parma, Parma, Italy 
Background: L-carnitine, besides playing a fundamental role in the β-
oxidation of fatty acids, has been recently identified as a modulator of 
immune function, although the underlying mechanisms remain to be 
clarified. In this study, we addressed the modulation of L-carnitine 
transport and the expression of the related transporters during the 
differentiation of human monocytes to macrophages. 
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Methods: Macrophages were obtained incubating human monocytes, 
isolated from buffy-coat, with GM-CSF for 5d. L-carnitine uptake was 
determined by incubation of the cells in EBSS containing L-[3H]carnitine. 
The expression of the transporters was determined by RT-PCR and by 
Western blot analysis 
Results: Although monocytes display a very modest uptake of L-carnitine, 
GM-CSF-induced differentiation massively increased the saturable Na+-
dependent uptake of L-carnitine. Kinetic and inhibition analyses 
demonstrate that in macrophages, L-carnitine transport is mediated by a 
high affinity component (Km ~ 4 µM) identifiable with the operation of 
OCTN2 transporter and a low affinity component (Km > 10mM)  identifiable 
with system A for neutral amino acids. Consistently, both 
SLC22A5/OCTN2 and SLC38A2/SNAT2 are induced during the 
differentiation of monocytes to macrophages at gene and protein levels. 
The elucidation of GM-CSF signaling demonstrates that the cytokine 
causes the activation of mTOR kinase leading to the phosphorylation and 
activation of the transcription factor STAT3, which is, in turn, responsible 
for the OCTN2 induction. 
Conclusions: Monocyte-to-macrophage differentiation associates with 
the upregulation  of carnitine transport due to the mTOR-dependent 
activation of STAT3. SLC22A5/OCTN2 emerges therefore as a novel 
member of the set of genes markers of macrophage differentiation. 
 
INIM16 Comparison between Anti-β2Glycoprotein I Antibody and 
Anti-Phosphatidylserine/Prothrombin Antibody Biological Effects on 
Peripheral Blood Monocytes 
A. Cifù1, C. Pistis1, R. Domenis2, F. Curcio1, M. Fabris1 
1University Hospital of Udine, Udine, Italy; 2University of Udine, Udine, 
Italy 
Background: Antiphospholipid syndrome (APS) is an autoimmune 
disorder characterized by vascular thrombosis and/or pregnancy morbidity 
and the persistent presence of antiphospholipid antibodies. The aim of this 
study was to compare the biological effects of anti-β2Glycoprotein I 
(aβ2GpI) and anti-phosphatidylserine/prothrombin (aPS/PT) antibodies on 
peripheral blood monocytes. 
Methods: Peripheral blood monocytes isolated from five blood donors 
(BD) were incubated per four hours with lypopolysaccarides (LPS) alone 
or in combination with  IgG fractions obtained from  the serum of six APS 
patients who were positive either for aβ2GpI or aPS/PT antibodies. As 
controls, monocytes were incubated with LPS plus the IgG fractions 
isolated from the serum of five different BD. The mRNA expression of 
tissue factor (TF), interleukin 1β (IL1β),  inflammasome 3 (NLRP3) and 
inflammasome 1 (NLRP1) were measured using real-time PCR. 
Results: Compared to the non-treated cells, no differences were found 
between treatment with LPS alone (6.4±1 fold) or LPS plus the IgG 
fraction from BD (6.5±1.7 fold), although LPS plus aB2GpI or aPS/PT IgG 
fraction isolated from APS patients demonstrated an increased expression 
of TF mRNA, without significant difference (respectively 8.2±0.9 fold and 
9.4±1.3 fold). LPS upregulates NLRP3 expression (but not NLRP1), but 
the addition of aB2GpI IgG fraction did not differ from LPS alone, while 
aPS/PT inhibits both LPS-induced NLRP3 and IL1β expression. 
Conclusions: aβ2GpI and aPS/PT upregulate TF expression in 
monocytes pre-activated with LPS, in line with their pathogenic role in 
APS. However the different effect on IL1β and NLRP3 LPS-induced 
expression could indicate that aβ2GpI and aPS/PT activate different 
inflammatory pathways. 
 
INIM17 Simultaneous Detection of Hepatitis B Surface Antigen 
(HBsAg) and Surface Antibody (Anti-HBs) in Acute Hepatitis B 
Infection 
M. Marangone1, G. Barbina1, U. Qualizza1, F. Curcio1 
1University Hospital of Udine, Udine, Italy 
Background: We report a case of transient coexistence of hepatitis B 
surface antigen (HBsAg) and surface antibody (anti-HBs) in a 50-year old 
patient with acute hepatitis B infection. Usually, anti-HBs is only detected 
in serum after HBsAg clearance, and a literature review did not provide 
clear evidence of transient coexistence. 
Methods: Chemiluminescent immunoassay ADVIA Centaur XP (Siemens 
Healthcare Diagnostics Inc., Tarrytown, NY,  USA) for qualitative 
determination of HBsAg and quantitative determination of anti-HBs in 
human serum and plasma.   Chemiluminescent immunoassay Liaison XL 
MUREX (DiaSorin S.p.A., Saluggia, VC, Italy) for  quantitative 
determination of HBsAg in human serum and plasma. 
Results: On 13th May 2016, the patient tested positive for both HBsAg 
and anti-HBs. Qualitative determination of HBsAg had an index of 19.7. 
Quantitative determination of HBsAg confirmed reactivity with a reading of 
0.3 IU/mL.   Anti-HBs quantitative result was 81 IU/L.   Other markers for 
hepatitis  B infection, such as total core antibody (anti-HBc), IgM antibody 
to core antigen (IgM anti-HBc), envelope antigen (HBeAg) and envelope 
antibody (anti-HBe), were also positive. Quantitative HBV-DNA testing 
showed a reading of 80490 IU/mL.   Four days later, HBsAg test resulted 
non-reactive with index dropping to 0.48, whereas anti-HBs remained 
reactive (53 IU/L). On 19th May, non-reactivity of HBsAg was confirmed 
with an index of 0.47, as well as anti-HBs positivity (45 IU/L). 
Conclusions: In our patient, HBsAg and anti-HBs were simultaneously 
detected, and they coexisted in the serum for four days before HBsAg 
clearance. 
 
INIM18 Correlation of Glycemic Control with Inflammatory and 
Endothelial Markers in Patients with Type 2 Diabetes   
 E. Palella1, R. Cimino1, F. Accattato1, M. Creco1, D.P. Foti1, E. Gulletta1 
1University of Magna Graecia, Catanzaro, Italy 
Background: Type 2 diabetes mellitus (T2DM) is a chronic disorder 
characterized by insulin resistance and by an increased risk of 
cardiovascular morbidity and mortality. Several studies have shown the 
relationship between insulin resistance, endothelial dysfunction, and 
systemic low-grade inflammation in the development of chronic 
complications in T2DM. This study aims to evaluate the correlation of the 
levels of some circulating adhesion molecules and neutrophil-lymphocyte 
ratio (NLR), an independent predictor of cardiovascular events, with 
glycemic control in T2DM patients. 
Methods: The study cohort consisted of 133 patients (71♀ and 62♂, 57-
74 years), divided into two groups according to their HbA1c (<7% and 
≥7%, n= 58 and n=75, respectively). HbA1c was measured by HA-8160 
(Menarini); leukocyte count was performed using ADVIA 2120 (Siemens) 
and NLR was calculated as the ratio between the absolute values of 
neutrophils and lymphocytes. Serum levels of adhesion molecules (V- and 
I-CAMs, E-, P-, and L-selectins) were measured by a multiplex biochip 
array (Randox). 
Results: Statistical analysis (Mann-Whitney test, SPSS 20.0) showed 
significantly higher levels of E- and P-selectins in patients with poor vs 
good glycemic control [16(IQR 11-22) ng/ml vs 11(IQR 4-18) ng/ml, p= 
0,003 and 66(IQR 42-97) ng/ml vs 53(IQR 24-78) ng/ml, p=0,024, 
respectively]. In the HbA1c ≥7% group, we found increased NLR values 
vs the HbA1c <7% group [2,1(IQR 1,6-2,9) vs 1,8(IQR 1,3-2,2), p=0,013]. 
Conclusions: E-, P-selectins and NLR significantly correlate with 
glycemic control. Further studies are needed to assess these parameters 
as adjuvant prognostic markers for vascular complications in diabetic 
patients. 
 
INIM19 Increasing Levels of Sputum Gamma-
Glutamyltransferase May be a Contraindication for Glutathione 
Inhalation Therapies In Cystic Fibrosis 
A. Corti1, M. Griese2, A. Hector3, A. Pompella1 
1University of Pisa, Pisa, Italy; 2Children’s Hospital, Ludwig-Maximilians-
University, Munich, Germany; 3Children’s Hospital, University of Tübingen, 
Tübingen, Germany 
Background: The antioxidant glutathione (GSH) is decreased in cystic 
fibrosis (CF) airways. GSH resupply by inhalation has become popular in 
CF patients, however conflicting results were reported to date. 
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Interestingly, CF airways present with increased levels of gamma-
glutamyltransferase (GGT), the enzyme capable of degrading GSH. 
Methods: We have determined GGT activity in sputum samples included 
in a previously published large study on GSH inhalation (AJRCCM 2013, 
188: 83). The biochemical parameters measured in that study were re-
evaluated for their potential correlations with sputum GGT levels. 
Results: Highly varying levels of GGT were detectable in CF sputum and 
strong correlations between GGT and markers of inflammation (neutrophil 
count, neutrophilic elastase) were found. Variations in GGT activity 
correlated with variations in levels of cysteinyl-glycine (i.e., the specific 
GSH metabolite), thus confirming that inhaled GSH was in fact undergoing 
GGT-mediated degradation. Only in the presence of decreasing levels of 
GGT did GSH inhalation result in lower levels of the proinflammatory 
cytokines IL-8, TNF-α and IL-1β; on the other hand, in samples with 
increasing GGT, higher levels of carbonylated proteins (an oxidative 
stress index) were detected. 
Conclusions: Data indicate that GGT activity – increasing in the airways 
of CF patients along with exacerbations of inflammation – can predict the 
expected outcome of GSH inhalation therapies. The latter appears 
capable of producing real – but at best, limited – benefits only in patients 
already presenting with a regression of lung inflammation.     
Acknowledgement:This study was supported by a grant from the Italian 
Cystic Fibrosis Research Foundation (Verona, Italy; Project FFC 
#18/2014). 
 
INIM20 Comparison of Two Methods of Urine Electrophoresis for 
BJ Detection: Preliminary Results 
S. Zago1, A. Colatutto1, A. Lorenzon1, F. Curcio1 
1University Hospital of Udine, Udine, Italy 
Background: In plasma cell dyscrasia (PCD), mutations in 
immunoglobulin genes induce a super production of light chains (Bence-
Jones proteins) that pass from serum to urine. Because electrophoresis is 
the best technique for identifying abnormal proteins in the urine, it is the 
first-choice screening test in patients with PCD diagnosis. Samples with 
abnormal electrophoretic patterns are further analyzed by immunofixation 
to assess their biochemical identity. This test combines electrophoresis of 
proteins with immunoprecipitation using specific antisera that present 
different binding specificity to protein domains of immunoglobulins. The 
aim of the study was to compare two different methods of urinary 
immunofixation. 
Methods: Between January-February and April-May 2016, we analyzed 
388 and 454 urine samples respectively, to compare Bence-Jones 
proteinuria and to perform urinary immunofixation. The former method 
(IFE 6, Interlab G26 Easy Fix) provided a urine electrophoretic step 
combined with immunofixation; the current method (IFE BJ 6, Interlab G26 
Easy Fix) is characterized by an additional step of antisera deposition, as 
to improve the diagnostic performance. 
Results: In the first group: 17.2% of the samples were positive for urinary 
free light chains, 11% showed weakly positivity and 71.8% were negative. 
Likewise, in the second group: 18.3% of the samples were positive, 10.8% 
were weakly positive and 70.9% resulted negative. 
Conclusions: The preliminary results of our study confirm that there is no 
statistically significant difference between the two methods. To define the 
highest sensitivity of the innovative method a wider cohort of patients or a 
longer follow-up are needed. 
 
INIM21 Low Level of Vitamin D is a Predictor of Cardiovascular 
Risk    
G. Giovanni1, G. Grande1, A. Luigi1, I. Odierno1, P. Tuccillo1, M. Acitorio1, 
C. Savarese1, G. Riccio1, M. Trezza1, G. D'Auria2, N. Capuano1, A. 
Centanni1 
1Hospital Umberto I Nocera Inferiore-Salerno, Naples, Italy; 2Hospital San 
Giuliano, Giugliano, Italy 
Background: Patients with Vitamin D deficiency show higher levels of 
interleukin-6 (IL-6), IL-10, and C-reactive protein (CRP). Our study aims to 
demonstrate that the majority of patients enrolled in cardiac rehabilitation, 
though relatively young and with no apparent metabolic problems, could 
show low levels of vitamin D, not always related to CRP. 
Methods: The study enrolled 79 patients (59 M and 20 F) with previous 
SCA, aged 37 to 76 years (average 56.3). We excluded patients with a 
history of endocrine and metabolic bone disease . All patients  had blood 
tests: Dosage vit D (DIASORIN) PCR ( COBAS -Roche) . 
Results: The dosage of vitamin D at entry showed a mean value of 21.2 
ng / ml (vn> 25ng/ml), with a minimum value of 9.3 and a maximum of 38. 
In the face of low values of vitamin D, CRP  averaged 3.2 (vn 0-5), not 
suggestive of inflammatory process in place. 
Conclusions: A low value of vitamin D could be considered a marker of 
cardiovascular risk more sensitive than CRP but well correlated to the 
ratio ECM / BCM.  Our data are too small to be significant. The Vitamin D 
and Omega-3 Trial (VITAL) should provide a clearer picture of the role of 
vitamin D and omega-3 fatty acids in the prevention of cardiovascular 
disease. 
 
INIM22 Cholinergic System Dysfunction in Multiple Sclerosis 
Patients 
E. Costantini1, M. Di Bari2, M. Di Nicola3, C. D'Angelo3, V. Gatta3, A. Tata4, 
M. Reale3 
1Università degli Studi G.D'Annunzio Chieti-Pescara, Chieti, Italy; 
2University of Rome "Sapienza", Rome, Italy; 3University "G. D'Annunzio", 
Chieti, Italy; 4University "Sapienza", Rome, Italy 
Background: Acetycholine (ACh) in the modulation of neuroinflammation 
has been described. Butyrylcholinesterase (BuChE) and 
acetylcholinesterase (AChE) hydrolyze the neurotransmitter acetylcholine 
(ACh). Recently, it was hypothesized that  BuChE and AChE genes could 
be considered as candidate genes for association studies in multiple 
sclerosis (MS). The aim of this study is to evaluate cholinergic system 
dysfunction in MS 
Methods: In CSF of patients with MS and with other neurological 
diseases (OND), ACh was measured by fluorimetric commercial kit and 
AChE and BuChE by enzymatic test of Ellman.  AChE and BuChE 
polymorphisms were analyzed by RFLP analysis. 
Results: CSF levels of AChE were higher in relapsing-remitting (RR) MS 
than OND (22.4±9.5 vs 9.0±2.2; p<0.05), although the BuChE levels were 
not significantly different (p=0.48). ACh levels in CSF of RR-MS patients 
were 124.3±56.4 pmol ACh/mL compared to 393.6±142.5 pmol ACh/mL 
in OND (p=0.03). We found a negative correlation between levels of AChE 
activity and levels of ACh in CSF of RR-MS patients.  AChE rs2571598 
and BuChE rs1803274 polymorphisms found in RR-MS patients may 
explain the altered activity of these enzymes. 
Conclusions: Our results suggest that decreased levels of ACh in MS 
may be related to increased activity of its hydrolytic enzymes. Our 
observations, together with the evidence that AChE inhibitors ameliorate 
the clinical symptoms in experimental autoimmune encephalomyelitis 
(EAE) models, suggest a new possible role for the cholinergic pathway in 
the demyelination and neuroinflammatory process characteristic of MS. 
 
INIM23 Age-related Expression of Cholinergic Markers and 
Cytokines in the Olfactory Bulb of a Rat Model of Alzheimer’s 
Disease 
C. D'Angelo1, M. Reale1, E. Costantini1, M. Di Nicola1, N. Salvador2, L. 
López-Mascaraque2 
1University "G.d'Annunzio", Chieti, Italy; 2Cajal Institute, CSIC, Madrid, 
Spain 
Background: Alzheimer’s disease (AD) is characterized by amyloid 
peptide formation and neurofibrillary tangle deposition, cholinergic 
dysfunction, neuroinflammation, and dementia; however, the interactions 
between these hallmarks remain poorly defined. In AD, impaired olfactory 
function appears earlier than memory loss, personality modification, and 
dementia. The aim of this study was to determine the age-related 
expression of nicotinic acetylcholine receptors, cholinergic enzyme, and 
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inflammatory cytokines and relationship with presence of Aβ in Olfactory 
Bulb (OB) of young and older transgenic mice. 
Methods: Wild-type C57BL/6 and 8- and 24-month old 
APPswe/PSEN1dE9 mice were obtained from Cajal Institute Animal 
House Facility and genotiped by PCR. Behavioral tests were performed to 
test learning and memory abilities. Mice were sacrificed by cervical 
dislocation and the OB was dissected out. Tissue was immunostained to 
detect Aβ plaque burden, and fluorescent images were acquired using a 
confocal laser-scanning microscope. To determine a7nAChR, a4nAChR, 
b2nAChR, AChE, BuChE, MCP-1, IL-1β and TNFα, RT-qPCR 
experiments were performed. 
Results: All cholinergic markers and cytokines analyzed were higher in 
transgenic mice than in wild-type. Aβ plaque load increased with age in 
OB of APPswe/PSEN1dE9 mice. The expression of nAChRs, AChE, 
BuChE, MCP-1 is higher in OB of 6-month old APPswe/PSEN1dE9 mice, 
although the expression of IL1β is lower than in 24-months old mice. In 
OB of 24-month old mice a significant correlation between AChE and 
TNFα was observed. 
Conclusions: In APPswe/PSEN1dE9 mice, Aβ accumulation in OB is 
age-dependent and correlated to AChE and BuChE and cytokine 
expression, suggesting a possible causal relationship between these 
factors. 
 
INIM24 Cytokine Levels and UVr Sensitivity in HaCaT Cells and 
Cetuximab Treated Patients. 
E. Costantini1, C. D'Angelo1, P. Amerio1, M. Reale1, M. De Tursi1, R. 
Muraro1 
1Università degli Studi G.D'Annunzio Chieti-Pescara, Chieti, Italy 
Background: Cetuximab, a chimeric monoclonal anti-EGFR, is used for 
the treatment of colorectal cancer. Cetuximab treatment increases the 
percentage of survival patients, but causes skin reaction of varying 
intensity.  Ultraviolet radiation (UVr) is related to skin response as a result 
of anti-EGFR therapy, with conflicting results. The aims of this study are 
the evaluation of inflammation in cetuximab treated patients and the 
investigation of the UVr effect on cetuximab stimulated keratinocytes. 
Methods: In immortalized human keratinocytes (HaCaT cell line) we 
analyzed the expression and release of cyto/chemokines by real-time 
PCR and ELISA assay after stimulation with serum of cetuximab  treated 
patients and UV irradiation. 
Results: Our results demonstrate that UVr causes significant activation of 
EGFR and an increased expression of proinflammatory interleukins, such 
as IL-1β, IL-6, IL-8, CCL-5 and CL-2 compared to non-exposed cells. IL-
1β, IL-6 and IL-8 serum levels in cetuximab treated patients were higher 
than in healthy controls. Expression of IL-1β, IL-6, IL-8, CCL-5 and CCL-2 
in HaCaT cells cultured with cetuximab treated patients’ serum and 
exposed to UVr was reduced compared to non-exposed cells. 
Conclusions: Cetuxima, promotes the increase of inflammatory cytokines 
and treatment with UV decreases systemic cytokine levels, playing a 
potential immunomodulatory role. Our data seem to rule out that adverse 
skin reactions due to the use of cetuxima, are increased by UV radiation. 
Therefore it is possible to use UV exposure to treat the adverse cutaneous 
reactions to avoid suspension of cetuximab therapy. 
 
INIM25 Circulating Adipokine Levels in Mild Psoriatic Patients 
C. D'Angelo1, E. Costantini1, P. Amerio1, M. Reale1 
1University "G. d'Annunzio", Chieti, Italy 
Background: Increased prevalence of metabolic syndrome in psoriasis 
patients has been reported, and  adipokines, independently or in 
combination with obesity, may be involved in the pathogenesis of 
psoriasis and its comorbidities. Thus, the aim of this study is to compare 
the levels of adipokines in patients with psoriasis and in healthy volunteers 
in relation to their body mass index (BMI), insulin resistance and beta-cell 
function (HOMA). 
Methods: Twenty-two consecutive patients with mild psoriasis assessed 
by PASI admitted to the dermatology outpatient clinic in the School of 
Medicine and 16 age-, sex-, and BMI-matched controls were included in 
the study. Venous blood samples were drawn from the subjects in the 
morning following a 12-h fasting period. Serum HMGB1, HMW-
adiponectin, apelin, visfatin and RBP4 levels were determined by 
commercial ELISA kits, according to the manufacturer’s instructions. 
Results: The mean values of HMW-adiponectin, visfatin and RBP4 were 
higher in psoriasis patients, whereas the mean value of apelin was lower. 
We showed that serum HMGB1 levels were elevated in patients with 
psoriasis compared with those in control subjects. There was not a 
significant linear correlation between adipokines and HMGB1 levels with 
HOMA and BMI. 
Conclusions: We suggest that in patients with mild psoriasis the 
imbalance of  proinflammatory adipokines may contribuite to the 
pathogenesis of the disease and to the potential psoriatic march to 
psoriasis comorbidities. Moreover, the u-regulation of HMW-adiponectin 
might represent a protective mechanism to the inflammatory state present 





MD1 Adipose Tissue Related Adipokines and Cytokines 
Regulate PCSK9 Expression in HepG2 Cells 
M. Ruscica1, M. Botta1, C. Macchi1, C. Songia1, A. Corsini1, P. Magni1, N. 
Ferri2 
1Università degli Studi di Milano, Milan, Italy; 2Università degli Studi di 
Padova, Padua, Italy 
Background: Proprotein convertase subtilisin/kexin type 9 (PCSK9) 
represents a key-regulator pathway for hepatic LDL receptor degradation. 
Clinical and experimental evidence indicates that PCSK9 may be either a 
cause or an effect of metabolic syndrome. PCSK9 levels correlate with 
metabolic syndrome features, namely atherogenic dyslipidemia and 
insulin sensitivity indices.  The aim was to study the possible molecular 
mechanisms linking the effects of cytokines (TNF-α and resistin) and 
adipokines (leptin) on PCSK9 expression and de novo lipogenesis. 
Methods: Human hepatocellular liver carcinoma cell line (HepG2) and 
HepG2 overexpressing PCSK9 (HepG2PCSK9) were used as in vitro 
tools. qPCR, Western blot, ELISA and luciferase reporter assays, together 
with siRNA directed to STAT3 and SOCS3, were used. 
Results: HepG2 expresses leptin (ObRl) and resistin (adenylyl cyclase-
associated protein 1, CAP1) receptors. HepG2PCSK9 expresses higher 
levels of ObRl and CAP1. 24-hour treatment of HepG2 with TNF-α (10 
ng/mL), and  48-h treatment with leptin (200 ng/mL) and resistin (50 
ng/mL) induced the expression of both PCSK9 (2.3-, 2.0- and 3.5-fold, 
respectively) and SOCS3 (3-, 1.8- and 1.9-fold, respectively). TNF-α and 
leptin increased the secretion of PCSK9 (+15% and +20%, respectively) 
but only leptin stimulated PCSK9 promoter activity (+20%). TNF-α, leptin, 
and resistin induced the gene expression of sterol regulatory element-
binding protein 1 (SREBP1), stearoyl-CoA desaturase-1 (SCD-1), fatty 
acid synthase (FAS) and microsomal triglyceride transfer protein (MTP). 
The TNF-α mediated effects were inhibited by transfection with siRNA 
anti-STAT3, suggesting the involvement of the JAK/STAT pathway. 
Conclusions: Proinflammatory cytokines and adipokines upregulate 
PCSK9 expression and the key genes involved in de novo lipogenesis. 
 
MD2 Hepatic Inflammation in Metabolic Syndrome 
E. Albano1, S. Sutti1, S. Bruzzì1, C. Bozzola1 
1University “Amedeo Avogadro” of East Piedmont, Novara, Italy 
Background: Hepatic steatosis, also known as nonalcoholic fatty liver 
disease (NAFLD), is a feature of metabolic syndrome.  Because of the 
increased incidence of obesity and type II diabetes, hepatic steatsosis has 
become the most common chronic liver disease in Western countries, 
affecting up to 30% of the general population.  About 20-30% of NAFLD 
patients develop steatohepatitis, or NASH, that can progress to liver 
fibrosis/cirrhosis. 
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Methods: Although NASH is a recognized leading cause of cirrhosis, the 
mechanisms involved in sustaining hepatic inflammation are still 
incompletely understood. 
Results: Several studies have implicated oxidative stress, inflammasome 
activation, lipotoxicity, and changes in gut microbiota as possible triggers 
of steatohepatitis. However, these factors do not fully account for the large 
inter-individual variability in NAFLD/NASH progression. Growing evidence 
points to the possible role of adaptive immunity as an additional factor in 
promoting hepatic inflammation in NASH. In fact, patients with NASH, but 
not those with steatosis only, are characterized by the presence of 
circulating antibodies and lymphocyte-mediated responses triggered by 
antigens originating from oxidative stress.  Similar immune responses are 
also detectable in experimental models of NASH and interference with 
oxidative stress or helper CD4+ and effector CD8+ T-lymphocytes 
ameliorates steatohepatitis.   In these settings, T-lymphocytes contribute 
to sustain lobular inflammation and fibrosis by stimulating macrophage 
activation as well as by promoting natural killer T-cell recruitment. 
Conclusions: Altogether, these results open the possibility of using 
immune-related markers to detect NAFLD patients at risk of progressing 
to fibrosis/cirrhosis. 
 
MD3 Is it Possible to Change Lifestyle Habits, Prevent 
Disease, and Reduce Health Spending? 
R. Verna1 
1Sapienza University of Rome, Roma, Italy 
Background: In 2016, the estimated Italian public health spending will 
reach 113.2 billion euro, a 1.9% increase compared to 2015. In 2012 it 
was 111 billion, equivalent to 7% of GDP (about 1,867 euro per year per 
inhabitant). Although health expenditure is increasing, the average life 
span is decreasing, even if only slightly. 
Methods: Physical inactivity is a health risk, producing 2 million deaths 
annually worldwide. In particular, physical inactivity is believed to cause 
10-16% of breast cancer, colon cancer, and diabetes cases and 22% of 
heart attacks. Regular physical activity is critical to prevention. 
Results: The health benefits brought by changes in lifestyle habits are 
proven by a 25-year study in which it was shown that change in lifestyle 
has reduced deaths from cardiovascular disease (-68%), stroke (-73% ), 
and cancer (-44%). A more active lifestyle would lead to the prevention of 
at least 2 million premature deaths and 20 million disability-adjusted life 
years (DALYs) in the world. Increasing the number of active people by 
only 1%would save 80 million euro per year in healthcare spending. 
Conclusions: In short: increasing physical activity would improve the 
health of the country, would reduce health spending, would give new 
opportunities of employment, and may also be a small step forward in the 
field of security. 
 
MD4 Serum ACTH in Children Affected with Type 1 Diabetes 
Mellitus: Preliminary Results 
M. Cioffi1, F. Pulcinelli1, A. Alamo1, A. De Rosa1, S. Vacchiano2, M. Vietri2, 
A. Molinari2 
1School of Medicine Specialization Degree Course in Clinical Pathology, 
Naples, Italy; 2UOC Clinical and Molecular Pathology, University Hospital, 
Naples, Italy 
Background: Type 1 Diabetes Mellitus (DM1) is one of the most common 
endocrinopathies in childhood and adolescence, with a higher risk of other 
organ-specific autoimmune disorders, including Addison’s disease (AD).   
AD is a rare condition caused by immune-mediated destruction of the 
adrenal cortex, with a prevalence of about 1.2% in DM1 patients. AD is 
characterized also by increased serum levels of adrenocorticotropic 
hormone (ACTH).    The addisonian crisis can be fatal if not precociously 
recognized and treated because there are no specific symptoms. AD is 
diagnosed by the presence of autoantibodies against 21-hydroxilase (21 
OH-Ab); however, 21 OH-Ab can remain undetected for a few years after 
diagnosis.   Actually, there is no international consensus on screening for 
AD in young patients with DM1. Despite this, some authors are in favour 
of screening. Adrenal function can be evaluated by annually measuring 
serum ACTH, independently of the presence of adrenal autoantibodies. 
Methods: Considering that this topic is still debated, we evaluated serum 
ACTH in 7397 patients admitted to the Paediatric Diabetology Unit from 
2010 to 2015 (mean age 14.08 yrs) affected with DM1 and evaluated 21 
OH-Absin patients with high levels of ACTH. 
Results: Out of 7397 patients affected with DM1, 142 (1.9%) had 
elevated ACTH serum levels, and 5/142 patients with high serum ACTH 
values were positive for 21 OH-Abs (3.5%). 
Conclusions: Considering the severity of Addison’s disease and the 
simple diagnostic assay, we suggest ACTH assessment in DM1 patients . 
 
MD5 β-Glucans and Postprandial Satiety: The Role of 
Gastrointestinal Hormones in Healthy Volunteers 
S. Vasto1, A. Barera1, S. Buscemi1, C. Caruso1, S. Baldassano1 
1University of Palermo, Palermo, Italy 
Background: It is well known that Mediterranean diet can positively 
influence the health of each individual. In particular it is know that fibers 
have an important role. In our study, we considered fibers like β-glucans 
that have been added to pasta aiming to evaluate the effects of β-glucan 
intake on levels of gut hormones known to modulate glucose tolerance 
and food intake through a variety of mechanisms. The effect on gut 
microbiome, known to be involved the pathogenesis of numerous common 
metabolic disorders, was also evaluated. 
Methods: This was a 30±3 days longitudinal, randomized, intervention 
study on the effect of consuming 80 g pasta supplemented with 6% of β-
glucan intake 4 times a week. At the beginning and at the end of the study 
a standardized test meal was administered in order to measure blood 
concentrations of GLP-1, ghrelin, PYY, CCK, and GLP-2. Body weight, 
height and blood pressure of all participants were measured and blood 
samples for haemato-chemical analysis were collected at the beginning 
and at the end of the study. Stool specimens were studied for the 
presence of Lactobacillus fermentum, L. acidophilus, L. salivarius, 
Bifidobacterium longum, and Enterococcus faecium before and after 30 
days of pasta intake. 
Results: Pasta induced a significant increase of plasma GLP-1 ghrelin 
and PYY levels, whereas plasma levels of GLP-2 and CCK were not 
affected. In addition microbiome changes were observed. 
Conclusions: Pasta prepared from barley flour enriched with β-glucan 
exhibited promising responses on gut hormone responses and on 
microbiome modification. Hence, β-glucan enriched pasta may influence 
metabolic diseases such as diabetes and obesity. 
 
REGENERATIVE MEDICINE AND STEM CELLS 
 
RMSC1 Transcriptomic Profile of PKHhigh Multipotent Renal Cells 
for the Identification of a Renal Stem Cell Signature 
C. Meregalli1, S. Bombelli1, G. Rossetti2, V. Ranzani2, B. Torsello1, S. De 
Marco1, G. Bovo3, M. Pagani2, G. Cattoretti1, G. Strada4, C. Bianchi1, R.A. 
Perego1 
1School of Medicine and Surgery, Milano-Bicocca University, Monza, Italy; 
2Istituto Nazionale Genetica Molecolare "Romeo e Enrica Invernizzi", 
Milano, Italy; 3Anatomo-Pathology Unit, San Gerardo Hospital, Monza, 
Italy; 4Urology Unit, Bassini ICP Hospital, Milano, Italy 
Background: In renal tissue the existence and the potential localization of 
an adult stem cell are still debated. We isolated a population of adult renal 
stem cells by sphere forming assay and self-renewal and differentiation 
ability evaluation. We showed that within our nephrospheres the cells with 
stem capacities are PKHhigh/CD133+/CD24-. To better characterize the 
PKHhigh status we aim to find the molecular signature of these cells. 
Methods: Transcriptomic and bioinformatic analysis performed on stem, 
progenitor and differentiated cells. Immunofluorescence performed to 
validate markers at protein level. 
Results: Differentially expressed genes (DEGs) between different cell 
types and exclusive genes for each cell type were evidenced. According 
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to gene set enrichment analysis, our stem cells positively correlated with 
CD133+/CD24+ renal cells and with mammary stem cells; they negatively 
correlated with embryonic stem cells. Therefore, our stem cells were 
similar to other adult stem cells but different from embryonic ones.To 
obtain stem cell signatures we crossed DEGs with stem cell exclusive 
genes and  we selected 4 potential markers for validation based on fold 
change and rare expression in adult renal tissue. 
Conclusions: The stem cell signature will allow localization and 
quantification of adult renal stem cells in normal and disease kidney and 
their direct isolation from tissue by FACS sorting.    
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RMSC2 Bone Demineralization in Space: Don’t Blame 
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Background: Bone demineralization is well documented in astronauts. It 
is a key medical concern and a limiting factor for space exploration. 
Several studies demonstrate that simulated or real microgravity alters the 
balance between osteoblast and osteoclast activity, but less is known 
about the behaviour of human bone mesenchymal stem cells (bMSC) in 
microgravity. bMSC are the precursors of osteoblasts and play an 
important role in the tissue homeostasis and repair after injury. 
Methods: We used the random position machine (RPM) to simulate 
microgravity. We performed a stress protein array to compare cells in the 
RPM vs controls. Cell differentiation was studied by real-time PCR for 
Runt-related transcription factor 2  (RUNX2) and osterix (OSX). Alizarin 
red staining was used to detect calcium deposition. 
Results: We observed the upregulation of the stress proteins HSP60 and 
HSP70, both involved in regulating bMSC performances. In particular, 
HSP70 induces the expression of RUNX2 and OSX, crucial transcriptional 
factor genes for osteogenic differentiation; HSP60 maintains cell viability. 
Indeed, we found that culture in the RPM for 4 days upregulates RUNX2 
and OSX. However, only the addition of an osteogenic cocktail activates 
the full differentiation process both in simulated microgravity and in the 
corresponding control. 
Conclusions: Simulated microgravity does not inhibit bMSC osteogenic 
differentiation in the presence of an osteogenic cocktail, thus suggesting 
that an impairment of the behavior of other bone cells is involved in space-
associated osteopenia. 
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Background: Proline-rich tyrosine kinase 2 (Pyk2) is a calcium and ROS-
sensitive kinase, involved in MAP kinase activation and in actin 
cytoskeleton organization, a critical process for cell migration and tumor 
metastasis. EPN-PKM3 cells, bearing a Pyk2 kinase-negative mutant, 
derived from non-transformed prostate cells (EPN), acquired increased 
cell motility and migration, both hallmarks of an aggressive phenotype. 
The aim of this study was to evaluate the role of Pyk2 in the modulation of 
metabolic machinery of prostate cells. 
Methods: Cell cycle, proliferation, ROS production, autophagy of both cell 
lines were assessed by cytofluorimetric analysis and western blotting. 
Metabolic assays were performed by extracellular flux analyzer. 
Results: Here we found that EPN-PKM3 cells are more glycolytic than 
EPN cells. This phenomenon leads to higher level of intracellular ROS, 
possibly responsible for the slow growth rate of EPN-PKM3 cells. 
Inhibition of glycolysis, by 2-deoxyglucose (2-DG), exerts dual and dose-
dependent effect on EPN and EPN-PKM3 cells. At high concentration (20 
mM), 2-DG-induced glycolysis inhibition leads to cell death in both cell 
lines, whereas low doses (1mM) of 2-DG, although reducing glycolysis 
and ROS production, significantly increases cell proliferation in EPN-
PKM3, but not in EPN wild-type. These events associated with activation 
of the autophagic machinery. Inhibition of autophagy by NH4Cl treatment 
or ULK1 silencing, reverted the effects of 1mM 2-DG, indicating that 2-DG 
increased proliferative rate of EPN-PKM3 cells is dependent on 
autophagy. 
Conclusions: Taken together these data suggest that Pyk2 is involved in 
metabolic control of prostate cell proliferation through modulation of 
autophagic machinery and ROS release. 
 
TOP2 Rare Hemoglobin Variants  
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Background: The consolidation of laboratory activities optimizes 
resources and improves the expertise of the staff that encounter rare and 
exceptional cases. In the recent years, the Romagna Greater Area 
Laboratory, which provides diagnostic services to over a million 
inhabitants in North Italy, detected two hemoglobin (Hb) variants 
investigating an alarm of Sysmex Hematology Analyzers. 
Methods: Cell blood count was carried out using XE-2100 and XS-1000 
Sysmex Hematology Analyzers. Blood smear morphology was examined, 
after May-Grunwald Giemsa staining, with Olympus BX41 microscope. 
High performance liquid chromatography (HPLC) was performed by 
Tosoh-G8 system. Molecular analysis was performed by direct 
sequencing of the β-globin gene (HBB) on ABI PRISM 3130xl Sequencing 
Analyzer. 
Results: From January 2013 to May 2016 14 patients were detected with 
a reduced fluorescence signal in the DIFF graph of XE-2100 and XS-
1000. All patients presented with irregular contracted red cells and target 
cells in the blood smear. HPLC detected the presence of Hb variants in all 
these cases; molecular analysis was performed in 4 of them, revealing the 
presence of Hb Leiden and Hb G-Ferrara. 
Conclusions: Our findings demonstrate that it is necessary to investigate 
samples with a persistent low fluorescence signal in DIFF graph when 
assayed using Sysmex analyzers. Heterozygotes for the Hb variants 
identified in this manner are asymptomatic but in specific clinical settings 
combined with other Hb variants could experience complications. The 
reported cases confirm the important role of tight integration between 
huge routine workload and specialized competence for the assessment of 
unusual patterns. 
 
TOP3 Characterization of Parotid Gland Epithelial Cell Primary 
Cultures from Patients Affected by Sjögren’s Syndrome 
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De Vita1, F. Curcio1 
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Background: It is well known that it is very difficult to obtain a primary 
culture of parotid gland epithelial cells (PGEC) isolated from patients 
affected by Sjögren’s Syndrome (SjS). Nonetheless. primary cultures of 
PGEC represent a unique opportunity to study the pathogenesis of this 
complex disease. 
Methods: Parotid gland biopsies were obtained from four patients with 
SjS diagnosed at the Clinic of Rheumatology of Udine. Tissue fragments 
underwent microdissection  and enzymatic digestion. Cells were then 
collected and seeded in 100-mm culture dishes. The culture medium 
consisted of F12 and M199 (1:1) supplemented with antibiotics, fetal 
bovine serum (FBS; 3 to 5%), freshly frozen bovine hypothalamus and 
pituitary extracts, epidermal growth factor, and a particular mixture of 
hormones designated 5H. Histologic characterization was performed by 
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immunofluorescence on cell monolayer. Cytokeratin 7 (CK7), vimentin, E-
cadherin and smooth muscular actin (SMA) expression were investigated. 
Results: In all four cases, a stable PGEC culture was obtained. 
Morphologically, cells appeared as a mixed epithelial- fibroblast 
population. From the second passage on, by adjusting FBS, bovine 
extracts and hormones concentrations, it was possible to obtain a 
population enriched in epithelial/myoepithelial cells, as demonstrated by 
the expression of CK7, E-cadherin and SMA. 
Conclusions: Several fundamental factors are implicated in isolation and 
survival of PGEC, including tissue fragment selection and media 
composition. We were able to stabilize PGEC in culture for at least three 
passages, maintaining their phenotypic and morphologic features. Our 
approach may be very useful for future studies. 
 
TOP4 Plasticity in Endothelial Cells and Endothelial Progenitor 
Cells: uPAR-mediated Amoeboid Angiogenesis 
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Rosso1 
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Background: Mesenchymal migration requires the activity of extracellular 
matrix (ECM) degrading proteases and depends on Rac-driven actin 
cytoskeleton contractility, while amoeboid motility is a Rho-ROCK-
dependent movement, which allows cells to glide through, rather than 
degrade, ECM barriers. Here we show that mature endothelial cells (ECs) 
and endothelial progenitor cells (EPCs) are able to migrate by 
mesenchymal and amoeboid style. We used a cocktail of physiologic 
inhibitors (Ph-C) of serine-proteases, metallo-proteases and cysteine-
proteases, thus mimicking the physiological environment that ECs and 
EPCs encounter during their migration within the angiogenesis sites. 
Methods: To evaluate the mesenchymal-ameboid transition we 
performed RhoA and Rac1 activation assay, immunofluorescence 
analysis of proteins involved in cytoskeleton organization. Cell invasion 
was studied in Boyden chambers. 
Results: RhoA and Rac1 activation assay showed, in both EPCs and 
HMVECs, a decrease of activated Rac1 and an increase of activated 
RhoA upon shifting of cells to the amoeboid conditions. Then we showed 
that under Ph-C inhibition both cell lines acquired a round morphology and 
showed a Matrigel invasion that was greatly enhanced with respect to that 
observed in the absence of protease inhibition. We didn’t see differences 
in tubular-like structures formation under mesenchymal or amoeboid 
conditions. uPAR silencing and uPAR-integrin uncoupling with the M25 
peptide abolished both mesenchymal and amoeboid angiogenesis of ECs 
and EPCs, indicating a role of the uPAR-integrin-actin axis in the 
regulation of amoeboid angiogenesis. 
Conclusions: The receptor of the urokinase plasminogen activator 
receptor (uPAR) is indispensable for ECs and EPCs to perform an 
efficient amoeboid angiogenesis, in terms of cell migration and capillary 
morphogenesis. 
 
TOP5 Hsp90, Thioredoxin, and Thioredoxin Reductase Form a 
Chaperone-Redox Machinery Enabling the Catalytic Activity of 
Clostridial Neurotoxins inside Nerve Terminals 
M. Pirazzini1, D. Azarnia Tehran1, G. Zanetti1, O. Leka1, A. Mattarei1, F. 
Lista2, T. Binz3, O. Rossetto1, C. Montecucco1 
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Background: Clostridial neurotoxins (CNTs) are the etiologic agents of 
botulism and tetanus. They are composed of a metalloprotease light chain 
(L) linked via a disulfide bond to a heavy chain (H). H mediates the 
binding to nerve terminals and the membrane translocation of L into the 
cytosol, where its substrates, the three SNARE proteins, are localized. 
Translocation is accompanied by unfolding of L that, once delivered on the 
cytosolic side of the endosome membrane, has to be reduced and 
refolded into the native structure for protease activity. 
Methods: Use of inhibitors of the thioredoxin-thioredoxin reductase 
system (TrxR-Trx) and of Hsp90 in vitro and in vivo. Brain 
subfractionation. Synaptic vesicle immunoisolation. Immunoblotting. 
Immunohistochemistry. Immunoprecipitation. 
Results: TrxR-Trx is responsible for the reduction of the interchain 
disulphide bond. Hsp90 aids L in reacquiring a cleavage-competent 
folding.  CNTs toxicity is potently hampered by inhibitors of TrxR-Trx or of 
Hsp90 in vitro and in vivo, which strongly synergise, suggesting that the 
processes of L chain refolding and interchain disulphide reduction are 
strictly coupled. TrxR-Trx and Hsp90 physically interact on synaptic 
vesicles, the organelles from which L translocates in the cytosol 
Conclusions: TrxR-Trx and Hsp90 orchestrate a chaperone-redox 
machinery which is exploited by CNTs to deliver and activate their 
catalytic part in the cytosol. This clue offers a rational target for the 
development of new antitoxins. 
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Background: Thyroid nodules occur in over 50% of the Italian population. 
In thyroid, H2O2 is largely produced and DNA lesions, generated by ROS 
excess, are physiologically removed by the BER system. Since EGF is a 
physiological regulator of thyroid functions, this study investigated the 
effect of oxidative stress on EGFR and BER signaling in goiter. 
Methods: Normal human thyroid cells, Nthy-ori3-1, were treated with 
H2O2, EGF, LY294002, and PD98059 alone and in combination. Goiter 
tissues were obtained from patients undergoing thyroidectomy. EGFR and 
BER pathways were analyzed by Western blot and RT-qPCR. 
Results: A time-dependent increase of OGG1 and MUTYH gene 
expression was observed after H2O2 treatment and was reversed by EGF 
and LY294002 alone or combined with H2O2. EGF and LY294002 induced 
EGFR overexpression, alone and combined with H2O2. H2O2 treatment, 
alone or combined with EGF, LY294002, and PD98059 resulted in 
increased EGFR and MAPK activation. In addition, H2O2, alone and 
combined with EGF, induced a rapid increase of ErbB2 gene expression, 
while LY294002, alone and combined with H2O2, reduced its expression. 
Surprisingly, PD98059 enhanced ErbB2 expression compared to H2O2-
treated and control cells. Tissue analysis showed a strong individual 
variability among patients. Preliminary data displayed a downregulation of 
OGG1 in pathologic tissue compared to control. The opposite trend was 
observed with the Nrf2 gene. 
Conclusions: These results indicate that EGFR and ErbB2 are 
upregulated in response to oxidative stress,  suggesting an Akt-dependent 
mechanism. Our observations present the first evidence that pronounced 
H2O2 tress may directly interact with ErbB2 and BER downstream 
signaling. 
 
 
